BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C, Armstrong D, Marshall JK, Kassam Z, Reinisch W, Lee CH. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology. 2015;149:102-109.e6. [PMID: 25857665 DOI: 10.1053/j.gastro.2015.04.001] [Cited by in Crossref: 733] [Cited by in F6Publishing: 770] [Article Influence: 104.7] [Reference Citation Analysis]
Number Citing Articles
1 Boix-amorós A, Monaco H, Sambataro E, Clemente JC. Novel technologies to characterize and engineer the microbiome in inflammatory bowel disease. Gut Microbes 2022;14:2107866. [DOI: 10.1080/19490976.2022.2107866] [Reference Citation Analysis]
2 Huang H, Zhu J, Yang L, Wu Q, Shou D, Chen H, Ma J, Li Y, Xu H, Zhou Y, Aqib AI. Fecal Microbiota Transplantation Combined with a Low FODMAP Diet for the Treatment of Irritable Bowel Syndrome with Predominant Diarrhea. Oxidative Medicine and Cellular Longevity 2022;2022:1-24. [DOI: 10.1155/2022/5121496] [Reference Citation Analysis]
3 Singh A, Mahajan R, Kahlon BK, Dhaliwal AS, Midha V, Mehta V, Bansal N, Singh D, Sood A. Early fecal microbiome transfer after donor defecation determines response in patients with moderate to severe ulcerative colitis. Indian J Gastroenterol 2022. [PMID: 36121613 DOI: 10.1007/s12664-022-01257-0] [Reference Citation Analysis]
4 Ianiro G, Punčochář M, Karcher N, Porcari S, Armanini F, Asnicar F, Beghini F, Blanco-míguez A, Cumbo F, Manghi P, Pinto F, Masucci L, Quaranta G, De Giorgi S, Sciumè GD, Bibbò S, Del Chierico F, Putignani L, Sanguinetti M, Gasbarrini A, Valles-colomer M, Cammarota G, Segata N. Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases. Nat Med. [DOI: 10.1038/s41591-022-01964-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang T, Zhang B, Tian W, Wang F, Zhang J, Ma X, Wei Y, Tang X. Research trends in ulcerative colitis: A bibliometric and visualized study from 2011 to 2021. Front Pharmacol 2022;13:951004. [DOI: 10.3389/fphar.2022.951004] [Reference Citation Analysis]
6 Chen B, Collen LV, Mowat C, Isaacs KL, Singh S, Kane SV, Loftus EV Jr, Farraye FA, Snapper S, Jneid H, Lavie CJ, Krittanawong C. Inflammatory bowel disease and cardiovascular diseases. Am J Med 2022:S0002-9343(22)00633-7. [PMID: 36058305 DOI: 10.1016/j.amjmed.2022.08.012] [Reference Citation Analysis]
7 Zhang P. Influence of Foods and Nutrition on the Gut Microbiome and Implications for Intestinal Health. IJMS 2022;23:9588. [DOI: 10.3390/ijms23179588] [Reference Citation Analysis]
8 Piazzesi A, Putignani L. Extremely small and incredibly close: Gut microbes as modulators of inflammation and targets for therapeutic intervention. Front Microbiol 2022;13:958346. [DOI: 10.3389/fmicb.2022.958346] [Reference Citation Analysis]
9 Wang M, Xie X, Zhao S, Han W, Zhang Y. Global research trends and hotspots of fecal microbiota transplantation: A bibliometric and visualization study. Front Microbiol 2022;13:990800. [DOI: 10.3389/fmicb.2022.990800] [Reference Citation Analysis]
10 Kedia S, Virmani S, K Vuyyuru S, Kumar P, Kante B, Sahu P, Kaushal K, Farooqui M, Singh M, Verma M, Bajaj A, Markandey M, Sachdeva K, Das P, Makharia GK, Ahuja V. Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial. Gut 2022:gutjnl-2022-327811. [PMID: 35973787 DOI: 10.1136/gutjnl-2022-327811] [Reference Citation Analysis]
11 Ciccia F, Gandolfo S. Will fecal microbiota transplantation eventually be an effective therapeutic strategy for systemic lupus erythematosus? Clin Immunol 2022;242:109096. [PMID: 35973639 DOI: 10.1016/j.clim.2022.109096] [Reference Citation Analysis]
12 Huang C, Huang Z, Ding L, Fu Y, Fan J, Mei Q, Lou L, Wang J, Yin N, Lu Y, Guo S, Zeng Y. Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis. J Transl Med 2022;20:354. [PMID: 35962454 DOI: 10.1186/s12967-022-03569-3] [Reference Citation Analysis]
13 He L, Chen R, Zhang B, Zhang S, Khan BA, Zhu D, Wu Z, Xiao C, Chen B, Chen F, Hou K. Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes mellitus. Front Immunol 2022;13:930872. [DOI: 10.3389/fimmu.2022.930872] [Reference Citation Analysis]
14 Fernandes D, Andreyev J. The Role of the Human Gut Microbiome in Inflammatory Bowel Disease and Radiation Enteropathy. Microorganisms 2022;10:1613. [DOI: 10.3390/microorganisms10081613] [Reference Citation Analysis]
15 Petersen AM. Gastrointestinal dysbiosis and Escherichia coli pathobionts in inflammatory bowel diseases. APMIS 2022;130 Suppl 144:1-38. [PMID: 35899316 DOI: 10.1111/apm.13256] [Reference Citation Analysis]
16 Huang T, Xu J, Wang M, Pu K, Li L, Zhang H, Liang Y, Sun W, Wang Y. An updated systematic review and meta-analysis of fecal microbiota transplantation for the treatment of ulcerative colitis. Medicine (Baltimore) 2022;101:e29790. [PMID: 35905229 DOI: 10.1097/MD.0000000000029790] [Reference Citation Analysis]
17 Haifer C, Luu LDW, Paramsothy S, Borody TJ, Leong RW, Kaakoush NO. Microbial determinants of effective donors in faecal microbiota transplantation for UC. Gut 2022:gutjnl-2022-327742. [PMID: 35879048 DOI: 10.1136/gutjnl-2022-327742] [Reference Citation Analysis]
18 Buhaș MC, Gavrilaș LI, Candrea R, Cătinean A, Mocan A, Miere D, Tătaru A. Gut Microbiota in Psoriasis. Nutrients 2022;14:2970. [DOI: 10.3390/nu14142970] [Reference Citation Analysis]
19 Biazzo M, Deidda G. Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases. J Clin Med 2022;11:4119. [PMID: 35887883 DOI: 10.3390/jcm11144119] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Inamura K, Hamada T, Bullman S, Ugai T, Yachida S, Ogino S. Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science. Gut 2022:gutjnl-2022-327209. [PMID: 35820782 DOI: 10.1136/gutjnl-2022-327209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Tan XY, Xie YJ, Liu XL, Li XY, Jia B. A Systematic Review and Meta-Analysis of Randomized Controlled Trials of Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease. Evid Based Complement Alternat Med 2022;2022:8266793. [PMID: 35795291 DOI: 10.1155/2022/8266793] [Reference Citation Analysis]
22 Gubatan J, Boye TL, Temby M, Sojwal RS, Holman DR, Sinha SR, Rogalla SR, Nielsen OH. Gut Microbiome in Inflammatory Bowel Disease: Role in Pathogenesis, Dietary Modulation, and Colitis-Associated Colon Cancer. Microorganisms 2022;10:1371. [DOI: 10.3390/microorganisms10071371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Xu X, Ying J. Gut Microbiota and Immunotherapy. Front Microbiol 2022;13:945887. [DOI: 10.3389/fmicb.2022.945887] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Gulliver EL, Young RB, Chonwerawong M, D'Adamo GL, Thomason T, Widdop JT, Rutten EL, Rossetto Marcelino V, Bryant RV, Costello SP, O'Brien CL, Hold GL, Giles EM, Forster SC. Review article: the future of microbiome-based therapeutics. Aliment Pharmacol Ther 2022;56:192-208. [PMID: 35611465 DOI: 10.1111/apt.17049] [Reference Citation Analysis]
25 Mazzawi T. Gut Microbiota Manipulation in Irritable Bowel Syndrome. Microorganisms 2022;10:1332. [DOI: 10.3390/microorganisms10071332] [Reference Citation Analysis]
26 El Hage Chehade N, Ghoneim S, Shah S, Chahine A, Mourad FH, Francis FF, Binion DG, Farraye FA, Hashash JG. Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Inflamm Bowel Dis 2022:izac135. [PMID: 35766805 DOI: 10.1093/ibd/izac135] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Wang X, Zhao J, Feng Y, Feng Z, Ye Y, Liu L, Kang G, Cao X. Evolutionary Insights Into Microbiota Transplantation in Inflammatory Bowel Disease. Front Cell Infect Microbiol 2022;12:916543. [DOI: 10.3389/fcimb.2022.916543] [Reference Citation Analysis]
28 Zhu R, Tang J, Xing C, Nan Q, Liang G, Luo J, Zhou J, Miao Y, Cao Y, Dai S, Lan D. The Distinguishing Bacterial Features From Active and Remission Stages of Ulcerative Colitis Revealed by Paired Fecal Metagenomes. Front Microbiol 2022;13:883495. [DOI: 10.3389/fmicb.2022.883495] [Reference Citation Analysis]
29 Watane A, Raolji S, Cavuoto K, Galor A. Microbiome and immune-mediated dry eye: a review. BMJ Open Ophth 2022;7:e000956. [DOI: 10.1136/bmjophth-2021-000956] [Reference Citation Analysis]
30 Qu Z, Tian P, Yang B, Zhao J, Wang G, Chen W. Fecal microbiota transplantation for diseases: Therapeutic potential, methodology, risk management in clinical practice. Life Sci 2022;304:120719. [PMID: 35716734 DOI: 10.1016/j.lfs.2022.120719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Rashed R, Valcheva R, Dieleman LA. Manipulation of Gut Microbiota as a Key Target for Crohn's Disease. Front Med 2022;9:887044. [DOI: 10.3389/fmed.2022.887044] [Reference Citation Analysis]
32 Hui Y, Vestergaard G, Deng L, Kot WP, Thymann T, Brunse A, Nielsen DS. Donor-dependent fecal microbiota transplantation efficacy against necrotizing enterocolitis in preterm pigs. NPJ Biofilms Microbiomes 2022;8:48. [PMID: 35680942 DOI: 10.1038/s41522-022-00310-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Pu D, Zhang Z, Feng B. Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases. Front Pharmacol 2022;13:906419. [DOI: 10.3389/fphar.2022.906419] [Reference Citation Analysis]
34 Huang C, Mei Q, Lou L, Huang Z, Fu Y, Fan J, Wang J, Yin N, Zheng Y, Lu Y, Zeng Y. Ulcerative Colitis in Response to Fecal Microbiota Transplantation via Modulation of Gut Microbiota and Th17/Treg Cell Balance. Cells 2022;11:1851. [DOI: 10.3390/cells11111851] [Reference Citation Analysis]
35 Facciotti F. Modulation of intestinal immune cell responses by eubiotic or dysbiotic microbiota in inflammatory bowel diseases. PharmaNutrition 2022. [DOI: 10.1016/j.phanu.2022.100303] [Reference Citation Analysis]
36 Chen C, Chen L, Sun D, Li C, Xi S, Ding S, Luo R, Geng Y, Bai Y. Adverse events of intestinal microbiota transplantation in randomized controlled trials: a systematic review and meta-analysis. Gut Pathog 2022;14:20. [PMID: 35619175 DOI: 10.1186/s13099-022-00491-3] [Reference Citation Analysis]
37 Caira-Chuquineyra B, Fernandez-Guzman D, Soriano-Moreno DR, Fernandez-Morales J, Flores-Lovon K, Medina-Ramírez SA, Gonzales-Uribe AG, Pelayo-Luis IP, Gonzales-Zamora JA, Huaringa-Marcelo J. Fecal Microbiota Transplantation for People Living with Human Immunodeficiency Virus: A Scoping Review. AIDS Res Hum Retroviruses 2022. [PMID: 35451337 DOI: 10.1089/AID.2022.0016] [Reference Citation Analysis]
38 Takáčová M, Bomba A, Tóthová C, Micháľová A, Turňa H. Any Future for Faecal Microbiota Transplantation as a Novel Strategy for Gut Microbiota Modulation in Human and Veterinary Medicine? Life 2022;12:723. [DOI: 10.3390/life12050723] [Reference Citation Analysis]
39 Joachim A, Schwerd T, Hölz H, Sokollik C, Konrad LA, Jordan A, Lanzersdorfer R, Schmidt-Choudhury A, Hünseler C, Adam R. [Fecal Microbiota Transfer (FMT) in Children and Adolescents - Review and statement by the GPGE microbiome working group]. Z Gastroenterol 2022. [PMID: 35533688 DOI: 10.1055/a-1801-0284] [Reference Citation Analysis]
40 Wu Z, Liu D, Deng F. The Role of Vitamin D in Immune System and Inflammatory Bowel Disease. JIR 2022;Volume 15:3167-85. [DOI: 10.2147/jir.s363840] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Wang B, Zhang L, Wang Y, Dai T, Qin Z, Zhou F, Zhang L. Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal Transduct Target Ther 2022;7:143. [PMID: 35487886 DOI: 10.1038/s41392-022-00986-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
42 Shang L, Tu J, Dai Z, Zeng X, Qiao S. Microbiota Transplantation in an Antibiotic-Induced Bacterial Depletion Mouse Model: Reproducible Establishment, Analysis, and Application. Microorganisms 2022;10:902. [PMID: 35630347 DOI: 10.3390/microorganisms10050902] [Reference Citation Analysis]
43 Zhang WH, Jin ZY, Yang ZH, Zhang JY, Ma XH, Guan J, Sun BL, Chen X. Fecal Microbiota Transplantation Ameliorates Active Ulcerative Colitis by Downregulating Pro-inflammatory Cytokines in Mucosa and Serum. Front Microbiol 2022;13:818111. [PMID: 35444617 DOI: 10.3389/fmicb.2022.818111] [Reference Citation Analysis]
44 Cruz N, Abernathy GA, Dichosa AEK, Kumar A. The Age of Next-Generation Therapeutic-Microbe Discovery: Exploiting Microbe-Microbe and Host-Microbe Interactions for Disease Prevention. Infect Immun 2022;:e0058921. [PMID: 35384688 DOI: 10.1128/iai.00589-21] [Reference Citation Analysis]
45 Yuan TY, Rajesh R, Tan M. Oral faecal microbiota transplantation in ulcerative colitis. The Lancet Gastroenterology & Hepatology 2022;7:286. [DOI: 10.1016/s2468-1253(21)00469-6] [Reference Citation Analysis]
46 Li M, Yang L, Mu C, Sun Y, Gu Y, Chen D, Liu T, Cao H. Gut Microbial Metabolome in Inflammatory Bowel Disease: from Association to Therapeutic Perspectives. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.03.038] [Reference Citation Analysis]
47 Smith BJ, Piceno Y, Zydek M, Zhang B, Syriani LA, Terdiman JP, Kassam Z, Ma A, Lynch SV, Pollard KS, El-Nachef N. Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis. Sci Rep 2022;12:5517. [PMID: 35365713 DOI: 10.1038/s41598-022-09307-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Thomas JP, Modos D, Rushbrook SM, Powell N, Korcsmaros T. The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease. Front Immunol 2022;13:829525. [PMID: 35185922 DOI: 10.3389/fimmu.2022.829525] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
49 Zhong Y, Cao J, Ma Y, Zhang Y, Liu J, Wang H. Fecal Microbiota Transplantation Donor and Dietary Fiber Intervention Collectively Contribute to Gut Health in a Mouse Model. Front Immunol 2022;13:842669. [PMID: 35185934 DOI: 10.3389/fimmu.2022.842669] [Reference Citation Analysis]
50 Bagheri Z, Moeinzadeh L, Razmkhah M. Roles of Microbiota in Cancer: From Tumor Development to Treatment. J Oncol 2022;2022:3845104. [PMID: 35342407 DOI: 10.1155/2022/3845104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Santana PT, Rosas SLB, Ribeiro BE, Marinho Y, de Souza HSP. Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets. Int J Mol Sci 2022;23:3464. [PMID: 35408838 DOI: 10.3390/ijms23073464] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 10.0] [Reference Citation Analysis]
52 Halaweish HF, Boatman S, Staley C. Encapsulated Fecal Microbiota Transplantation: Development, Efficacy, and Clinical Application. Front Cell Infect Microbiol 2022;12:826114. [DOI: 10.3389/fcimb.2022.826114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Ishikawa D, Zhang X, Nomura K, Seki N, Haraikawa M, Haga K, Shibuya T, Kim YG, Nagahara A. A Randomized Placebo-Controlled Trial of Combination Therapy With Post-triple-antibiotic-therapy Fecal Microbiota Transplantation and Alginate for Ulcerative Colitis: Protocol. Front Med (Lausanne) 2022;9:779205. [PMID: 35273972 DOI: 10.3389/fmed.2022.779205] [Reference Citation Analysis]
54 Chen L, Wang J. Gut microbiota and inflammatory bowel disease. WIREs Mech Dis 2022;14:e1540. [PMID: 35266651 DOI: 10.1002/wsbm.1540] [Reference Citation Analysis]
55 Ni Q, Zhang P, Li Q, Han Z. Oxidative Stress and Gut Microbiome in Inflammatory Skin Diseases. Front Cell Dev Biol 2022;10:849985. [DOI: 10.3389/fcell.2022.849985] [Reference Citation Analysis]
56 Underhill DM, Braun J. Fungal microbiome in inflammatory bowel disease: a critical assessment. J Clin Invest 2022;132:e155786. [PMID: 35229726 DOI: 10.1172/JCI155786] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
57 Dizman N, Meza L, Bergerot P, Alcantara M, Dorff T, Lyou Y, Frankel P, Cui Y, Mira V, Llamas M, Hsu J, Zengin Z, Salgia N, Salgia S, Malhotra J, Chawla N, Chehrazi-Raffle A, Muddasani R, Gillece J, Reining L, Trent J, Takahashi M, Oka K, Higashi S, Kortylewski M, Highlander SK, Pal SK. Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. Nat Med 2022. [PMID: 35228755 DOI: 10.1038/s41591-022-01694-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 20.0] [Reference Citation Analysis]
58 Stallmach A, Grunert P, Stallhofer J, Löffler B, Baier M, Rödel J, Kiehntopf M, Neugebauer S, Pieper DH, Junca H, Tannapfel A, Merkel U, Schumacher U, Breternitz-Gruhne M, Heller T, Schauer A, Hartmann M, Steube A. Transfer of FRozen Encapsulated multi-donor Stool filtrate for active ulcerative Colitis (FRESCO): study protocol for a prospective, multicenter, double-blind, randomized, controlled trial. Trials 2022;23:173. [PMID: 35193638 DOI: 10.1186/s13063-022-06095-1] [Reference Citation Analysis]
59 Qiu P, Ishimoto T, Fu L, Zhang J, Zhang Z, Liu Y. The Gut Microbiota in Inflammatory Bowel Disease. Front Cell Infect Microbiol 2022;12:733992. [DOI: 10.3389/fcimb.2022.733992] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
60 Metwaly A, Reitmeier S, Haller D. Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders. Nat Rev Gastroenterol Hepatol. [DOI: 10.1038/s41575-022-00581-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
61 Luo H, Cao G, Luo C, Tan D, Vong CT, Xu Y, Wang S, Lu H, Wang Y, Jing W. Emerging Pharmacotherapy for Inflammatory Bowel Diseases. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
62 Khan R, Roy N, Ali H, Naeem M, Sakai E. Fecal Microbiota Transplants for Inflammatory Bowel Disease Treatment: Synthetic- and Engineered Communities-Based Microbiota Transplants Are the Future. Gastroenterology Research and Practice 2022;2022:1-9. [DOI: 10.1155/2022/9999925] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Bourdiol A, Roquilly A. New Insights in the Pathophysiology of Hospital- and Ventilator-Acquired Pneumonia: A Complex Interplay between Dysbiosis and Critical-Illness-Related Immunosuppression. Semin Respir Crit Care Med 2022. [PMID: 35100649 DOI: 10.1055/s-0041-1740606] [Reference Citation Analysis]
64 Gweon TG, Lee YJ, Kim KO, Yim SK, Soh JS, Kim SY, Park JJ, Shin SY, Lee TH, Choi CH, Cho YS, Yong D, Chung JW, Lee KJ, Lee OY, Choi MG, Choi M; Gut Microbiota and Therapy Research Group Under the Korean Society of Neurogastroenterology and Motility. Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea. J Neurogastroenterol Motil 2022;28:28-42. [PMID: 34980687 DOI: 10.5056/jnm21221] [Reference Citation Analysis]
65 Guo X, Huang C, Xu J, Xu H, Liu L, Zhao H, Wang J, Huang W, Peng W, Chen Y, Nie Y, Zhou Y, Zhou Y. Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease. Front Nutr 2022;8:818902. [DOI: 10.3389/fnut.2021.818902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
66 Su L, Hong Z, Zhou T, Jian Y, Xu M, Zhang X, Zhu X, Wang J. Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation. Sci Rep 2022;12:1152. [PMID: 35064189 DOI: 10.1038/s41598-022-05127-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
67 Merrick B, Tamilarasan AG, Luber R, Yong PFK, Cheent K, Irving PM, Meda M, Goldenberg SD. Recurrent Campylobacter jejuni Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)—A Case Report. Infectious Disease Reports 2022;14:56-62. [DOI: 10.3390/idr14010007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Cai Z, Wang S, Li J. Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Front Med (Lausanne) 2021;8:765474. [PMID: 34988090 DOI: 10.3389/fmed.2021.765474] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
69 Chen R, Zheng J, Li L, Li C, Chao K, Zeng Z, Chen M, Zhang S. Metabolomics facilitate the personalized management in inflammatory bowel disease. Therap Adv Gastroenterol 2021;14:17562848211064489. [PMID: 34987610 DOI: 10.1177/17562848211064489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Sorbara MT, Pamer EG. Microbiome-based therapeutics. Nat Rev Microbiol 2022. [PMID: 34992261 DOI: 10.1038/s41579-021-00667-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 19.0] [Reference Citation Analysis]
71 Tkach S, Dorofeyev A, Kuzenko I, Boyko N, Falalyeyeva T, Boccuto L, Scarpellini E, Kobyliak N, Abenavoli L. Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation. Medicina (Kaunas) 2022;58:84. [PMID: 35056392 DOI: 10.3390/medicina58010084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
72 Lavelle A, Nancey S, Reimund JM, Laharie D, Marteau P, Treton X, Allez M, Roblin X, Malamut G, Oeuvray C, Rolhion N, Dray X, Rainteau D, Lamaziere A, Gauliard E, Kirchgesner J, Beaugerie L, Seksik P, Peyrin-Biroulet L, Sokol H. Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer. Gut Microbes 2022;14:2078620. [PMID: 35638103 DOI: 10.1080/19490976.2022.2078620] [Reference Citation Analysis]
73 Servetas SL, Daschner PJ, Guyard C, Thomas V, Affagard H, Sergaki C, Sokol H, Wargo JA, Wu GD, Sabot P. Evolution of FMT – From early clinical to standardized treatments. Biologicals 2022. [DOI: 10.1016/j.biologicals.2022.01.004] [Reference Citation Analysis]
74 Watane A, Cavuoto KM, Rojas M, Dermer H, Day JO, Banerjee S, Galor A. Fecal Microbial Transplant in Individuals With Immune-Mediated Dry Eye. Am J Ophthalmol 2022;233:90-100. [PMID: 34214453 DOI: 10.1016/j.ajo.2021.06.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
75 He R, Li P, Wang J, Cui B, Zhang F, Zhao F. The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation. Gut Microbes 2022;14:2100197. [PMID: 35854629 DOI: 10.1080/19490976.2022.2100197] [Reference Citation Analysis]
76 Arnauts K, Sudhakar P, Verstockt S, Lapierre C, Potche S, Caenepeel C, Verstockt B, Raes J, Vermeire S, Sabino J, Verfaillie C, Ferrante M. Microbiota, not host origin drives ex vivo intestinal epithelial responses. Gut Microbes 2022;14:2089003. [PMID: 35758256 DOI: 10.1080/19490976.2022.2089003] [Reference Citation Analysis]
77 Hu Y, Ye Z, Wu M, She Y, Li L, Xu Y, Qin K, Hu Z, Yang M, Lu F, Ye Q. The Communication Between Intestinal Microbiota and Ulcerative Colitis: An Exploration of Pathogenesis, Animal Models, and Potential Therapeutic Strategies. Front Med (Lausanne) 2021;8:766126. [PMID: 34966755 DOI: 10.3389/fmed.2021.766126] [Reference Citation Analysis]
78 Chen S, Luo S, Yan C. Gut Microbiota Implications for Health and Welfare in Farm Animals: A Review. Animals (Basel) 2021;12:93. [PMID: 35011199 DOI: 10.3390/ani12010093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Boscaini S, Leigh SJ, Lavelle A, García-Cabrerizo R, Lipuma T, Clarke G, Schellekens H, Cryan JF. Microbiota and body weight control: Weight watchers within? Mol Metab 2021;:101427. [PMID: 34973469 DOI: 10.1016/j.molmet.2021.101427] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
80 Balan Y, Gaur A, Sakthivadivel V, Kamble B, Sundaramurthy R. Is the Gut Microbiota a Neglected Aspect of Gut and Brain Disorders? Cureus 2021;13:e19740. [PMID: 34938619 DOI: 10.7759/cureus.19740] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Kim JY, Choi MJ, Ha S, Hwang J, Koyanagi A, Dragioti E, Radua J, Smith L, Jacob L, de Pablo GS, Lee SW, Yon DK, Thompson T, Cortese S, Lollo G, Liang CS, Chu CS, Fusar-Poli P, Cheon KA, Shin JI, Solmi M. Association between autism spectrum disorder and inflammatory bowel disease: A systematic review and meta-analysis. Autism Res 2021. [PMID: 34939353 DOI: 10.1002/aur.2656] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
82 Pan Q, Guo F, Huang Y, Li A, Chen S, Chen J, Liu HF, Pan Q. Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies. Front Immunol 2021;12:799788. [PMID: 34925385 DOI: 10.3389/fimmu.2021.799788] [Reference Citation Analysis]
83 Zhang Y, Xue X, Su S, Zhou H, Jin Y, Shi Y, Lin J, Wang J, Li X, Yang G, Philpott JR, Liang J. Patients and physicians' attitudes change on fecal microbiota transplantation for inflammatory bowel disease over the past 3 years. Ann Transl Med 2021;9:1619. [PMID: 34926663 DOI: 10.21037/atm-21-3683] [Reference Citation Analysis]
84 Yao D, Dai W, Dong M, Dai C, Wu S. MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis. EBioMedicine 2021;74:103751. [PMID: 34902790 DOI: 10.1016/j.ebiom.2021.103751] [Reference Citation Analysis]
85 Chauhan U, Popov J, Farbod Y, Kalantar M, Wolfe M, Moayyedi P, Marshall JK, Halder S, Kaasalainen S. Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis: A Qualitative Assessment of Patient Perceptions and Experiences. J Can Assoc Gastroenterol 2021;4:e120-9. [PMID: 34877470 DOI: 10.1093/jcag/gwab007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Ren R, Gao X, Shi Y, Li J, Peng L, Sun G, Wang Z, Yan B, Zhi J, Yang Y. Long-Term Efficacy of Low-Intensity Single Donor Fecal Microbiota Transplantation in Ulcerative Colitis and Outcome-Specific Gut Bacteria. Front Microbiol 2021;12:742255. [PMID: 34867859 DOI: 10.3389/fmicb.2021.742255] [Reference Citation Analysis]
87 Chen HL, Zeng YB, Zhang ZY, Kong CY, Zhang SL, Li ZM, Huang JT, Xu YY, Mao YQ, Cai PR, Han B, Wang WQ, Wang LS. Gut and Cutaneous Microbiome Featuring Abundance of Lactobacillus reuteri Protected Against Psoriasis-Like Inflammation in Mice. J Inflamm Res 2021;14:6175-90. [PMID: 34853526 DOI: 10.2147/JIR.S337031] [Reference Citation Analysis]
88 Fischer M, Khoruts A. Oral lyophilised microbiota for the treatment of ulcerative colitis. Lancet Gastroenterol Hepatol 2021:S2468-1253(21)00433-7. [PMID: 34863329 DOI: 10.1016/S2468-1253(21)00433-7] [Reference Citation Analysis]
89 Haifer C, Paramsothy S, Kaakoush NO, Saikal A, Ghaly S, Yang T, Luu LDW, Borody TJ, Leong RW. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol 2021:S2468-1253(21)00400-3. [PMID: 34863330 DOI: 10.1016/S2468-1253(21)00400-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
90 Lee Y, Kamada N, Moon JJ. Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome. Adv Drug Deliv Rev 2021;179:114021. [PMID: 34710529 DOI: 10.1016/j.addr.2021.114021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
91 Nath S, Zilm P, Jamieson L, Kapellas K, Goswami N, Ketagoda K, Weyrich LS. Development and characterization of an oral microbiome transplant among Australians for the treatment of dental caries and periodontal disease: A study protocol. PLoS One 2021;16:e0260433. [PMID: 34843568 DOI: 10.1371/journal.pone.0260433] [Reference Citation Analysis]
92 Michailidis L, Currier AC, Le M, Flomenhoft DR. Adverse events of fecal microbiota transplantation: a meta-analysis of high-quality studies. Ann Gastroenterol 2021;34:802-14. [PMID: 34815646 DOI: 10.20524/aog.2021.0655] [Reference Citation Analysis]
93 Wang Y, Zhang J, Xu L, Ma J, Lu M, Ma J, Liu Z, Wang F, Tang X. Modified Gegen Qinlian Decoction Regulates Treg/Th17 Balance to Ameliorate DSS-Induced Acute Experimental Colitis in Mice by Altering the Gut Microbiota. Front Pharmacol 2021;12:756978. [PMID: 34803700 DOI: 10.3389/fphar.2021.756978] [Reference Citation Analysis]
94 Yadav M, Chauhan NS. Microbiome therapeutics: exploring the present scenario and challenges. Gastroenterology Report 2021. [DOI: 10.1093/gastro/goab046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
95 Zhou H, Yuan Y, Wang H, Xiang W, Li S, Zheng H, Wen Y, Ming Y, Chen L, Zhou J. Gut Microbiota: A Potential Target for Cancer Interventions. Cancer Manag Res 2021;13:8281-96. [PMID: 34764691 DOI: 10.2147/CMAR.S328249] [Reference Citation Analysis]
96 Liang G, Cobián-Güemes AG, Albenberg L, Bushman F. The gut virome in inflammatory bowel diseases. Curr Opin Virol 2021;51:190-8. [PMID: 34763180 DOI: 10.1016/j.coviro.2021.10.005] [Reference Citation Analysis]
97 Waller KMJ, Leong RW, Paramsothy S. An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases. J Gastroenterol Hepatol 2021. [PMID: 34735024 DOI: 10.1111/jgh.15731] [Reference Citation Analysis]
98 Zhong Y, Cao J, Deng Z, Ma Y, Liu J, Wang H. Effect of Fiber and Fecal Microbiota Transplantation Donor on Recipient Mice Gut Microbiota. Front Microbiol 2021;12:757372. [PMID: 34721365 DOI: 10.3389/fmicb.2021.757372] [Reference Citation Analysis]
99 An L, Wuri J, Zheng Z, Li W, Yan T. Microbiota modulate Doxorubicin induced cardiotoxicity. Eur J Pharm Sci 2021;166:105977. [PMID: 34416387 DOI: 10.1016/j.ejps.2021.105977] [Reference Citation Analysis]
100 Lima SF, Longman RS. Eating for Two: Diet and the Microbiome in Ulcerative Colitis. J Crohns Colitis 2021:jjab181. [PMID: 34718490 DOI: 10.1093/ecco-jcc/jjab181] [Reference Citation Analysis]
101 Sarbagili-Shabat C, Albenberg L, Van Limbergen J, Pressman N, Otley A, Yaakov M, Wine E, Weiner D, Levine A. A Novel UC Exclusion Diet and Antibiotics for Treatment of Mild to Moderate Pediatric Ulcerative Colitis: A Prospective Open-Label Pilot Study. Nutrients 2021;13:3736. [PMID: 34835992 DOI: 10.3390/nu13113736] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Popov J, Caputi V, Nandeesha N, Rodriguez DA, Pai N. Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies. Int J Mol Sci 2021;22:11365. [PMID: 34768795 DOI: 10.3390/ijms222111365] [Reference Citation Analysis]
103 Fehily SR, Basnayake C, Wright EK, Kamm MA. The gut microbiota and gut disease. Intern Med J 2021;51:1594-604. [PMID: 34664371 DOI: 10.1111/imj.15520] [Reference Citation Analysis]
104 Yan C, Xiao J, Li Z, Liu H, Zhao X, Liu J, Chen S, Zhao X. Exogenous Fecal Microbial Transplantation Alters Fearfulness, Intestinal Morphology, and Gut Microbiota in Broilers. Front Vet Sci 2021;8:706987. [PMID: 34660756 DOI: 10.3389/fvets.2021.706987] [Reference Citation Analysis]
105 Bekkers M, Stojkovic B, Kaiko GE. Mining the Microbiome and Microbiota-Derived Molecules in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:11243. [PMID: 34681902 DOI: 10.3390/ijms222011243] [Reference Citation Analysis]
106 Sultan S, El-Mowafy M, Elgaml A, Ahmed TAE, Hassan H, Mottawea W. Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease. Front Physiol 2021;12:715506. [PMID: 34646151 DOI: 10.3389/fphys.2021.715506] [Reference Citation Analysis]
107 Yau YK, Mak WYJ, Lui NSR, Ng WYR, Cheung CYK, Li YLA, Ching YLJ, Chin ML, Lau HSL, Chan KLF, Chan KSP, Ng SC. High prevalence of extended-spectrum beta-lactamase organisms and the COVID-19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong. United European Gastroenterol J 2021;9:1027-38. [PMID: 34623758 DOI: 10.1002/ueg2.12160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
108 Shimizu H, Arai K, Asahara T, Takahashi T, Tsuji H, Matsumoto S, Takeuchi I, Kyodo R, Yamashiro Y. Stool preparation under anaerobic conditions contributes to retention of obligate anaerobes: potential improvement for fecal microbiota transplantation. BMC Microbiol 2021;21:275. [PMID: 34627158 DOI: 10.1186/s12866-021-02325-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
109 Pernigoni N, Zagato E, Calcinotto A, Troiani M, Mestre RP, Calì B, Attanasio G, Troisi J, Minini M, Mosole S, Revandkar A, Pasquini E, Elia AR, Bossi D, Rinaldi A, Rescigno P, Flohr P, Hunt J, Neeb A, Buroni L, Guo C, Welti J, Ferrari M, Grioni M, Gauthier J, Gharaibeh RZ, Palmisano A, Lucchini GM, D'Antonio E, Merler S, Bolis M, Grassi F, Esposito A, Bellone M, Briganti A, Rescigno M, Theurillat JP, Jobin C, Gillessen S, de Bono J, Alimonti A. Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis. Science 2021;374:216-24. [PMID: 34618582 DOI: 10.1126/science.abf8403] [Cited by in Crossref: 4] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
110 Chia AYT, Ang GWX, Chan ASY, Chan W, Chong TKY, Leung YY. Managing Psoriatic Arthritis With Inflammatory Bowel Disease and/or Uveitis. Front Med (Lausanne) 2021;8:737256. [PMID: 34604268 DOI: 10.3389/fmed.2021.737256] [Reference Citation Analysis]
111 Al-Ali D, Ahmed A, Shafiq A, McVeigh C, Chaari A, Zakaria D, Bendriss G. Fecal microbiota transplants: A review of emerging clinical data on applications, efficacy, and risks (2015-2020). Qatar Med J 2021;2021:5. [PMID: 34604008 DOI: 10.5339/qmj.2021.5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Cibulková I, Řehořová V, Hajer J, Duška F. Fecal Microbial Transplantation in Critically Ill Patients-Structured Review and Perspectives. Biomolecules 2021;11:1459. [PMID: 34680092 DOI: 10.3390/biom11101459] [Reference Citation Analysis]
113 Lima S, Gogokhia L, Viladomiu M, Chou L, Putzel G, Jin W, Pires S, Guo CJ, Gerardin Y, Crawford CV, Jacob V, Scherl E, Brown SE, Hambor J, Longman R. Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation. Gastroenterology 2021:S0016-5085(21)03610-6. [PMID: 34606847 DOI: 10.1053/j.gastro.2021.09.061] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
114 Vuyyuru SK, Kedia S, Kalaivani M, Sahu P, Kante B, Kumar P, Ranjan MK, Makharia G, Ananthakrishnan A, Ahuja V. Efficacy and safety of fecal transplantation versus targeted therapies in ulcerative colitis: network meta-analysis. Future Microbiol 2021;16:1215-27. [PMID: 34590904 DOI: 10.2217/fmb-2020-0242] [Reference Citation Analysis]
115 Aggarwala V, Mogno I, Li Z, Yang C, Britton GJ, Chen-Liaw A, Mitcham J, Bongers G, Gevers D, Clemente JC, Colombel JF, Grinspan A, Faith J. Precise quantification of bacterial strains after fecal microbiota transplantation delineates long-term engraftment and explains outcomes. Nat Microbiol 2021;6:1309-18. [PMID: 34580445 DOI: 10.1038/s41564-021-00966-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
116 Wolter M, Grant ET, Boudaud M, Steimle A, Pereira GV, Martens EC, Desai MS. Leveraging diet to engineer the gut microbiome. Nat Rev Gastroenterol Hepatol 2021;18:885-902. [PMID: 34580480 DOI: 10.1038/s41575-021-00512-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
117 Liu Y, Alnababtah K, Cook S, Yu Y. Healthcare providers' perception of faecal microbiota transplantation with clostridium difficile infection and inflammatory bowel disease: a quantitative systematic review. Therap Adv Gastroenterol 2021;14:17562848211042679. [PMID: 34567271 DOI: 10.1177/17562848211042679] [Reference Citation Analysis]
118 Sarbagili Shabat C, Scaldaferri F, Zittan E, Hirsch A, Mentella MC, Musca T, Cohen NA, Ron Y, Fliss Isakov N, Pfeffer J, Yaakov M, Fanali C, Turchini L, Masucci L, Quaranta G, Kolonimos N, Godneva A, Weinberger A, Kopylov U, Levine A, Maharshak N. Use of Fecal transplantation with a novel diet for mild to moderate active ulcerative colitis: The CRAFT UC randomized controlled trial. J Crohns Colitis 2021:jjab165. [PMID: 34514495 DOI: 10.1093/ecco-jcc/jjab165] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Stojek M, Jabłońska A, Adrych K. The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease. J Clin Med 2021;10:4055. [PMID: 34575166 DOI: 10.3390/jcm10184055] [Reference Citation Analysis]
120 Cheng WY, Lam KL, Li X, Kong AP, Cheung PC. Circadian disruption-induced metabolic syndrome in mice is ameliorated by oat β-glucan mediated by gut microbiota. Carbohydr Polym 2021;267:118216. [PMID: 34119170 DOI: 10.1016/j.carbpol.2021.118216] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
121 Zhang Y, Li CX, Zhang XZ. Bacteriophage-mediated modulation of microbiota for diseases treatment. Adv Drug Deliv Rev 2021;176:113856. [PMID: 34237403 DOI: 10.1016/j.addr.2021.113856] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
122 Li Z, Wang Y, Liu J, Rawding P, Bu J, Hong S, Hu Q. Chemically and Biologically Engineered Bacteria-Based Delivery Systems for Emerging Diagnosis and Advanced Therapy. Adv Mater 2021;33:e2102580. [PMID: 34347325 DOI: 10.1002/adma.202102580] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 15.0] [Reference Citation Analysis]
123 Schupack DA, Mars RAT, Voelker DH, Abeykoon JP, Kashyap PC. The promise of the gut microbiome as part of individualized treatment strategies. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34453142 DOI: 10.1038/s41575-021-00499-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
124 Bjerrum JT, Wang YL, Seidelin JB, Nielsen OH. IBD metabonomics predicts phenotype, disease course, and treatment response. EBioMedicine 2021;71:103551. [PMID: 34419930 DOI: 10.1016/j.ebiom.2021.103551] [Reference Citation Analysis]
125 Tamilarasan AG, Krishnananthan T. Faecal microbiota transplantation: what's beyond Clostridium difficile infection? Eur J Gastroenterol Hepatol 2021;33:487-94. [PMID: 33177380 DOI: 10.1097/MEG.0000000000001938] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Li Q, Zhang T, Ding X, Xiang L, Cui B, Buch H, Zhang F. Enhancing patient adherence to fecal microbiota transplantation maintains the long-term clinical effects in ulcerative colitis. Eur J Gastroenterol Hepatol. 2020;32:955-962. [PMID: 32282545 DOI: 10.1097/meg.0000000000001725] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
127 Jo HG, Seo GS. [Efficacy and Safety of Fecal Microbiota Transplantation and Prospect of Microbe-based Therapies for Inflammatory Bowel Disease]. Korean J Gastroenterol 2021;78:31-6. [PMID: 34312355 DOI: 10.4166/kjg.2021.089] [Reference Citation Analysis]
128 Chu ND, Crothers JW, Nguyen LTT, Kearney SM, Smith MB, Kassam Z, Collins C, Xavier R, Moses PL, Alm EJ. Dynamic Colonization of Microbes and Their Functions after Fecal Microbiota Transplantation for Inflammatory Bowel Disease. mBio 2021;12:e0097521. [PMID: 34281401 DOI: 10.1128/mBio.00975-21] [Reference Citation Analysis]
129 Baunwall SMD, Dahlerup JF, Engberg JH, Erikstrup C, Helms M, Juel MA, Kjeldsen J, Nielsen HL, Nilsson AC, Rode AA, Vinter-Jensen L, Hvas CL. Danish national guideline for the treatment of Clostridioides difficile infection and use of faecal microbiota transplantation (FMT). Scand J Gastroenterol 2021;56:1056-77. [PMID: 34261379 DOI: 10.1080/00365521.2021.1922749] [Reference Citation Analysis]
130 Gu X, Lu Q, Zhang C, Tang Z, Chu L. Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review. Semin Liver Dis 2021. [PMID: 34261137 DOI: 10.1055/s-0041-1732319] [Reference Citation Analysis]
131 Zhu F, Ke Y, Luo Y, Wu J, Wu P, Ma F, Liu Y. Effects of Different Treatment of Fecal Microbiota Transplantation Techniques on Treatment of Ulcerative Colitis in Rats. Front Microbiol 2021;12:683234. [PMID: 34335508 DOI: 10.3389/fmicb.2021.683234] [Reference Citation Analysis]
132 Li Q, Ding X, Liu K, Marcella C, Liu X, Zhang T, Liu Y, Li P, Xiang L, Cui B, Wang J, Bai J, Zhang F. Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes. Clin Transl Gastroenterol 2020;11:e00224. [PMID: 32955197 DOI: 10.14309/ctg.0000000000000224] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
133 Trichka J, Zou WQ. Modulation of Neuroinflammation by the Gut Microbiota in Prion and Prion-Like Diseases. Pathogens 2021;10:887. [PMID: 34358037 DOI: 10.3390/pathogens10070887] [Reference Citation Analysis]
134 Chande N, Costello SP, Limketkai BN, Parker CE, Nguyen TM, Macdonald JK, Feagan BG. Alternative and Complementary Approaches for the Treatment of Inflammatory Bowel Disease: Evidence From Cochrane Reviews. Inflamm Bowel Dis 2020;26:843-51. [PMID: 31560744 DOI: 10.1093/ibd/izz223] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
135 El-Salhy M, Hausken T, Hatlebakk JG. Current status of fecal microbiota transplantation for irritable bowel syndrome. Neurogastroenterol Motil 2021;:e14157. [PMID: 34236740 DOI: 10.1111/nmo.14157] [Reference Citation Analysis]
136 Crothers JW, Chu ND, Nguyen LTT, Phillips M, Collins C, Fortner K, Del Rio-Guerra R, Lavoie B, Callas P, Velez M, Cohn A, Elliott RJ, Wong WF, Vo E, Wilcox R, Smith M, Kassam Z, Budd R, Alm EJ, Mawe GM, Moses PL. Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study. BMC Gastroenterol 2021;21:281. [PMID: 34238227 DOI: 10.1186/s12876-021-01856-9] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
137 Feng J, Tang YN, Zhou LX, Pan JS. Standardized Nursing Procedures for Fecal Microbiota Transplantation via Upper Endoscopy. Gastroenterol Nurs 2021;44:227-32. [PMID: 34176888 DOI: 10.1097/SGA.0000000000000577] [Reference Citation Analysis]
138 Fehily SR, Basnayake C, Wright EK, Kamm MA. Fecal microbiota transplantation therapy in Crohn's disease: Systematic review. J Gastroenterol Hepatol 2021. [PMID: 34169565 DOI: 10.1111/jgh.15598] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Březina J, Bajer L, Wohl P, Ďuricová D, Hrabák P, Novotný A, Koželuhová J, Lukáš M, Mrázek J, Fliegerová KO, Kvasnová S, Chahrazed M, Mareš J, Špičák J, Drastich P. Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis-Results of a Randomized Controlled Trial. J Clin Med 2021;10:2753. [PMID: 34206663 DOI: 10.3390/jcm10132753] [Reference Citation Analysis]
140 Wu N, Mah C, Koentgen S, Zhang L, Grimm MC, El-Omar E, Hold GL. Inflammatory bowel disease and the gut microbiota. Proc Nutr Soc 2021;:1-11. [PMID: 34165053 DOI: 10.1017/S002966512100197X] [Reference Citation Analysis]
141 Nishida A, Nishino K, Sakai K, Owaki Y, Noda Y, Imaeda H. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease? World J Gastroenterol 2021; 27(23): 3317-3326 [PMID: 34163114 DOI: 10.3748/wjg.v27.i23.3317] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
142 Gupta S, Mullish BH, Allegretti JR. Fecal Microbiota Transplantation: The Evolving Risk Landscape. Am J Gastroenterol 2021;116:647-56. [PMID: 33982930 DOI: 10.14309/ajg.0000000000001075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
143 Pavel FM, Vesa CM, Gheorghe G, Diaconu CC, Stoicescu M, Munteanu MA, Babes EE, Tit DM, Toma MM, Bungau S. Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease. Diagnostics (Basel) 2021;11:1090. [PMID: 34203609 DOI: 10.3390/diagnostics11061090] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 El-Salhy M, Patcharatrakul T, Gonlachanvit S. Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century. World J Gastroenterol 2021; 27(22): 2921-2943 [PMID: 34168399 DOI: 10.3748/wjg.v27.i22.2921] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
145 Sun Y, Zhang Z, Zheng CQ, Sang LX. Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: A review. World J Gastroenterol 2021; 27(22): 2963-2978 [PMID: 34168401 DOI: 10.3748/wjg.v27.i22.2963] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
146 Wang T, Liu W, Li C, Si G, Liang Z, Yin J. Mist1 promoted inflammation in colitis model via K+-ATPase NLRP3 inflammasome by SNAI1. Pathol Res Pract 2021;224:153511. [PMID: 34214845 DOI: 10.1016/j.prp.2021.153511] [Reference Citation Analysis]
147 Yeh YM, Cheng HT, Le PH, Chen CC, Kuo CJ, Chen CL, Chiu CT, Chiu CH. Implementation of fecal microbiota transplantation in a medical center for recurrent or refractory Clostridioides difficile infection and report of preliminary outcome. Biomed J 2021:S2319-4170(21)00067-6. [PMID: 34118466 DOI: 10.1016/j.bj.2021.06.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Núñez F P, Quera R, Bay C, Thomson P. Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases. Gastroenterol Hepatol 2021:S0210-5705(21)00192-8. [PMID: 34118321 DOI: 10.1016/j.gastrohep.2021.05.009] [Reference Citation Analysis]
149 Torun A, Hupalowska A, Trzonkowski P, Kierkus J, Pyrzynska B. Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children. Front Immunol 2021;12:642166. [PMID: 34163468 DOI: 10.3389/fimmu.2021.642166] [Reference Citation Analysis]
150 Kvakova M, Bertkova I, Stofilova J, Savidge TC. Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation. Foods 2021;10:1297. [PMID: 34200108 DOI: 10.3390/foods10061297] [Reference Citation Analysis]
151 Hanssen NMJ, de Vos WM, Nieuwdorp M. Fecal microbiota transplantation in human metabolic diseases: From a murky past to a bright future? Cell Metab 2021;33:1098-110. [PMID: 34077717 DOI: 10.1016/j.cmet.2021.05.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
152 van Olst L, Roks SJM, Kamermans A, Verhaar BJH, van der Geest AM, Muller M, van der Flier WM, de Vries HE. Contribution of Gut Microbiota to Immunological Changes in Alzheimer's Disease. Front Immunol 2021;12:683068. [PMID: 34135909 DOI: 10.3389/fimmu.2021.683068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
153 LeBlanc JF, Segal JP, de Campos Braz LM, Hart AL. The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis. Nutrients 2021;13:1780. [PMID: 34071065 DOI: 10.3390/nu13061780] [Reference Citation Analysis]
154 Biagioli M, Marchianò S, Carino A, Di Giorgio C, Santucci L, Distrutti E, Fiorucci S. Bile Acids Activated Receptors in Inflammatory Bowel Disease. Cells 2021;10:1281. [PMID: 34064187 DOI: 10.3390/cells10061281] [Reference Citation Analysis]
155 Wilson BC, Vatanen T, Jayasinghe TN, Leong KSW, Derraik JGB, Albert BB, Chiavaroli V, Svirskis DM, Beck KL, Conlon CA, Jiang Y, Schierding W, Holland DJ, Cutfield WS, O'Sullivan JM. Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity. Microbiome 2021;9:107. [PMID: 33985595 DOI: 10.1186/s40168-021-01060-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
156 Pai N, Popov J, Hill L, Hartung E, Grzywacz K, Moayyedi P; McMaster Pediatric Fecal Microbiota Transplant Research Collaboration. Results of the First Pilot Randomized Controlled Trial of Fecal Microbiota Transplant In Pediatric Ulcerative Colitis: Lessons, Limitations, and Future Prospects. Gastroenterology 2021;161:388-393.e3. [PMID: 33961887 DOI: 10.1053/j.gastro.2021.04.067] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
157 Kragsnaes MS, Kjeldsen J, Horn HC, Munk HL, Pedersen JK, Just SA, Ahlquist P, Pedersen FM, de Wit M, Möller S, Andersen V, Kristiansen K, Kinggaard Holm D, Holt HM, Christensen R, Ellingsen T. Safety and efficacy of faecal microbiota transplantation for active peripheral psoriatic arthritis: an exploratory randomised placebo-controlled trial. Ann Rheum Dis 2021;80:1158-67. [PMID: 33926922 DOI: 10.1136/annrheumdis-2020-219511] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
158 Danne C, Rolhion N, Sokol H. Recipient factors in faecal microbiota transplantation: one stool does not fit all. Nat Rev Gastroenterol Hepatol 2021;18:503-13. [PMID: 33907321 DOI: 10.1038/s41575-021-00441-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 31.0] [Reference Citation Analysis]
159 Liu X, Li Y, Wu K, Shi Y, Chen M. Fecal Microbiota Transplantation as Therapy for Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract 2021;2021:6612970. [PMID: 33981340 DOI: 10.1155/2021/6612970] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
160 Golob JL, Rao K. Signal Versus Noise: How to Analyze the Microbiome and Make Progress on Antimicrobial Resistance. J Infect Dis 2021;223:S214-21. [PMID: 33880565 DOI: 10.1093/infdis/jiab184] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
161 Nomura K, Ishikawa D, Okahara K, Ito S, Haga K, Takahashi M, Arakawa A, Shibuya T, Osada T, Kuwahara-Arai K, Kirikae T, Nagahara A. Bacteroidetes Species Are Correlated with Disease Activity in Ulcerative Colitis. J Clin Med 2021;10:1749. [PMID: 33920646 DOI: 10.3390/jcm10081749] [Reference Citation Analysis]
162 Shen H, Zhang S, Zhao W, Ren S, Ke X, Gu Q, Tang Z, Xie J, Chen S, Chen Y, Zou J, Zhang L, Shen Z, Zheng K, Liu Y, Gu P, Cheng J, Hu J, Zhu L. Randomised clinical trial: Efficacy and safety of Qing-Chang-Hua-Shi granules in a multicenter, randomized, and double-blind clinical trial of patients with moderately active ulcerative colitis. Biomed Pharmacother 2021;139:111580. [PMID: 33857914 DOI: 10.1016/j.biopha.2021.111580] [Reference Citation Analysis]
163 Li W, Deng X, Chen T. Exploring the Modulatory Effects of Gut Microbiota in Anti-Cancer Therapy. Front Oncol 2021;11:644454. [PMID: 33928033 DOI: 10.3389/fonc.2021.644454] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
164 Park SY, Seo GS. Fecal Microbiota Transplantation: Is It Safe? Clin Endosc 2021;54:157-60. [PMID: 33827154 DOI: 10.5946/ce.2021.072] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
165 Bolte LA, Klaassen MAY, Collij V, Vich Vila A, Fu J, van der Meulen TA, de Haan JJ, Versteegen GJ, Dotinga A, Zhernakova A, Wijmenga C, Weersma RK, Imhann F. Patient attitudes towards faecal sampling for gut microbiome studies and clinical care reveal positive engagement and room for improvement. PLoS One 2021;16:e0249405. [PMID: 33831035 DOI: 10.1371/journal.pone.0249405] [Reference Citation Analysis]
166 Quraishi MN, Iqbal TH, Hart AL. Precision Medicine with FMT for Ulcerative Colitis: Are We There Yet? J Crohns Colitis 2021;15:519-20. [PMID: 33079179 DOI: 10.1093/ecco-jcc/jjaa190] [Reference Citation Analysis]
167 Herman A, Bajaka A. The role of the intestinal microbiota in eating disorders - bulimia nervosa and binge eating disorder. Psychiatry Res 2021;300:113923. [PMID: 33857846 DOI: 10.1016/j.psychres.2021.113923] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
168 Guo XY, Liu XJ, Hao JY. Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment. J Dig Dis. 2020;21:147-159. [PMID: 32040250 DOI: 10.1111/1751-2980.12849] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]
169 Moon CM, Hong SN. Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection. Clin Endosc 2021;54:149-51. [PMID: 33765728 DOI: 10.5946/ce.2021.068] [Reference Citation Analysis]
170 Gweon TG, Na SY. Next Generation Fecal Microbiota Transplantation. Clin Endosc 2021;54:152-6. [PMID: 33761228 DOI: 10.5946/ce.2021.053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
171 Lu K, Zhou J, Deng J, Li Y, Wu C, Bao J. Periplaneta americana Oligosaccharides Exert Anti-Inflammatory Activity through Immunoregulation and Modulation of Gut Microbiota in Acute Colitis Mice Model. Molecules 2021;26:1718. [PMID: 33808686 DOI: 10.3390/molecules26061718] [Reference Citation Analysis]
172 Kazemian N, Kao D, Pakpour S. Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic. Int J Mol Sci 2021;22:3004. [PMID: 33809421 DOI: 10.3390/ijms22063004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
173 Keller JJ, Ooijevaar RE, Hvas CL, Terveer EM, Lieberknecht SC, Högenauer C, Arkkila P, Sokol H, Gridnyev O, Mégraud F, Kump PK, Nakov R, Goldenberg SD, Satokari R, Tkatch S, Sanguinetti M, Cammarota G, Dorofeev A, Gubska O, Laniro G, Mattila E, Arasaradnam RP, Sarin SK, Sood A, Putignani L, Alric L, Baunwall SMD, Kupcinskas J, Link A, Goorhuis AG, Verspaget HW, Ponsioen C, Hold GL, Tilg H, Kassam Z, Kuijper EJ, Gasbarrini A, Mulder CJJ, Williams HRT, Vehreschild MJGT. A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group. United European Gastroenterol J 2021;9:229-47. [PMID: 33151137 DOI: 10.1177/2050640620967898] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
174 Dalal RS, Allegretti JR. Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease. Curr Opin Gastroenterol 2021;37:336-43. [PMID: 33654015 DOI: 10.1097/MOG.0000000000000739] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
175 Mocanu V, Rajaruban S, Dang J, Kung JY, Deehan EC, Madsen KL. Repeated Fecal Microbial Transplantations and Antibiotic Pre-Treatment Are Linked to Improved Clinical Response and Remission in Inflammatory Bowel Disease: A Systematic Review and Pooled Proportion Meta-Analysis. J Clin Med 2021;10:959. [PMID: 33804464 DOI: 10.3390/jcm10050959] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
176 Berland M, Cadiou J, Levenez F, Galleron N, Quinquis B, Thirion F, Gauthier F, Le Chatelier E, Plaza Oñate F, Schwintner C, Rabot S, Lepage P, Ehrlich D, Doré J, Juste C. High engraftment capacity of frozen ready-to-use human fecal microbiota transplants assessed in germ-free mice. Sci Rep 2021;11:4365. [PMID: 33623056 DOI: 10.1038/s41598-021-83638-7] [Reference Citation Analysis]
177 D Goldenberg S, Merrick B. The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection. Ther Adv Infect Dis 2021;8:2049936120981526. [PMID: 33614028 DOI: 10.1177/2049936120981526] [Reference Citation Analysis]
178 He L, Zhang F, Jian Z, Sun J, Chen J, Liapao V, He Q. Stachyose modulates gut microbiota and alleviates dextran sulfate sodium-induced acute colitis in mice. Saudi J Gastroenterol 2020;26:153-9. [PMID: 32270772 DOI: 10.4103/sjg.SJG_580_19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
179 Ghosh S, Whitley CS, Haribabu B, Jala VR. Regulation of Intestinal Barrier Function by Microbial Metabolites. Cell Mol Gastroenterol Hepatol 2021;11:1463-82. [PMID: 33610769 DOI: 10.1016/j.jcmgh.2021.02.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
180 Barbuti RC, Schiavon LL, Oliveira CP, Alvares-DA-Silva MR, Sassaki LY, Passos MDCF, Farias AQ, Barros LL, Barreto BP, Albuquerque GBML, Alves AM, Navarro-Rodriguez T, Bittencourt PL. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG). Arq Gastroenterol 2020;57:381-98. [PMID: 33331485 DOI: 10.1590/S0004-2803.202000000-72] [Reference Citation Analysis]
181 Kim M, Huda MN, Bennett BJ. Sequence Meets Function-Microbiota And Cardiovascular Disease. Cardiovasc Res 2021:cvab030. [PMID: 33537709 DOI: 10.1093/cvr/cvab030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Akagawa S, Akagawa Y, Yamanouchi S, Kimata T, Tsuji S, Kaneko K. Development of the gut microbiota and dysbiosis in children. Biosci Microbiota Food Health 2021;40:12-8. [PMID: 33520564 DOI: 10.12938/bmfh.2020-034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Karjalainen EK, Renkonen-Sinisalo L, Satokari R, Mustonen H, Ristimäki A, Arkkila P, Lepistö AH. Fecal Microbiota Transplantation in Chronic Pouchitis: A Randomized, Parallel, Double-Blinded Clinical Trial. Inflamm Bowel Dis 2021:izab001. [PMID: 33501942 DOI: 10.1093/ibd/izab001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
184 Jansma J, El Aidy S. Understanding the host-microbe interactions using metabolic modeling. Microbiome 2021;9:16. [PMID: 33472685 DOI: 10.1186/s40168-020-00955-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
185 Fang H, Fu L, Li X, Lu C, Su Y, Xiong K, Zhang L. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study. Microb Cell Fact 2021;20:18. [PMID: 33468164 DOI: 10.1186/s12934-021-01513-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
186 Tocia C, Dumitru IM, Alexandrescu L, Petcu LC, Dumitru E. Does rifaximin offer any promise in Crohn's disease in remission and concurrent irritable bowel syndrome-like symptoms? Medicine (Baltimore) 2021;100:e24059. [PMID: 33429768 DOI: 10.1097/MD.0000000000024059] [Reference Citation Analysis]
187 Zheng L, Wen XL. Gut microbiota and inflammatory bowel disease: The current status and perspectives. World J Clin Cases 2021; 9(2): 321-333 [PMID: 33521100 DOI: 10.12998/wjcc.v9.i2.321] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
188 Saha S, Mara K, Pardi DS, Khanna S. Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. Gastroenterology 2021;160:1961-1969.e3. [PMID: 33444573 DOI: 10.1053/j.gastro.2021.01.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
189 Hmar EBL, Paul S, Boruah N, Sarkar P, Borah S, Sharma HK. Apprehending Ulcerative Colitis Management With Springing Up Therapeutic Approaches: Can Nanotechnology Play a Nascent Role? Curr Pathobiol Rep 2021;9:9-32. [DOI: 10.1007/s40139-020-00218-6] [Reference Citation Analysis]
190 Utay NS, Monczor AN, Somasunderam A, Lupo S, Jiang ZD, Alexander AS, Finkelman M, Vigil KJ, Lake JE, Hanson B, DuPont HL, Arduino RC. Evaluation of Six Weekly Oral Fecal Microbiota Transplants in People with HIV. Pathog Immun 2020;5:364-81. [PMID: 33501400 DOI: 10.20411/pai.v5i1.388] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
191 Abbasi A, Hajipour N, Hasannezhad P, Baghbanzadeh A, Aghebati-maleki L. Potential in vivo delivery routes of postbiotics. Critical Reviews in Food Science and Nutrition. [DOI: 10.1080/10408398.2020.1865260] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
192 Wu WH, Zegarra-Ruiz DF, Diehl GE. Intestinal Microbes in Autoimmune and Inflammatory Disease. Front Immunol 2020;11:597966. [PMID: 33424846 DOI: 10.3389/fimmu.2020.597966] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
193 Holster S, Repsilber D, Geng D, Hyötyläinen T, Salonen A, Lindqvist CM, Rajan SK, de Vos WM, Brummer RJ, König J. Correlations between microbiota and metabolites after faecal microbiota transfer in irritable bowel syndrome. Benef Microbes 2021;12:17-30. [PMID: 33350360 DOI: 10.3920/BM2020.0010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
194 Poletti M, Arnauts K, Ferrante M, Korcsmaros T. Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD. J Crohns Colitis 2021;15:1222-35. [PMID: 33341879 DOI: 10.1093/ecco-jcc/jjaa257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
195 Green JE, Davis JA, Berk M, Hair C, Loughman A, Castle D, Athan E, Nierenberg AA, Cryan JF, Jacka F, Marx W. Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis. Gut Microbes 2020;12:1-25. [PMID: 33345703 DOI: 10.1080/19490976.2020.1854640] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
196 Gerardin Y, Timberlake S, Allegretti JR, Smith MB, Kassam Z. Beyond Fecal Microbiota Transplantation: Developing Drugs from the Microbiome. J Infect Dis 2021;223:S276-82. [PMID: 33330910 DOI: 10.1093/infdis/jiaa700] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
197 Basson AR, Gomez-Nguyen A, Menghini P, Buttó LF, Di Martino L, Aladyshkina N, Osme A, LaSalla A, Fischer D, Ezeji JC, Erkkila HL, Brennan CJ, Lam M, Rodriguez-Palacios A, Cominelli F. Human Gut Microbiome Transplantation in Ileitis Prone Mice: A Tool for the Functional Characterization of the Microbiota in Inflammatory Bowel Disease Patients. Inflamm Bowel Dis 2020;26:347-59. [PMID: 31750921 DOI: 10.1093/ibd/izz242] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
198 Haifer C, Saikal A, Paramsothy R, Kaakoush NO, Leong RW, Borody TJ, Kamm MA, Paramsothy S. Response to faecal microbiota transplantation in ulcerative colitis is not sustained long term following induction therapy. Gut 2020:gutjnl-2020-323581. [PMID: 33303563 DOI: 10.1136/gutjnl-2020-323581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
199 Niina A, Kibe R, Suzuki R, Yuchi Y, Teshima T, Matsumoto H, Kataoka Y, Koyama H. Fecal microbiota transplantation as a new treatment for canine inflammatory bowel disease. Biosci Microbiota Food Health 2021;40:98-104. [PMID: 33996366 DOI: 10.12938/bmfh.2020-049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
200 Malard F, Dore J, Gaugler B, Mohty M. Introduction to host microbiome symbiosis in health and disease. Mucosal Immunol 2021;14:547-54. [PMID: 33299088 DOI: 10.1038/s41385-020-00365-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
201 Fiorucci S, Carino A, Baldoni M, Santucci L, Costanzi E, Graziosi L, Distrutti E, Biagioli M. Bile Acid Signaling in Inflammatory Bowel Diseases. Dig Dis Sci 2021;66:674-93. [PMID: 33289902 DOI: 10.1007/s10620-020-06715-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 15.0] [Reference Citation Analysis]
202 Singh A, Mahajan R, Kao D, Midha V, Sood A. Long term management of ulcerative colitis with Faecal Microbiota Transplantation. Medicine in Microecology 2020;6:100026. [DOI: 10.1016/j.medmic.2020.100026] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
203 Ding X, Yang X, Wang H. Methodology, efficacy and safety of fecal microbiota transplantation in treating inflammatory bowel disease. Medicine in Microecology 2020;6:100028. [DOI: 10.1016/j.medmic.2020.100028] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
204 Olesen SW. Power calculations for detecting differences in efficacy of fecal microbiota donors. Contemp Clin Trials Commun 2020;20:100674. [PMID: 33241161 DOI: 10.1016/j.conctc.2020.100674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
205 Lee M, Chang EB. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues. Gastroenterology 2021;160:524-37. [PMID: 33253681 DOI: 10.1053/j.gastro.2020.09.056] [Cited by in Crossref: 10] [Cited by in F6Publishing: 68] [Article Influence: 5.0] [Reference Citation Analysis]
206 Mima K, Kosumi K, Baba Y, Hamada T, Baba H, Ogino S. The microbiome, genetics, and gastrointestinal neoplasms: the evolving field of molecular pathological epidemiology to analyze the tumor-immune-microbiome interaction. Hum Genet 2021;140:725-46. [PMID: 33180176 DOI: 10.1007/s00439-020-02235-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
207 Vural M, Gilbert B, Üstün I, Caglar S, Finckh A. Mini-Review: Human Microbiome and Rheumatic Diseases. Front Cell Infect Microbiol 2020;10:491160. [PMID: 33304855 DOI: 10.3389/fcimb.2020.491160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
208 Niu W, Chen X, Xu R, Dong H, Yang F, Wang Y, Zhang Z, Ju J. Polysaccharides from natural resources exhibit great potential in the treatment of ulcerative colitis: A review. Carbohydr Polym 2021;254:117189. [PMID: 33357839 DOI: 10.1016/j.carbpol.2020.117189] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
209 Khoruts A, Hoffmann DE, Palumbo FB. The Impact of Regulatory Policies on the Future of Fecal Microbiota Transplantation. J Law Med Ethics 2019;47:482-504. [PMID: 31957587 DOI: 10.1177/1073110519897726] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
210 Holster S, Rode J, Bohr J, Kumawat AK, Veress G, Hultgren Hörnquist E, Brummer RJ, König J. Faecal microbiota transfer in patients with microscopic colitis - a pilot study in collagenous colitis. Scand J Gastroenterol 2020;55:1454-66. [PMID: 33142068 DOI: 10.1080/00365521.2020.1839544] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
211 Sherrill-Mix S, Connors K, Aldrovandi GM, Brenchley JM, Boucher C, Bushman FD, Collman RG, Dandekar S, Klatt NR, Lagenaur LA, Paredes R, Tachedjian G, Turpin JA, Landay AL, Ghosh M. A Summary of the Fifth Annual Virology Education HIV Microbiome Workshop. AIDS Res Hum Retroviruses 2020;36:886-95. [PMID: 32777940 DOI: 10.1089/AID.2020.0121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
212 Thompson C, Taleban S. Incorporating Frailty in the Treatment Program of Elderly Patients with Gastrointestinal Disease. Curr Treat Options Gastro 2020;18:635-56. [DOI: 10.1007/s11938-020-00310-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
213 Moayyedi P, MacQueen G, Bernstein CN, Vanner S, Bercik P, Madsen KL, Surette M, Rioux JD, Dieleman LA, Verdú E, de Souza RJ, Otley A, Targownik L, Lavis J, Cunningham J, Marshall DA, Zelinsky S, Fernandes A. IMAGINE Network's Mind And Gut Interactions Cohort (MAGIC) Study: a protocol for a prospective observational multicentre cohort study in inflammatory bowel disease and irritable bowel syndrome. BMJ Open 2020;10:e041733. [PMID: 33087380 DOI: 10.1136/bmjopen-2020-041733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
214 Wen Q, Liu KJ, Cui BT, Li P, Wu X, Zhong M, Wei L, Tu H, Yuan Y, Lin D, Hsu WH, Wu DC, Yin H, Zhang FM. Impact of cap-assisted colonoscopy during transendoscopic enteral tubing: A randomized controlled trial. World J Gastroenterol 2020; 26(39): 6098-6110 [PMID: 33132658 DOI: 10.3748/wjg.v26.i39.6098] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
215 Rajendiran E, Ramadass B, Ramprasath V. Understanding connections and roles of gut microbiome in cardiovascular diseases. Can J Microbiol 2021;67:101-11. [PMID: 33079568 DOI: 10.1139/cjm-2020-0043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
216 Grigoryan Z, Shen MJ, Twardus SW, Beuttler MM, Chen LA, Bateman-House A. Fecal microbiota transplantation: Uses, questions, and ethics. Med Microecol 2020;6:100027. [PMID: 33834162 DOI: 10.1016/j.medmic.2020.100027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
217 Schierová D, Březina J, Mrázek J, Fliegerová KO, Kvasnová S, Bajer L, Drastich P. Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy. Cells 2020;9:E2283. [PMID: 33066233 DOI: 10.3390/cells9102283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
218 Zhao HL, Chen SZ, Xu HM, Zhou YL, He J, Huang HL, Xu J, Nie YQ. Efficacy and safety of fecal microbiota transplantation for treating patients with ulcerative colitis: A systematic review and meta-analysis. J Dig Dis 2020;21:534-48. [PMID: 33439534 DOI: 10.1111/1751-2980.12933] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
219 Haifer C, Leong RW, Paramsothy S. The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease. Curr Opin Pharmacol 2020;55:8-16. [PMID: 33035780 DOI: 10.1016/j.coph.2020.08.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
220 Kelly CR, Yen EF, Grinspan AM, Kahn SA, Atreja A, Lewis JD, Moore TA, Rubin DT, Kim AM, Serra S, Nersesova Y, Fredell L, Hunsicker D, McDonald D, Knight R, Allegretti JR, Pekow J, Absah I, Hsu R, Vincent J, Khanna S, Tangen L, Crawford CV, Mattar MC, Chen LA, Fischer M, Arsenescu RI, Feuerstadt P, Goldstein J, Kerman D, Ehrlich AC, Wu GD, Laine L. Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry. Gastroenterology 2021;160:183-192.e3. [PMID: 33011173 DOI: 10.1053/j.gastro.2020.09.038] [Cited by in Crossref: 54] [Cited by in F6Publishing: 40] [Article Influence: 27.0] [Reference Citation Analysis]
221 Sood A, Singh A, Midha V, Mahajan R, Kao D, Rubin DT, Bernstein CN. Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy. Crohn's & Colitis 360 2020;2:otaa067. [DOI: 10.1093/crocol/otaa067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
222 Chen M, Liu XL, Zhang YJ, Nie YZ, Wu KC, Shi YQ. Efficacy and safety of fecal microbiota transplantation by washed preparation in patients with moderate to severely active ulcerative colitis. J Dig Dis 2020;21:621-8. [PMID: 32909356 DOI: 10.1111/1751-2980.12938] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
223 Cheng YW, Fischer M. Fecal Microbiota Transplantation for Ulcerative Colitis. Are We Ready for Primetime? Gastroenterol Clin North Am 2020;49:739-52. [PMID: 33121693 DOI: 10.1016/j.gtc.2020.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
224 Ambrozkiewicz F, Karczmarski J, Kulecka M, Paziewska A, Niemira M, Zeber-Lubecka N, Zagorowicz E, Kretowski A, Ostrowski J. In search for interplay between stool microRNAs, microbiota and short chain fatty acids in Crohn's disease - a preliminary study. BMC Gastroenterol 2020;20:307. [PMID: 32958038 DOI: 10.1186/s12876-020-01444-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
225 Cold F, Kousgaard SJ, Halkjaer SI, Petersen AM, Nielsen HL, Thorlacius-Ussing O, Hansen LH. Fecal Microbiota Transplantation in the Treatment of Chronic Pouchitis: A Systematic Review. Microorganisms 2020;8:E1433. [PMID: 32962069 DOI: 10.3390/microorganisms8091433] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
226 Caldeira LF, Borba HH, Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R. Fecal microbiota transplantation in inflammatory bowel disease patients: A systematic review and meta-analysis. PLoS One 2020;15:e0238910. [PMID: 32946509 DOI: 10.1371/journal.pone.0238910] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
227 Azimirad M, Yadegar A, Gholami F, Shahrokh S, Asadzadeh Aghdaei H, Ianiro G, Suzuki H, Cammarota G, Zali MR. Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease. J Inflamm Res 2020;13:563-70. [PMID: 32982371 DOI: 10.2147/JIR.S265520] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
228 Tan P, Li X, Shen J, Feng Q. Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update. Front Pharmacol. 2020;11:574533. [PMID: 33041818 DOI: 10.3389/fphar.2020.574533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
229 Tan Y, Shen J, Si T, Ho CL, Li Y, Dai L. Engineered Live Biotherapeutics: Progress and Challenges. Biotechnol J 2020;15:2000155. [DOI: 10.1002/biot.202000155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
230 Zhang L, Zhou W, Zhan L, Hou S, Zhao C, Bi T, Lu X. Fecal microbiota transplantation alters the susceptibility of obese rats to type 2 diabetes mellitus. Aging (Albany NY) 2020;12:17480-502. [PMID: 32920548 DOI: 10.18632/aging.103756] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
231 Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, Bernstein CN, Danese S, Peyrin-Biroulet L, Hibi T. Ulcerative colitis.Nat Rev Dis Primers. 2020;6:74. [PMID: 32913180 DOI: 10.1038/s41572-020-0205-x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 206] [Article Influence: 26.0] [Reference Citation Analysis]
232 Chen H, Li H, Liu Z. Interplay of intestinal microbiota and mucosal immunity in inflammatory bowel disease: a relationship of frenemies. Therap Adv Gastroenterol 2020;13:1756284820935188. [PMID: 32952611 DOI: 10.1177/1756284820935188] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
233 Roussin L, Prince N, Perez-Pardo P, Kraneveld AD, Rabot S, Naudon L. Role of the Gut Microbiota in the Pathophysiology of Autism Spectrum Disorder: Clinical and Preclinical Evidence. Microorganisms 2020;8:E1369. [PMID: 32906656 DOI: 10.3390/microorganisms8091369] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
234 Zhong M, Sun Y, Wang HG, Marcella C, Cui BT, Miao YL, Zhang FM. Awareness and attitude of fecal microbiota transplantation through transendoscopic enteral tubing among inflammatory bowel disease patients. World J Clin Cases 2020; 8(17): 3786-3796 [PMID: 32953854 DOI: 10.12998/wjcc.v8.i17.3786] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
235 Segal JP, Mullish BH, Quraishi MN, Iqbal T, Marchesi JR, Sokol H. Mechanisms underpinning the efficacy of faecal microbiota transplantation in treating gastrointestinal disease. Therap Adv Gastroenterol 2020;13:1756284820946904. [PMID: 32952613 DOI: 10.1177/1756284820946904] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
236 Lee KA, Shaw HM, Bataille V, Nathan P, Spector TD. Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implications. Eur J Cancer 2020;138:149-55. [PMID: 32889369 DOI: 10.1016/j.ejca.2020.07.026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
237 Mukherji R, Weinberg BA. The gut microbiome and potential implications for early-onset colorectal cancer. Colorectal Cancer 2020;9:CRC25. [DOI: 10.2217/crc-2020-0007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
238 Kong L, Lloyd-Price J, Vatanen T, Seksik P, Beaugerie L, Simon T, Vlamakis H, Sokol H, Xavier RJ. Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease. Gastroenterology 2020;159:2193-2202.e5. [PMID: 32860788 DOI: 10.1053/j.gastro.2020.08.045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
239 Costello SP, Day A, Yao CK, Bryant RV. Faecal microbiota transplantation (FMT) with dietary therapy for acute severe ulcerative colitis. BMJ Case Rep 2020;13:e233135. [PMID: 32843418 DOI: 10.1136/bcr-2019-233135] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
240 Olesen SW, Gerardin Y. Re-Evaluating the Evidence for Faecal Microbiota Transplantation ‘Super-Donors’ in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2021;15:453-61. [DOI: 10.1093/ecco-jcc/jjaa170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
241 Britton GJ, Contijoch EJ, Spindler MP, Aggarwala V, Dogan B, Bongers G, San Mateo L, Baltus A, Das A, Gevers D, Borody TJ, Kaakoush NO, Kamm MA, Mitchell H, Paramsothy S, Clemente JC, Colombel JF, Simpson KW, Dubinsky MC, Grinspan A, Faith JJ. Defined microbiota transplant restores Th17/RORγt+ regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotas. Proc Natl Acad Sci U S A 2020;117:21536-45. [PMID: 32817490 DOI: 10.1073/pnas.1922189117] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
242 Sood A, Singh A, Mahajan R, Midha V, Kaur K, Singh D, Bansal N, Dharni K. Clinical Predictors of response to Faecal Microbiota Transplantation in patients with active ulcerative colitis. J Crohns Colitis 2020:jjaa163. [PMID: 32772093 DOI: 10.1093/ecco-jcc/jjaa163] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
243 Li K, Wei S, Hu L, Yin X, Mai Y, Jiang C, Peng X, Cao X, Huang Z, Zhou H, Ma G, Liu Z, Li H, Zhao B. Protection of Fecal Microbiota Transplantation in a Mouse Model of Multiple Sclerosis. Mediators Inflamm 2020;2020:2058272. [PMID: 32831634 DOI: 10.1155/2020/2058272] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
244 Huang YW, Pan P, Echeveste CE, Wang HT, Oshima K, Lin CW, Yearsley M, Xiao J, Chen J, Sun C, Yu J, Wang LS. Transplanting fecal material from wild-type mice fed black raspberries alters the immune system of recipient mice. Food Front 2020;1:253-9. [PMID: 34308364 DOI: 10.1002/fft2.34] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
245 Henrina J, Cahyadi I, Hadi Gunawan HF, Paskah Suciadi L. Gut Microbiota as a Potential Treatment Target in Patient with Chronic Heart Failure. SN Compr Clin Med 2020;2:1614-27. [DOI: 10.1007/s42399-020-00436-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
246 Vallecoccia MS, Dominedò C, Cutuli SL, Martin-Loeches I, Torres A, De Pascale G. Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia? Eur Respir Rev 2020;29:200023. [PMID: 32759376 DOI: 10.1183/16000617.0023-2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
247 Henn MR, O'Brien EJ, Diao L, Feagan BG, Sandborn WJ, Huttenhower C, Wortman JR, McGovern BH, Wang-Weigand S, Lichter DI, Chafee M, Ford CB, Bernardo P, Zhao P, Simmons S, Tomlinson AD, Cook DN, Pomerantz RJ, Misra BK, Auninš JG, Trucksis M. A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis. Gastroenterology 2021;160:115-127.e30. [PMID: 32763240 DOI: 10.1053/j.gastro.2020.07.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
248 Holster S, Lindqvist CM, Repsilber D, Salonen A, de Vos WM, König J, Brummer RJ. The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study. Clin Transl Gastroenterol 2019;10:e00034. [PMID: 31009405 DOI: 10.14309/ctg.0000000000000034] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 17.0] [Reference Citation Analysis]
249 Mańkowska-Wierzbicka D, Stelmach-Mardas M, Gabryel M, Tomczak H, Skrzypczak-Zielińska M, Zakerska-Banaszak O, Sowińska A, Mahadea D, Baturo A, Wolko Ł, Słomski R, Dobrowolska A. The Effectiveness of Multi-Session FMT Treatment in Active Ulcerative Colitis Patients: A Pilot Study. Biomedicines 2020;8:E268. [PMID: 32756350 DOI: 10.3390/biomedicines8080268] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
250 Akkol EK, Karpuz B, Sobarzo-Sánchez E, Khan H. A phytopharmacological overview of medicinal plants used for prophylactic and treatment of colitis. Food Chem Toxicol 2020;144:111628. [PMID: 32738379 DOI: 10.1016/j.fct.2020.111628] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
251 Ianiro G, Segal JP, Mullish BH, Quraishi MN, Porcari S, Fabiani G, Gasbarrini A, Cammarota G. Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders. Future Microbiol 2020;15:1173-83. [PMID: 32954843 DOI: 10.2217/fmb-2020-0061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
252 Beniwal-Patel P, Stein DJ, Munoz-Price LS. The Juncture Between Clostridioides difficile Infection and Inflammatory Bowel Diseases. Clin Infect Dis 2019;69:366-72. [PMID: 30689770 DOI: 10.1093/cid/ciz061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
253 Oka A, Sartor RB. Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases. Dig Dis Sci. 2020;65:757-788. [PMID: 32006212 DOI: 10.1007/s10620-020-06090-z] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 26.5] [Reference Citation Analysis]
254 DuPont HL, Jiang ZD, DuPont AW, Utay NS. Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation. Dig Dis Sci 2020;65:741-56. [PMID: 32008133 DOI: 10.1007/s10620-020-06102-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
255 Glassner KL, Abraham BP, Quigley EMM. The microbiome and inflammatory bowel disease. J Allergy Clin Immunol. 2020;145:16-27. [PMID: 31910984 DOI: 10.1016/j.jaci.2019.11.003] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 36.5] [Reference Citation Analysis]
256 Iacob SA, Olariu MC, Iacob DG. Eosinophilic Colitis and Clostridioides difficile Sepsis With Rapid Remission After Antimicrobial Treatment; A Rare Coincidence and Its Pathogenic Implications. Front Med (Lausanne) 2020;7:328. [PMID: 32903297 DOI: 10.3389/fmed.2020.00328] [Reference Citation Analysis]
257 Jouhten H, Ronkainen A, Aakko J, Salminen S, Mattila E, Arkkila P, Satokari R. Cultivation and Genomics Prove Long-Term Colonization of Donor's Bifidobacteria in Recurrent Clostridioides difficile Patients Treated With Fecal Microbiota Transplantation. Front Microbiol 2020;11:1663. [PMID: 32760391 DOI: 10.3389/fmicb.2020.01663] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 Lahtinen P, Jalanka J, Hartikainen A, Mattila E, Hillilä M, Punkkinen J, Koskenpato J, Anttila VJ, Tillonen J, Satokari R, Arkkila P. Letter: faecal microbiota transplantation for irritable bowel syndrome. Authors' reply. Aliment Pharmacol Ther 2020;52:557-8. [PMID: 32656839 DOI: 10.1111/apt.15875] [Reference Citation Analysis]
259 Matsuoka K. Fecal microbiota transplantation for ulcerative colitis. Immunol Med 2021;44:30-4. [PMID: 32663072 DOI: 10.1080/25785826.2020.1792040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
260 Xiao Y, Angulo MT, Lao S, Weiss ST, Liu YY. An ecological framework to understand the efficacy of fecal microbiota transplantation. Nat Commun 2020;11:3329. [PMID: 32620839 DOI: 10.1038/s41467-020-17180-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
261 Biagioli M, Carino A, Di Giorgio C, Marchianò S, Bordoni M, Roselli R, Distrutti E, Fiorucci S. Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation. Nutrients 2020;12:E1945. [PMID: 32629887 DOI: 10.3390/nu12071945] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
262 Claytor JD, El-nachef N. Fecal microbial transplant for inflammatory bowel disease. Current Opinion in Clinical Nutrition & Metabolic Care 2020;23:355-60. [DOI: 10.1097/mco.0000000000000676] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
263 Liu S, Zhao W, Lan P, Mou X. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy. Protein Cell 2021;12:331-45. [PMID: 32601832 DOI: 10.1007/s13238-020-00745-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
264 Hatton GB, Ran S, Tranah TH, Shawcross DL. Lessons Learned from Faecal Microbiota Transplantation in Cirrhosis. Curr Hepatology Rep 2020;19:159-67. [DOI: 10.1007/s11901-020-00520-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
265 McQuade JL, Ologun GO, Arora R, Wargo JA. Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers. Curr Oncol Rep 2020;22:74. [PMID: 32577835 DOI: 10.1007/s11912-020-00913-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
266 Basson AR, Zhou Y, Seo B, Rodriguez-Palacios A, Cominelli F. Autologous fecal microbiota transplantation for the treatment of inflammatory bowel disease. Transl Res 2020;226:1-11. [PMID: 32585148 DOI: 10.1016/j.trsl.2020.05.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
267 Inamura K. Gut microbiota contributes towards immunomodulation against cancer: New frontiers in precision cancer therapeutics. Semin Cancer Biol 2021;70:11-23. [PMID: 32580023 DOI: 10.1016/j.semcancer.2020.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
268 Wang Y, Ren R, Sun G, Peng L, Tian Y, Yang Y. Pilot study of cytokine changes evaluation after fecal microbiota transplantation in patients with ulcerative colitis. Int Immunopharmacol 2020;85:106661. [PMID: 32563025 DOI: 10.1016/j.intimp.2020.106661] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
269 Edwards JA, Tan N, Toussaint N, Ou P, Mueller C, Stanek A, Zinsou V, Roudnitsky S, Sagal M, Dresner L, Schwartzman A, Huan C. Role of regenerating islet-derived proteins in inflammatory bowel disease. World J Gastroenterol 2020; 26(21): 2702-2714 [PMID: 32550748 DOI: 10.3748/wjg.v26.i21.2702] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
270 Bibbò S, Settanni CR, Porcari S, Bocchino E, Ianiro G, Cammarota G, Gasbarrini A. Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor. J Clin Med 2020;9:E1757. [PMID: 32517023 DOI: 10.3390/jcm9061757] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
271 Trang-Poisson C, Kerdreux E, Poinas A, Planche L, Sokol H, Bemer P, Cabanas K, Hivernaud E, Biron L, Flet L, Montassier E, Le Garcasson G, Chiffoleau A, Jobert A, Lepelletier D, Caillon J, Le Pape P, Imbert BM, Bourreille A. Impact of fecal microbiota transplantation on chronic recurrent pouchitis in ulcerative colitis with ileo-anal anastomosis: study protocol for a prospective, multicenter, double-blind, randomized, controlled trial. Trials 2020;21:455. [PMID: 32493442 DOI: 10.1186/s13063-020-04330-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
272 Zatorski H, Nakov R. Faecal Microbiota Transplantation in Inflammatory Bowel Disease: Current Concepts and Future Challenges. Curr Drug Targets 2020;21:1440-7. [PMID: 32484770 DOI: 10.2174/1389450121666200602125507] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
273 Ricciuto A, Sherman PM, Laxer RM. Gut microbiota in chronic inflammatory disorders: A focus on pediatric inflammatory bowel diseases and juvenile idiopathic arthritis. Clinical Immunology 2020;215:108415. [DOI: 10.1016/j.clim.2020.108415] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
274 Wu Q, Chen T, El-nezami H, Savidge TC. Food ingredients in human health: Ecological and metabolic perspectives implicating gut microbiota function. Trends in Food Science & Technology 2020;100:103-17. [DOI: 10.1016/j.tifs.2020.04.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
275 Okahara K, Ishikawa D, Nomura K, Ito S, Haga K, Takahashi M, Shibuya T, Osada T, Nagahara A. Matching between Donors and Ulcerative Colitis Patients Is Important for Long-Term Maintenance after Fecal Microbiota Transplantation. J Clin Med 2020;9:E1650. [PMID: 32486476 DOI: 10.3390/jcm9061650] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
276 Merrick B, Robinson E, Bunce C, Allen L, Bisnauthsing K, Izundu CC, Bell J, Amos G, Shankar-Hari M, Goodman A, Shawcross DL, Goldenberg SD. Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic Resistant Organisms (FERARO): a prospective, randomised placebo-controlled feasibility trial. BMJ Open 2020;10:e038847. [PMID: 32457083 DOI: 10.1136/bmjopen-2020-038847] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
277 Meng ZW, Baumgart DC. Darvadstrocel for the treatment of perianal fistulas in Crohn's disease. Expert Rev Gastroenterol Hepatol 2020;14:405-10. [PMID: 32354239 DOI: 10.1080/17474124.2020.1764349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 Amoroso C, Perillo F, Strati F, Fantini MC, Caprioli F, Facciotti F. The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation. Cells 2020;9:E1234. [PMID: 32429359 DOI: 10.3390/cells9051234] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 25.0] [Reference Citation Analysis]
279 Jain N. The Need for Personalized Approaches to Microbiome Modulation. Front Public Health 2020;8:144. [PMID: 32411648 DOI: 10.3389/fpubh.2020.00144] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
280 Plichta DR, Graham DB, Subramanian S, Xavier RJ. Therapeutic Opportunities in Inflammatory Bowel Disease: Mechanistic Dissection of Host-Microbiome Relationships. Cell. 2019;178:1041-1056. [PMID: 31442399 DOI: 10.1016/j.cell.2019.07.045] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 30.5] [Reference Citation Analysis]
281 Tang LL, Feng WZ, Cheng JJ, Gong YN. Clinical remission of ulcerative colitis after different modes of faecal microbiota transplantation: a meta-analysis. Int J Colorectal Dis 2020;35:1025-34. [PMID: 32388604 DOI: 10.1007/s00384-020-03599-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
282 Iruzubieta P, Medina JM, Fernández-López R, Crespo J, de la Cruz F. A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression. J Clin Med 2020;9:E1369. [PMID: 32392712 DOI: 10.3390/jcm9051369] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
283 Haifer C, Kelly CR, Paramsothy S, Andresen D, Papanicolas LE, McKew GL, Borody TJ, Kamm M, Costello SP, Andrews JM, Begun J, Chan HT, Connor S, Ghaly S, Johnson PD, Lemberg DA, Paramsothy R, Redmond A, Sheorey H, van der Poorten D, Leong RW. Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice. Gut 2020;69:801-10. [PMID: 32047093 DOI: 10.1136/gutjnl-2019-320260] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]
284 Bajaj JS, Khoruts A. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis. Journal of Hepatology 2020;72:1003-27. [DOI: 10.1016/j.jhep.2020.01.017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 17.0] [Reference Citation Analysis]
285 Weir V, Reddy KR. Nonpharmacologic Management of Hepatic Encephalopathy. Clinics in Liver Disease 2020;24:243-61. [DOI: 10.1016/j.cld.2020.01.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
286 Barbara G, Ianiro G. Faecal microbial transplantation in IBS: ready for prime time? Gut 2020;69:795-6. [PMID: 32102925 DOI: 10.1136/gutjnl-2019-320411] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
287 Chen HT, Huang HL, Li YQ, Xu HM, Zhou YJ. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view. World J Gastroenterol 2020; 26(16): 1901-1911 [PMID: 32390701 DOI: 10.3748/wjg.v26.i16.1901] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
288 Lahtinen P, Jalanka J, Hartikainen A, Mattila E, Hillilä M, Punkkinen J, Koskenpato J, Anttila V, Tillonen J, Satokari R, Arkkila P. Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome. Aliment Pharmacol Ther 2020;51:1321-31. [DOI: 10.1111/apt.15740] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 16.0] [Reference Citation Analysis]
289 Porter RJ, Kalla R, Ho GT. Ulcerative colitis: Recent advances in the understanding of disease pathogenesis. F1000Res 2020;9:F1000 Faculty Rev-294. [PMID: 32399194 DOI: 10.12688/f1000research.20805.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
290 Zhu L, Xu LZ, Zhao S, Shen ZF, Shen H, Zhan LB. Protective effect of baicalin on the regulation of Treg/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitis. Appl Microbiol Biotechnol 2020;104:5449-60. [PMID: 32322944 DOI: 10.1007/s00253-020-10527-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
291 Nicco C, Paule A, Konturek P, Edeas M. From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation. Diseases 2020;8:E9. [PMID: 32326509 DOI: 10.3390/diseases8020009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
292 Leong KSW, O'Sullivan JM, Derraik JGB, Cutfield WS. Gut microbiome transfer-Finding the perfect fit. Clin Endocrinol (Oxf) 2020;93:3-10. [PMID: 32181906 DOI: 10.1111/cen.14183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
293 Leonardi I, Paramsothy S, Doron I, Semon A, Kaakoush NO, Clemente JC, Faith JJ, Borody TJ, Mitchell HM, Colombel JF, Kamm MA, Iliev ID. Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis. Cell Host Microbe 2020;27:823-829.e3. [PMID: 32298656 DOI: 10.1016/j.chom.2020.03.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 15.0] [Reference Citation Analysis]
294 Kousgaard SJ, Michaelsen TY, Nielsen HL, Kirk KF, Brandt J, Albertsen M, Thorlacius-Ussing O. Clinical results and microbiota changes after faecal microbiota transplantation for chronic pouchitis: a pilot study. Scand J Gastroenterol 2020;55:421-9. [PMID: 32285709 DOI: 10.1080/00365521.2020.1748221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
295 Hiippala K, Kainulainen V, Suutarinen M, Heini T, Bowers JR, Jasso-Selles D, Lemmer D, Valentine M, Barnes R, Engelthaler DM, Satokari R. Isolation of Anti-Inflammatory and Epithelium Reinforcing Bacteroides and Parabacteroides Spp. from A Healthy Fecal Donor. Nutrients 2020;12:E935. [PMID: 32230951 DOI: 10.3390/nu12040935] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 23.0] [Reference Citation Analysis]
296 Sinagra E, Utzeri E, Morreale GC, Fabbri C, Pace F, Anderloni A. Microbiota-gut-brain axis and its affect inflammatory bowel disease: Pathophysiological concepts and insights for clinicians. World J Clin Cases 2020; 8(6): 1013-1025 [PMID: 32258072 DOI: 10.12998/wjcc.v8.i6.1013] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
297 Vujkovic-Cvijin I, Somsouk M. HIV and the Gut Microbiota: Composition, Consequences, and Avenues for Amelioration. Curr HIV/AIDS Rep 2019;16:204-13. [PMID: 31037552 DOI: 10.1007/s11904-019-00441-w] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 17.5] [Reference Citation Analysis]
298 Dang X, Xu M, Liu D, Zhou D, Yang W. Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis. PLoS One. 2020;15:e0228846. [PMID: 32182248 DOI: 10.1371/journal.pone.0228846] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
299 Davidovics ZH, Michail S, Nicholson MR, Kociolek LK, Pai N, Hansen R, Schwerd T, Maspons A, Shamir R, Szajewska H, Thapar N, de Meij T, Mosca A, Vandenplas Y, Kahn SA, Kellermayer R; FMT Special Interest Group of the North American Society of Pediatric Gastroenterology Hepatology, Nutrition, the European Society for Pediatric Gastroenterology Hepatology, Nutrition. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2019;68:130-43. [PMID: 30540704 DOI: 10.1097/MPG.0000000000002205] [Cited by in Crossref: 43] [Cited by in F6Publishing: 19] [Article Influence: 21.5] [Reference Citation Analysis]
300 Knox NC, Forbes JD, Peterson CL, Van Domselaar G, Bernstein CN. The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases. Am J Gastroenterol. 2019;114:1051-1070. [PMID: 31232832 DOI: 10.14309/ajg.0000000000000305] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
301 Allegretti JR, Kassam Z, Carrellas M, Mullish BH, Marchesi JR, Pechlivanis A, Smith M, Gerardin Y, Timberlake S, Pratt DS, Korzenik JR. Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial. Am J Gastroenterol. 2019;114:1071-1079. [PMID: 30730351 DOI: 10.14309/ajg.0000000000000115] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 29.5] [Reference Citation Analysis]
302 Lu H, Yan H, Masey O’neill H, Bradley C, Bedford M, Wilcock P, Nakatsu C, Adeola O, Ajuwon K, Miglior F. Effect of timing of postweaning xylanase supplementation on growth performance, nutrient digestibility, and fecal microbial composition in weanling pigs. Can J Anim Sci 2020;100:27-36. [DOI: 10.1139/cjas-2019-0021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
303 Gupta A, Saha S, Khanna S. Therapies to modulate gut microbiota: Past, present and future. World J Gastroenterol 2020; 26(8): 777-788 [PMID: 32148376 DOI: 10.3748/wjg.v26.i8.777] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 27] [Article Influence: 16.0] [Reference Citation Analysis]
304 Jin CY, Hu Y, Jin B. Faecal microbiota transplantation: Application in treatment of some digestive diseases and safety concerns. Shijie Huaren Xiaohua Zazhi 2020; 28(4): 135-143 [DOI: 10.11569/wcjd.v28.i4.135] [Reference Citation Analysis]
305 Lopetuso LR, Ianiro G, Allegretti JR, Bibbò S, Gasbarrini A, Scaldaferri F, Cammarota G. Fecal transplantation for ulcerative colitis: current evidence and future applications. Expert Opin Biol Ther 2020;20:343-51. [PMID: 32083498 DOI: 10.1080/14712598.2020.1733964] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
306 Chen K, Fu Y, Wang Y, Liao L, Xu H, Zhang A, Zhang J, Fan L, Ren J, Fang B. Therapeutic Effects of the In Vitro Cultured Human Gut Microbiota as Transplants on Altering Gut Microbiota and Improving Symptoms Associated with Autism Spectrum Disorder. Microb Ecol 2020;80:475-86. [DOI: 10.1007/s00248-020-01494-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
307 Sood A, Mahajan R, Singh A, Midha V, Mehta V, Narang V, Singh T, Singh Pannu A. Role of Faecal Microbiota Transplantation for Maintenance of Remission in Patients With Ulcerative Colitis: A Pilot Study. J Crohns Colitis. 2019;13:1311-1317. [PMID: 30873549 DOI: 10.1093/ecco-jcc/jjz060] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 24.0] [Reference Citation Analysis]
308 Chen HT, Huang HL, Xu HM, Luo QL, He J, Li YQ, Zhou YL, Nie YQ, Zhou YJ. Fecal microbiota transplantation ameliorates active ulcerative colitis. ExpTher Med. 2020;19:2650-2660. [PMID: 32256746 DOI: 10.3892/etm.2020.8512] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
309 Ding X, Li Q, Li P, Zhang T, Cui B, Ji G, Lu X, Zhang F. Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis. Drug Saf. 2019;42:869-880. [PMID: 30972640 DOI: 10.1007/s40264-019-00809-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 28.0] [Reference Citation Analysis]
310 Park S, Kang Y, Koh H, Kim S. Increasing incidence of inflammatory bowel disease in children and adolescents: significance of environmental factors. Clin Exp Pediatr 2020;63:337-44. [PMID: 32024322 DOI: 10.3345/cep.2019.00500] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
311 Fitzgibbon G, Mills KHG. The microbiota and immune-mediated diseases: Opportunities for therapeutic intervention. Eur J Immunol 2020;50:326-37. [PMID: 31991477 DOI: 10.1002/eji.201948322] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
312 Hazel K, O'Connor A. Emerging treatments for inflammatory bowel disease. Ther Adv Chronic Dis 2020;11:2040622319899297. [PMID: 32076497 DOI: 10.1177/2040622319899297] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 14.0] [Reference Citation Analysis]
313 Sokol H, Landman C, Seksik P, Berard L, Montil M, Nion-Larmurier I, Bourrier A, Le Gall G, Lalande V, De Rougemont A, Kirchgesner J, Daguenel A, Cachanado M, Rousseau A, Drouet É, Rosenzwajg M, Hagege H, Dray X, Klatzman D, Marteau P, Beaugerie L, Simon T; Saint-Antoine IBD Network. Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study. Microbiome 2020;8:12. [PMID: 32014035 DOI: 10.1186/s40168-020-0792-5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 91] [Article Influence: 25.0] [Reference Citation Analysis]
314 Magen R, Shaoul R. Alternative & complementary treatment for pediatric inflammatory bowel disease. Transl Pediatr 2019;8:428-35. [PMID: 31993357 DOI: 10.21037/tp.2019.09.02] [Reference Citation Analysis]
315 Mizuno S, Ono K, Mikami Y, Naganuma M, Fukuda T, Minami K, Masaoka T, Terada S, Yoshida T, Saigusa K, Hirahara N, Miyata H, Suda W, Hattori M, Kanai T. 5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis. Intest Res 2020;18:69-78. [PMID: 32013315 DOI: 10.5217/ir.2019.00084] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
316 Oliphant K, Cochrane K, Schroeter K, Daigneault MC, Yen S, Verdu EF, Allen-Vercoe E. Effects of Antibiotic Pretreatment of an Ulcerative Colitis-Derived Fecal Microbial Community on the Integration of Therapeutic Bacteria In Vitro. mSystems 2020;5:e00404-19. [PMID: 31992630 DOI: 10.1128/mSystems.00404-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
317 Yamamoto EA, Jørgensen TN. Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity. Front Immunol 2019;10:3141. [PMID: 32038645 DOI: 10.3389/fimmu.2019.03141] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 14.0] [Reference Citation Analysis]
318 Papanicolas LE, Gordon DL, Wesselingh SL, Rogers GB. Improving Risk-Benefit in Faecal Transplantation through Microbiome Screening. Trends Microbiol 2020;28:331-9. [PMID: 31952909 DOI: 10.1016/j.tim.2019.12.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
319 Ortigão R, Pimentel-Nunes P, Dinis-Ribeiro M, Libânio D. Gastrointestinal Microbiome - What We Need to Know in Clinical Practice. GE Port J Gastroenterol 2020;27:336-51. [PMID: 32999906 DOI: 10.1159/000505036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
320 Zhang T, Lu G, Zhao Z, Liu Y, Shen Q, Li P, Chen Y, Yin H, Wang H, Marcella C, Cui B, Cheng L, Ji G, Zhang F. Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening. Protein Cell. 2020;11:251-266. [PMID: 31919742 DOI: 10.1007/s13238-019-00684-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 17.0] [Reference Citation Analysis]
321 Newman KM, Vaughn BP. Efficacy of intestinal microbiota transplantation in ulcerative colitis: a review of current literature and knowledge. Minerva Gastroenterol Dietol 2019;65. [DOI: 10.23736/s1121-421x.19.02610-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
322 Ng SC, Kamm MA, Yeoh YK, Chan PKS, Zuo T, Tang W, Sood A, Andoh A, Ohmiya N, Zhou Y, Ooi CJ, Mahachai V, Wu CY, Zhang F, Sugano K, Chan FKL. Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE). Gut 2020;69:83-91. [PMID: 31611298 DOI: 10.1136/gutjnl-2019-319407] [Cited by in Crossref: 39] [Cited by in F6Publishing: 46] [Article Influence: 19.5] [Reference Citation Analysis]
323 Zhou Q, Ma L, Zhao W, Zhao W, Han X, Niu J, Li R, Zhao C. Flaxseed oil alleviates dextran sulphate sodium-induced ulcerative colitis in rats. Journal of Functional Foods 2020;64:103602. [DOI: 10.1016/j.jff.2019.103602] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
324 Kayal M, Shah S. Ulcerative Colitis: Current and Emerging Treatment Strategies. J Clin Med 2019;9:E94. [PMID: 31905945 DOI: 10.3390/jcm9010094] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
325 Ocansey DKW, Wang L, Wang J, Yan Y, Qian H, Zhang X, Xu W, Mao F. Mesenchymal stem cell-gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect. Clin Transl Med 2019;8:31. [PMID: 31872304 DOI: 10.1186/s40169-019-0251-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
326 Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019;114:384-413. [PMID: 30840605 DOI: 10.14309/ajg.0000000000000152] [Cited by in Crossref: 300] [Cited by in F6Publishing: 254] [Article Influence: 100.0] [Reference Citation Analysis]
327 Lo Presti A, Del Chierico F, Altomare A, Zorzi F, Cella E, Putignani L, Guarino MPL, Monteleone G, Cicala M, Angeletti S, Ciccozzi M. Exploring the genetic diversity of the 16S rRNA gene of Akkermansia muciniphila in IBD and IBS. Future Microbiol 2019;14:1497-509. [PMID: 31850811 DOI: 10.2217/fmb-2019-0175] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
328 Costello SP, Bryant RV. Faecal microbiota transplantation in Australia: bogged down in regulatory uncertainty. Intern Med J 2019;49:148-51. [PMID: 30754077 DOI: 10.1111/imj.14212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
329 Zou M, Jie Z, Cui B, Wang H, Feng Q, Zou Y, Zhang X, Yang H, Wang J, Zhang F, Jia H. Fecal microbiota transplantation results in bacterial strain displacement in patients with inflammatory bowel diseases. FEBS Open Bio 2020;10:41-55. [PMID: 31622538 DOI: 10.1002/2211-5463.12744] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
330 Tariq R, Disbrow MB, Dibaise JK, Orenstein R, Saha S, Solanky D, Loftus EV, Pardi DS, Khanna S. Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020;26:1415-1420. [PMID: 31821444 DOI: 10.1093/ibd/izz299] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
331 Pittayanon R, Lau JT, Leontiadis GI, Tse F, Yuan Y, Surette M, Moayyedi P. Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review. Gastroenterology. 2020;158:930-946.e1. [PMID: 31812509 DOI: 10.1053/j.gastro.2019.11.294] [Cited by in Crossref: 65] [Cited by in F6Publishing: 152] [Article Influence: 21.7] [Reference Citation Analysis]
332 Cammarota G, Ianiro G, Kelly CR, Mullish BH, Allegretti JR, Kassam Z, Putignani L, Fischer M, Keller JJ, Costello SP, Sokol H, Kump P, Satokari R, Kahn SA, Kao D, Arkkila P, Kuijper EJ, Vehreschild MJG, Pintus C, Lopetuso L, Masucci L, Scaldaferri F, Terveer EM, Nieuwdorp M, López-Sanromán A, Kupcinskas J, Hart A, Tilg H, Gasbarrini A. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut 2019;68:2111-21. [PMID: 31563878 DOI: 10.1136/gutjnl-2019-319548] [Cited by in Crossref: 160] [Cited by in F6Publishing: 156] [Article Influence: 53.3] [Reference Citation Analysis]
333 Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H, Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB; IBD guidelines eDelphi consensus group. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019;68:s1-s106. [PMID: 31562236 DOI: 10.1136/gutjnl-2019-318484] [Cited by in Crossref: 617] [Cited by in F6Publishing: 555] [Article Influence: 205.7] [Reference Citation Analysis]
334 Pai N, Popov J, Hill L, Hartung E. Protocol for a double-blind, randomised, placebo-controlled pilot study for assessing the feasibility and efficacy of faecal microbiota transplant in a paediatric Crohn's disease population: PediCRaFT Trial. BMJ Open 2019;9:e030120. [PMID: 31784432 DOI: 10.1136/bmjopen-2019-030120] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
335 Quraishi MN, Shaheen W, Oo YH, Iqbal TH. Immunological Mechanisms Underpinning Faecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease. Clin Exp Immunol. 2019;199:24-38. [PMID: 31777058 DOI: 10.1111/cei.13397] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
336 Yalchin M, Segal JP, Mullish BH, Quraishi MN, Iqbal TH, Marchesi JR, Hart AL. Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease. Therap Adv Gastroenterol. 2019;12:1756284819891038. [PMID: 31803254 DOI: 10.1177/1756284819891038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
337 Digby-Bell JL, Atreya R, Monteleone G, Powell N. Interrogating host immunity to predict treatment response in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2020;17:9-20. [PMID: 31767987 DOI: 10.1038/s41575-019-0228-5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 16.3] [Reference Citation Analysis]
338 Lynch KE, Parke EC, O’malley MA. How causal are microbiomes? A comparison with the Helicobacter pylori explanation of ulcers. Biol Philos 2019;34. [DOI: 10.1007/s10539-019-9702-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
339 Freitag TL, Hartikainen A, Jouhten H, Sahl C, Meri S, Anttila VJ, Mattila E, Arkkila P, Jalanka J, Satokari R. Minor Effect of Antibiotic Pre-treatment on the Engraftment of Donor Microbiota in Fecal Transplantation in Mice. Front Microbiol 2019;10:2685. [PMID: 31824463 DOI: 10.3389/fmicb.2019.02685] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
340 Sharma A, Das P, Buschmann M, Gilbert JA. The Future of Microbiome-Based Therapeutics in Clinical Applications. Clin Pharmacol Ther 2020;107:123-8. [PMID: 31617205 DOI: 10.1002/cpt.1677] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
341 Actis GC, Pellicano R, Fagoonee S, Ribaldone DG. History of Inflammatory Bowel Diseases. J Clin Med. 2019;8:1970. [PMID: 31739460 DOI: 10.3390/jcm8111970] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
342 Quraishi MNN, Yalchin M, Blackwell C, Segal J, Sharma N, Hawkey P, McCune V, Hart AL, Gaya D, Ives NJ, Magill L, Loi S, Hewitt C, Gerasimidis K, Loman NJ, Hansen R, McMullan C, Mathers J, Quince C, Crees N, Iqbal T. STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis. BMJ Open 2019;9:e030659. [PMID: 31719078 DOI: 10.1136/bmjopen-2019-030659] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
343 Carbone C, Piro G, Di Noia V, D'Argento E, Vita E, Ferrara MG, Pilotto S, Milella M, Cammarota G, Gasbarrini A, Tortora G, Bria E. Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer. Mediators Inflamm 2019;2019:7652014. [PMID: 31827379 DOI: 10.1155/2019/7652014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
344 Ghaly S, Hart PH, Lawrance IC. Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome. Expert Rev Gastroenterol Hepatol 2019;13:1039-48. [PMID: 31657973 DOI: 10.1080/17474124.2019.1685874] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
345 Sun Y, Li L, Xie R, Wang B, Jiang K, Cao H. Stress Triggers Flare of Inflammatory Bowel Disease in Children and Adults. Front Pediatr 2019;7:432. [PMID: 31709203 DOI: 10.3389/fped.2019.00432] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
346 Singh SP, Chand HS, Banerjee S, Agarwal H, Raizada V, Roy S, Sopori M. Acetylcholinesterase Inhibitor Pyridostigmine Bromide Attenuates Gut Pathology and Bacterial Dysbiosis in a Murine Model of Ulcerative Colitis. Dig Dis Sci 2020;65:141-9. [PMID: 31643033 DOI: 10.1007/s10620-019-05838-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
347 Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos K, Croft N, Navas-López V, Wilson DC, Lawrence S, Russell RK. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;67:257-91. [PMID: 30044357 DOI: 10.1097/MPG.0000000000002035] [Cited by in Crossref: 106] [Cited by in F6Publishing: 30] [Article Influence: 35.3] [Reference Citation Analysis]
348 Mamo Y, Woodworth MH, Wang T, Dhere T, Kraft CS. Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection. Clin Infect Dis 2018;66:1705-11. [PMID: 29272401 DOI: 10.1093/cid/cix1097] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
349 Lleal M, Sarrabayrouse G, Willamil J, Santiago A, Pozuelo M, Manichanh C. A single faecal microbiota transplantation modulates the microbiome and improves clinical manifestations in a rat model of colitis. EBioMedicine 2019;48:630-41. [PMID: 31628021 DOI: 10.1016/j.ebiom.2019.10.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
350 Lin DM, Koskella B, Ritz NL, Lin D, Carroll-Portillo A, Lin HC. Transplanting Fecal Virus-Like Particles Reduces High-Fat Diet-Induced Small Intestinal Bacterial Overgrowth in Mice. Front Cell Infect Microbiol 2019;9:348. [PMID: 31750259 DOI: 10.3389/fcimb.2019.00348] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
351 Elangovan A, Allegretti JR, Fischer M. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation. Expert Opin Biol Ther 2019;19:1343-55. [PMID: 31570017 DOI: 10.1080/14712598.2019.1673725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
352 Stange EF, Schroeder BO. Microbiota and mucosal defense in IBD: an update. Expert Rev Gastroenterol Hepatol. 2019;13:963-976. [PMID: 31603356 DOI: 10.1080/17474124.2019.1671822] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
353 Duvallet C, Zellmer C, Panchal P, Budree S, Osman M, Alm EJ. Framework for rational donor selection in fecal microbiota transplant clinical trials. PLoS One 2019;14:e0222881. [PMID: 31600222 DOI: 10.1371/journal.pone.0222881] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 6.3] [Reference Citation Analysis]
354 Holster S, Hooiveld GJ, Repsilber D, Vos WM, Brummer RJ, König J. Allogenic Faecal Microbiota Transfer Induces Immune-Related Gene Sets in the Colon Mucosa of Patients with Irritable Bowel Syndrome. Biomolecules 2019;9:E586. [PMID: 31597320 DOI: 10.3390/biom9100586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
355 Smith RP, Easson C, Lyle SM, Kapoor R, Donnelly CP, Davidson EJ, Parikh E, Lopez JV, Tartar JL. Gut microbiome diversity is associated with sleep physiology in humans. PLoS One 2019;14:e0222394. [PMID: 31589627 DOI: 10.1371/journal.pone.0222394] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 14.7] [Reference Citation Analysis]
356 Drewes JL, Corona A, Sanchez U, Fan Y, Hourigan SK, Weidner M, Sidhu SD, Simner PJ, Wang H, Timp W, Oliva-Hemker M, Sears CL. Transmission and clearance of potential procarcinogenic bacteria during fecal microbiota transplantation for recurrent Clostridioides difficile. JCI Insight 2019;4:130848. [PMID: 31578306 DOI: 10.1172/jci.insight.130848] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
357 Cryan JF, O'riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, Guzzetta KE, Jaggar M, Long-smith CM, Lyte JM, Martin JA, Molinero-perez A, Moloney G, Morelli E, Morillas E, O'connor R, Cruz-pereira JS, Peterson VL, Rea K, Ritz NL, Sherwin E, Spichak S, Teichman EM, van de Wouw M, Ventura-silva AP, Wallace-fitzsimons SE, Hyland N, Clarke G, Dinan TG. The Microbiota-Gut-Brain Axis. Physiological Reviews 2019;99:1877-2013. [DOI: 10.1152/physrev.00018.2018] [Cited by in Crossref: 551] [Cited by in F6Publishing: 492] [Article Influence: 183.7] [Reference Citation Analysis]
358 Bian X, Wu W, Yang L, Lv L, Wang Q, Li Y, Ye J, Fang D, Wu J, Jiang X, Shi D, Li L. Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice. Front Microbiol 2019;10:2259. [PMID: 31632373 DOI: 10.3389/fmicb.2019.02259] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 27.3] [Reference Citation Analysis]
359 Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore D, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Williams HR, Goldenberg SD. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. J Hosp Infect. 2018;100 Suppl 1:S1-S31. [PMID: 30173851 DOI: 10.1016/j.jhin.2018.07.037] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
360 Ishikawa D, Sasaki T, Takahashi M, Kuwahara-Arai K, Haga K, Ito S, Okahara K, Nakajima A, Shibuya T, Osada T, Hiramatsu K, Watanabe S, Nagahara A. The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics. Inflamm Bowel Dis 2018;24:2590-8. [PMID: 30124831 DOI: 10.1093/ibd/izy266] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
361 Spalinger MR, Schwarzfischer M, Hering L, Shawki A, Sayoc A, Santos A, Gottier C, Lang S, Bäbler K, Geirnaert A, Lacroix C, Leventhal GE, Dai X, Rawlings D, Chan AA, Rogler G, Mccole DF, Scharl M. Loss of PTPN22 abrogates the beneficial effect of cohousing-mediated fecal microbiota transfer in murine colitis. Mucosal Immunol 2019;12:1336-47. [DOI: 10.1038/s41385-019-0201-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
362 Poyet M, Groussin M, Gibbons SM, Avila-Pacheco J, Jiang X, Kearney SM, Perrotta AR, Berdy B, Zhao S, Lieberman TD, Swanson PK, Smith M, Roesemann S, Alexander JE, Rich SA, Livny J, Vlamakis H, Clish C, Bullock K, Deik A, Scott J, Pierce KA, Xavier RJ, Alm EJ. A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research. Nat Med 2019;25:1442-52. [PMID: 31477907 DOI: 10.1038/s41591-019-0559-3] [Cited by in Crossref: 106] [Cited by in F6Publishing: 111] [Article Influence: 35.3] [Reference Citation Analysis]
363 Sood A, Singh A, Mahajan R, Midha V, Mehta V, Gupta YK, Narang V, Kaur K. Acceptability, tolerability, and safety of fecal microbiota transplantation in patients with active ulcerative colitis (AT&S Study). J Gastroenterol Hepatol 2020;35:418-24. [PMID: 31408913 DOI: 10.1111/jgh.14829] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
364 Allegretti JR, Mullish BH, Kelly C, Fischer M. The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications. Lancet. 2019;394:420-431. [PMID: 31379333 DOI: 10.1016/s0140-6736(19)31266-8] [Cited by in Crossref: 108] [Cited by in F6Publishing: 55] [Article Influence: 36.0] [Reference Citation Analysis]
365 Flux MC, Lowry CA. Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience. Neurobiol Dis 2020;135:104578. [PMID: 31454550 DOI: 10.1016/j.nbd.2019.104578] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
366 Chang CS, Kao CY. Current understanding of the gut microbiota shaping mechanisms. J Biomed Sci 2019;26:59. [PMID: 31434568 DOI: 10.1186/s12929-019-0554-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 53] [Article Influence: 13.0] [Reference Citation Analysis]
367 Rosenbaum JT, Asquith M. The microbiome and HLA-B27-associated acute anterior uveitis. Nat Rev Rheumatol 2018;14:704-13. [PMID: 30301938 DOI: 10.1038/s41584-018-0097-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 15.3] [Reference Citation Analysis]
368 Hasan N, Yang H. Factors affecting the composition of the gut microbiota, and its modulation. PeerJ 2019;7:e7502. [PMID: 31440436 DOI: 10.7717/peerj.7502] [Cited by in Crossref: 95] [Cited by in F6Publishing: 77] [Article Influence: 31.7] [Reference Citation Analysis]
369 Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T, Che T, Zhang C. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Pathogens 2019;8:E126. [PMID: 31412603 DOI: 10.3390/pathogens8030126] [Cited by in Crossref: 127] [Cited by in F6Publishing: 113] [Article Influence: 42.3] [Reference Citation Analysis]
370 Yevdokimova NV, Chyornenkaya TV. Fecal Microbiota Transplantation: Past, Present and Future. Neotložnaâ med pomoŝʹ 2019;8:160-5. [DOI: 10.23934/2223-9022-2019-8-2-160-165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
371 Parker A, Fonseca S, Carding SR. Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. Gut Microbes 2020;11:135-57. [PMID: 31368397 DOI: 10.1080/19490976.2019.1638722] [Cited by in Crossref: 123] [Cited by in F6Publishing: 105] [Article Influence: 41.0] [Reference Citation Analysis]
372 Yang Z, Bu C, Yuan W, Shen Z, Quan Y, Wu S, Zhu C, Wang X. Fecal Microbiota Transplant via Endoscopic Delivering Through Small Intestine and Colon: No Difference for Crohn’s Disease. Dig Dis Sci 2020;65:150-7. [DOI: 10.1007/s10620-019-05751-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
373 Zhou Y, Xu H, Huang H, Li Y, Chen H, He J, Du Y, Chen Y, Zhou Y, Nie Y. Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders? Biomed Res Int. 2019;2019:3469754. [PMID: 31467881 DOI: 10.1155/2019/3469754] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
374 Huang H, Xu H, Luo Q, He J, Li M, Chen H, Tang W, Nie Y, Zhou Y. Fecal microbiota transplantation to treat Parkinson's disease with constipation: A case report. Medicine (Baltimore) 2019;98:e16163. [PMID: 31261545 DOI: 10.1097/MD.0000000000016163] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 11.7] [Reference Citation Analysis]
375 Ribaldone DG, Pellicano R, Actis GC. Inflammation in gastrointestinal disorders: prevalent socioeconomic factors. Clin Exp Gastroenterol 2019;12:321-9. [PMID: 31410046 DOI: 10.2147/CEG.S210844] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
376 Moayyedi P. Faecal microbiota transplantation for IBS: still a long way to go. Lancet Gastroenterol Hepatol. 2019;4:656-657. [PMID: 31326346 DOI: 10.1016/s2468-1253(19)30226-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
377 Aroniadis OC, Brandt LJ, Oneto C, Feuerstadt P, Sherman A, Wolkoff AW, Kassam Z, Sadovsky RG, Elliott RJ, Budree S, Kim M, Keller MJ. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2019;4:675-685. [PMID: 31326345 DOI: 10.1016/s2468-1253(19)30198-0] [Cited by in Crossref: 56] [Cited by in F6Publishing: 35] [Article Influence: 18.7] [Reference Citation Analysis]
378 Simrén M, Tack J. New treatments and therapeutic targets for IBS and other functional bowel disorders. Nat Rev Gastroenterol Hepatol 2018;15:589-605. [PMID: 29930260 DOI: 10.1038/s41575-018-0034-5] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 25.3] [Reference Citation Analysis]
379 Olesen SW, Leier MM, Alm EJ, Kahn SA. Searching for superstool: maximizing the therapeutic potential of FMT.Nat Rev Gastroenterol Hepatol. 2018;15:387-388. [PMID: 29703976 DOI: 10.1038/s41575-018-0019-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
380 Selvig D, Piceno Y, Terdiman J, Zydek M, Umetsu SE, Balitzer D, Fadrosh D, Lynch K, Lamere B, Leith T, Kassam Z, Beck K, Lewin S, Ma A, Somsouk M, Lynch SV, El-Nachef N. Fecal Microbiota Transplantation in Pouchitis: Clinical, Endoscopic, Histologic, and Microbiota Results from a Pilot Study. Dig Dis Sci 2020;65:1099-106. [PMID: 31302808 DOI: 10.1007/s10620-019-05715-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
381 Cammarota G, Ianiro G. FMT for ulcerative colitis: closer to the turning point. Nat Rev Gastroenterol Hepatol 2019;16:266-8. [PMID: 30850823 DOI: 10.1038/s41575-019-0131-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
382 Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol. 2019;16:605-616. [PMID: 31296969 DOI: 10.1038/s41575-019-0173-3] [Cited by in Crossref: 461] [Cited by in F6Publishing: 404] [Article Influence: 153.7] [Reference Citation Analysis]
383 Knoop KA, Holtz LR, Newberry RD. Inherited nongenetic influences on the gut microbiome and immune system. Birth Defects Res 2018;110:1494-503. [PMID: 30576093 DOI: 10.1002/bdr2.1436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
384 Gogokhia L, Buhrke K, Bell R, Hoffman B, Brown DG, Hanke-Gogokhia C, Ajami NJ, Wong MC, Ghazaryan A, Valentine JF, Porter N, Martens E, O'Connell R, Jacob V, Scherl E, Crawford C, Stephens WZ, Casjens SR, Longman RS, Round JL. Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis. Cell Host Microbe 2019;25:285-299.e8. [PMID: 30763538 DOI: 10.1016/j.chom.2019.01.008] [Cited by in Crossref: 129] [Cited by in F6Publishing: 128] [Article Influence: 43.0] [Reference Citation Analysis]
385 Huang HL, Chen HT, Luo QL, Xu HM, He J, Li YQ, Zhou YL, Yao F, Nie YQ, Zhou YJ. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota. J Dig Dis. 2019;20:401-408. [PMID: 31070838 DOI: 10.1111/1751-2980.12756] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
386 Britton GJ, Contijoch EJ, Mogno I, Vennaro OH, Llewellyn SR, Ng R, Li Z, Mortha A, Merad M, Das A, Gevers D, McGovern DPB, Singh N, Braun J, Jacobs JP, Clemente JC, Grinspan A, Sands BE, Colombel JF, Dubinsky MC, Faith JJ. Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice. Immunity 2019;50:212-224.e4. [PMID: 30650377 DOI: 10.1016/j.immuni.2018.12.015] [Cited by in Crossref: 132] [Cited by in F6Publishing: 130] [Article Influence: 44.0] [Reference Citation Analysis]
387 Monif GRG. Is ulcerative colitis a disease of a dysfunctional microbiota? Med Hypotheses 2019;131:109300. [PMID: 31443761 DOI: 10.1016/j.mehy.2019.109300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
388 Rode AA, Bytzer P, Pedersen OB, Engberg J. Establishing a donor stool bank for faecal microbiota transplantation: methods and feasibility. Eur J Clin Microbiol Infect Dis 2019;38:1837-47. [PMID: 31273647 DOI: 10.1007/s10096-019-03615-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
389 Gutin L, Piceno Y, Fadrosh D, Lynch K, Zydek M, Kassam Z, Lamere B, Terdiman J, Ma A, Somsouk M, Lynch S, El-nachef N. Fecal microbiota transplant for Crohn disease: A study evaluating safety, efficacy, and microbiome profile. United European Gastroenterol j 2019;7:807-14. [DOI: 10.1177/2050640619845986] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 12.7] [Reference Citation Analysis]
390 Dutta SK, Verma S, Jain V, Surapaneni BK, Vinayek R, Phillips L, Nair PP. Parkinson's Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation. J Neurogastroenterol Motil 2019;25:363-76. [PMID: 31327219 DOI: 10.5056/jnm19044] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 21.0] [Reference Citation Analysis]
391 Aron-wisnewsky J, Clément K, Nieuwdorp M. Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes? Curr Diab Rep 2019;19. [DOI: 10.1007/s11892-019-1180-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
392 Borody TJ, Clancy A. Fecal microbiota transplantation for ulcerative colitis-where to from here? Transl Gastroenterol Hepatol 2019;4:48. [PMID: 31304425 DOI: 10.21037/tgh.2019.06.04] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
393 Jørgensen SMD, Hvas CL, Dahlerup JF, Mikkelsen S, Ehlers L, Hammeken LH, Licht TR, Bahl MI, Erikstrup C. Banking feces: a new frontier for public blood banks? Transfusion 2019;59:2776-82. [PMID: 31241182 DOI: 10.1111/trf.15422] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
394 Costello SP, Conlon MA, Andrews JM. Fecal Microbiota Transplantation for Ulcerative Colitis-Reply. JAMA 2019;321:2240-1. [PMID: 31184735 DOI: 10.1001/jama.2019.3950] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
395 Nusbaum DJ, Sun F, Ren J, Zhu Z, Ramsy N, Pervolarakis N, Kunde S, England W, Gao B, Fiehn O, Michail S, Whiteson K. Gut microbial and metabolomic profiles after fecal microbiota transplantation in pediatric ulcerative colitis patients. FEMS Microbiol Ecol 2018;94. [PMID: 30010747 DOI: 10.1093/femsec/fiy133] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 11.3] [Reference Citation Analysis]
396 D'Haens GR, Jobin C. Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection. Gastroenterology 2019;157:624-36. [PMID: 31220424 DOI: 10.1053/j.gastro.2019.04.053] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 10.7] [Reference Citation Analysis]
397 Wang JW, Wang YK, Zhang F, Su YC, Wang JY, Wu DC, Hsu WH. Initial experience of fecal microbiota transplantation in gastrointestinal disease: A case series. Kaohsiung J Med Sci. 2019;35:566-571. [PMID: 31197926 DOI: 10.1002/kjm2.12094] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
398 Leshem A, Horesh N, Elinav E. Fecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome. Front Immunol 2019;10:1341. [PMID: 31258528 DOI: 10.3389/fimmu.2019.01341] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
399 Wortelboer K, Nieuwdorp M, Herrema H. Fecal microbiota transplantation beyond Clostridioides difficile infections. EBioMedicine 2019;44:716-29. [PMID: 31201141 DOI: 10.1016/j.ebiom.2019.05.066] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 11.3] [Reference Citation Analysis]
400 Nichols RG, Peters JM, Patterson AD. Interplay Between the Host, the Human Microbiome, and Drug Metabolism. Hum Genomics 2019;13:27. [PMID: 31186074 DOI: 10.1186/s40246-019-0211-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 34] [Article Influence: 8.7] [Reference Citation Analysis]
401 Giau VV, Lee H, An SSA, Hulme J. Recent advances in the treatment of C. difficile using biotherapeutic agents. Infect Drug Resist 2019;12:1597-615. [PMID: 31354309 DOI: 10.2147/IDR.S207572] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
402 Picardo SL, Coburn B, Hansen AR. The microbiome and cancer for clinicians. Crit Rev Oncol Hematol. 2019;141:1-12. [PMID: 31202124 DOI: 10.1016/j.critrevonc.2019.06.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
403 Roquilly A, Torres A, Villadangos JA, Netea MG, Dickson R, Becher B, Asehnoune K. Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia. Lancet Respir Med 2019;7:710-20. [PMID: 31182406 DOI: 10.1016/S2213-2600(19)30140-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 7.3] [Reference Citation Analysis]
404 Sorrentino D, Nguyen VQ, Chitnavis MV. Capturing the Biologic Onset of Inflammatory Bowel Diseases: Impact on Translational and Clinical Science. Cells 2019;8:E548. [PMID: 31174359 DOI: 10.3390/cells8060548] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
405 Jayakumar S, Loomba R. Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications. Aliment Pharmacol Ther 2019;50:144-58. [PMID: 31149745 DOI: 10.1111/apt.15314] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
406 Burrello C, Giuffrè MR, Macandog AD, Diaz-Basabe A, Cribiù FM, Lopez G, Borgo F, Nezi L, Caprioli F, Vecchi M, Facciotti F. Fecal Microbiota Transplantation Controls Murine Chronic Intestinal Inflammation by Modulating Immune Cell Functions and Gut Microbiota Composition. Cells 2019;8:E517. [PMID: 31142049 DOI: 10.3390/cells8060517] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
407 Ianiro G, Eusebi LH, Black CJ, Gasbarrini A, Cammarota G, Ford AC. Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome.Aliment Pharmacol Ther. 2019;50:240-248. [PMID: 31136009 DOI: 10.1111/apt.15330] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 29.3] [Reference Citation Analysis]
408 Kellermayer R. Fecal microbiota transplantation: great potential with many challenges. Transl Gastroenterol Hepatol 2019;4:40. [PMID: 31231707 DOI: 10.21037/tgh.2019.05.10] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
409 Choi RY, Asquith M, Rosenbaum JT. Fecal transplants in spondyloarthritis and uveitis: ready for a clinical trial? Curr Opin Rheumatol 2018;30:303-9. [PMID: 29538010 DOI: 10.1097/BOR.0000000000000506] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
410 de Souza HSP, Fiocchi C. Network Medicine: A Mandatory Next Step for Inflammatory Bowel Disease. Inflamm Bowel Dis 2018;24:671-9. [PMID: 29562278 DOI: 10.1093/ibd/izx111] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
411 McSweeney B, Allegretti JR, Fischer M, Xu H, Goodman KJ, Monaghan T, McLeod C, Mullish BH, Petrof EO, Phelps EL, Chis R, Edmison A, Juby A, Ennis-Davis R, Roach B, Wong K, Kao D. In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation. Gut Microbes 2020;11:51-62. [PMID: 31122134 DOI: 10.1080/19490976.2019.1611153] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
412 Saha S, Khanna S. Management of Clostridioides difficile colitis: insights for the gastroenterologist. Therap Adv Gastroenterol 2019;12:1756284819847651. [PMID: 31105766 DOI: 10.1177/1756284819847651] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
413 Zhang F, Zhang T, Zhu H, Borody TJ. Evolution of fecal microbiota transplantation in methodology and ethical issues. CurrOpinPharmacol. 2019;49:11-16. [PMID: 31059962 DOI: 10.1016/j.coph.2019.04.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
414 van Dijkhuizen EHP, Del Chierico F, Malattia C, Russo A, Pires Marafon D, Ter Haar NM, Magni-Manzoni S, Vastert SJ, Dallapiccola B, Prakken B, Martini A, De Benedetti F, Putignani L; Model Driven Paediatric European Digital Repository Consortium. Microbiome Analytics of the Gut Microbiota in Patients With Juvenile Idiopathic Arthritis: A Longitudinal Observational Cohort Study. Arthritis Rheumatol. 2019;71:1000-1010. [PMID: 30592383 DOI: 10.1002/art.40827] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 7.7] [Reference Citation Analysis]
415 Hsu WH, Wang JY, Kuo CH. Current applications of fecal microbiota transplantation in intestinal disorders. Kaohsiung J Med Sci 2019;35:327-31. [PMID: 31017741 DOI: 10.1002/kjm2.12069] [Reference Citation Analysis]
416 Beale AL, Kaye DM, Marques FZ. The role of the gut microbiome in sex differences in arterial pressure. Biol Sex Differ 2019;10:22. [PMID: 31023366 DOI: 10.1186/s13293-019-0236-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 11.0] [Reference Citation Analysis]
417 Sasaki K, Inoue J, Sasaki D, Hoshi N, Shirai T, Fukuda I, Azuma T, Kondo A, Osawa R. Construction of a Model Culture System of Human Colonic Microbiota to Detect Decreased Lachnospiraceae Abundance and Butyrogenesis in the Feces of Ulcerative Colitis Patients. Biotechnol J 2019;14:e1800555. [PMID: 30791234 DOI: 10.1002/biot.201800555] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
418 Lam WC, Zhao C, Ma WJ, Yao L. The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis. Gastroenterol Res Pract 2019;2019:1287493. [PMID: 31178906 DOI: 10.1155/2019/1287493] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
419 Saha S, Tariq R, Tosh PK, Pardi DS, Khanna S. Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review. Clin Microbiol Infect. 2019;25:958-963. [PMID: 30986562 DOI: 10.1016/j.cmi.2019.04.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 10.3] [Reference Citation Analysis]
420 Kang DW, Adams JB, Coleman DM, Pollard EL, Maldonado J, McDonough-Means S, Caporaso JG, Krajmalnik-Brown R. Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota. Sci Rep. 2019;9:5821. [PMID: 30967657 DOI: 10.1038/s41598-019-42183-0] [Cited by in Crossref: 146] [Cited by in F6Publishing: 212] [Article Influence: 48.7] [Reference Citation Analysis]
421 Lavelle A, Hill C. Gut Microbiome in Health and Disease: Emerging Diagnostic Opportunities. Gastroenterol Clin North Am 2019;48:221-35. [PMID: 31046972 DOI: 10.1016/j.gtc.2019.02.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
422 Cold F, Browne PD, Günther S, Halkjaer SI, Petersen AM, Al-Gibouri Z, Hansen LH, Christensen AH. Multidonor FMT capsules improve symptoms and decrease fecal calprotectin in ulcerative colitis patients while treated - an open-label pilot study. Scand J Gastroenterol 2019;54:289-96. [PMID: 30946615 DOI: 10.1080/00365521.2019.1585939] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
423 Paramsothy S, Nielsen S, Kamm MA, Deshpande NP, Faith JJ, Clemente JC, Paramsothy R, Walsh AJ, van den Bogaerde J, Samuel D, Leong RW, Connor S, Ng W, Lin E, Borody TJ, Wilkins MR, Colombel J, Mitchell HM, Kaakoush NO. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis. Gastroenterology 2019;156:1440-1454.e2. [DOI: 10.1053/j.gastro.2018.12.001] [Cited by in Crossref: 112] [Cited by in F6Publishing: 172] [Article Influence: 37.3] [Reference Citation Analysis]
424 Falony G, Vandeputte D, Caenepeel C, Vieira-Silva S, Daryoush T, Vermeire S, Raes J. The human microbiome in health and disease: hype or hope. Acta Clin Belg 2019;74:53-64. [PMID: 30810508 DOI: 10.1080/17843286.2019.1583782] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
425 Adler E, Tabaa A, Kassam Z, Zydek M, Terdiman J, El-Nachef N. Capsule-Delivered Fecal Microbiota Transplant Is Safe and Well Tolerated in Patients with Ulcerative Colitis. Dig Dis Sci 2019;64:2452-4. [PMID: 30919208 DOI: 10.1007/s10620-019-05596-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
426 Mukhopadhya I, Segal JP, Carding SR, Hart AL, Hold GL. The gut virome: the 'missing link' between gut bacteria and host immunity? Therap Adv Gastroenterol 2019;12:1756284819836620. [PMID: 30936943 DOI: 10.1177/1756284819836620] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 18.3] [Reference Citation Analysis]
427 Roubalová R, Procházková P, Papežová H, Smitka K, Bilej M, Tlaskalová-Hogenová H. Anorexia nervosa: Gut microbiota-immune-brain interactions. Clin Nutr 2020;39:676-84. [PMID: 30952533 DOI: 10.1016/j.clnu.2019.03.023] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
428 Levy AN, Allegretti JR. Insights into the role of fecal microbiota transplantation for the treatment of inflammatory bowel disease. Therap Adv Gastroenterol 2019;12:1756284819836893. [PMID: 30906424 DOI: 10.1177/1756284819836893] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
429 Bajaj JS, Hays RA. Manipulation of the Gut-Liver Axis Using Microbiome Restoration Therapy in Primary Sclerosing Cholangitis. Am J Gastroenterol 2019;114:1027-9. [DOI: 10.14309/ajg.0000000000000191] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
430 Uchiyama K, Naito Y, Takagi T. Intestinal microbiome as a novel therapeutic target for local and systemic inflammation. Pharmacol Ther 2019;199:164-72. [PMID: 30877020 DOI: 10.1016/j.pharmthera.2019.03.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
431 Skelly AN, Sato Y, Kearney S, Honda K. Mining the microbiota for microbial and metabolite-based immunotherapies. Nat Rev Immunol 2019;19:305-23. [DOI: 10.1038/s41577-019-0144-5] [Cited by in Crossref: 106] [Cited by in F6Publishing: 112] [Article Influence: 35.3] [Reference Citation Analysis]
432 Chen C, Chen Y, Liou J, Wu M; for the Taiwan Gastrointestinal Disease and Helicobacter Consortium. From germ theory to germ therapy. Kaohsiung J Med Sci 2019;35:73-82. [DOI: 10.1002/kjm2.12011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
433 Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA. The microbiome, cancer, and cancer therapy. Nat Med 2019;25:377-88. [DOI: 10.1038/s41591-019-0377-7] [Cited by in Crossref: 250] [Cited by in F6Publishing: 348] [Article Influence: 83.3] [Reference Citation Analysis]
434 Meng X, Zhou HY, Shen HH, Lufumpa E, Li XM, Guo B, Li BZ. Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity. Autoimmun Rev 2019;18:455-75. [PMID: 30844549 DOI: 10.1016/j.autrev.2019.03.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
435 Mcilroy JR, Segal JP, Mullish BH, Nabil Quraishi M, Gasbarrini A, Cammarota G, Ianiro G. Current and future targets for faecal microbiota transplantation. Human Microbiome Journal 2019;11:100045. [DOI: 10.1016/j.humic.2018.08.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
436 Abu-Sbeih H, Ali FS, Wang Y. Clinical Review on the Utility of Fecal Microbiota Transplantation in Immunocompromised Patients. Curr Gastroenterol Rep 2019;21:8. [PMID: 30815766 DOI: 10.1007/s11894-019-0677-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
437 Schoultz I, Keita ÅV. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function. Cells 2019;8:E193. [PMID: 30813280 DOI: 10.3390/cells8020193] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 27.3] [Reference Citation Analysis]
438 Alagón Fernández Del Campo P, De Orta Pando A, Straface JI, López Vega JR, Toledo Plata D, Niezen Lugo SF, Alvarez Hernández D, Barrientos Fortes T, Gutiérrez-Kobeh L, Solano-Gálvez SG, Vázquez-López R. The Use of Probiotic Therapy to Modulate the Gut Microbiota and Dendritic Cell Responses in Inflammatory Bowel Diseases. Med Sci (Basel) 2019;7:E33. [PMID: 30813381 DOI: 10.3390/medsci7020033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
439 Woodhouse CA, Patel VC, Goldenberg S, Sanchez-Fueyo A, China L, O'Brien A, Flach C, Douiri A, Shawcross D. PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial. BMJ Open 2019;9:e023518. [PMID: 30772848 DOI: 10.1136/bmjopen-2018-023518] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
440 Kelly CR, Ananthakrishnan AN. Manipulating the Microbiome With Fecal Transplantation to Treat Ulcerative Colitis. JAMA 2019;321:151-2. [PMID: 30644970 DOI: 10.1001/jama.2018.20397] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
441 Kwon YH, Wang H, Denou E, Ghia JE, Rossi L, Fontes ME, Bernier SP, Shajib MS, Banskota S, Collins SM, Surette MG, Khan WI. Modulation of Gut Microbiota Composition by Serotonin Signaling Influences Intestinal Immune Response and Susceptibility to Colitis. Cell Mol Gastroenterol Hepatol 2019;7:709-28. [PMID: 30716420 DOI: 10.1016/j.jcmgh.2019.01.004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 15.3] [Reference Citation Analysis]
442 Ma D, Chen Y, Chen T. Vaginal microbiota transplantation for the treatment of bacterial vaginosis: a conceptual analysis. FEMS Microbiology Letters 2019;366. [DOI: 10.1093/femsle/fnz025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
443 Fukuda T, Naganuma M, Kanai T. Current new challenges in the management of ulcerative colitis. Intest Res 2019;17:36-44. [PMID: 30678445 DOI: 10.5217/ir.2018.00126] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
444 Ihekweazu FD, Fofanova TY, Queliza K, Nagy-Szakal D, Stewart CJ, Engevik MA, Hulten KG, Tatevian N, Graham DY, Versalovic J, Petrosino JF, Kellermayer R. Bacteroides ovatus ATCC 8483 monotherapy is superior to traditional fecal transplant and multi-strain bacteriotherapy in a murine colitis model. Gut Microbes 2019;10:504-20. [PMID: 30663928 DOI: 10.1080/19490976.2018.1560753] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
445 Ning L, Lou X, Zhang F, Xu G. Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease. Mediators Inflamm 2019;2019:2624941. [PMID: 30804707 DOI: 10.1155/2019/2624941] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
446 Wilson BC, Vatanen T, Cutfield WS, O'Sullivan JM. The Super-Donor Phenomenon in Fecal Microbiota Transplantation. Front Cell Infect Microbiol. 2019;9:2. [PMID: 30719428 DOI: 10.3389/fcimb.2019.00002] [Cited by in Crossref: 117] [Cited by in F6Publishing: 98] [Article Influence: 39.0] [Reference Citation Analysis]
447 Knox NC, Forbes JD, Van Domselaar G, Bernstein CN. The Gut Microbiome as a Target for IBD Treatment: Are We There Yet? Curr Treat Options Gastro 2019;17:115-26. [DOI: 10.1007/s11938-019-00221-w] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 15.7] [Reference Citation Analysis]
448 Costello SP, Hughes PA, Waters O, Bryant RV, Vincent AD, Blatchford P, Katsikeros R, Makanyanga J, Campaniello MA, Mavrangelos C, Rosewarne CP, Bickley C, Peters C, Schoeman MN, Conlon MA, Roberts-Thomson IC, Andrews JM. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial. JAMA 2019;321:156-64. [PMID: 30644982 DOI: 10.1001/jama.2018.20046] [Cited by in Crossref: 321] [Cited by in F6Publishing: 276] [Article Influence: 107.0] [Reference Citation Analysis]
449 Moutinho BD, Baima JP, Rigo FF, Saad-Hossne R, Rodrigues J, Romeiro FG, Sassaki LY. Fecal microbiota transplantation in refractory ulcerative colitis - a case report. J Int Med Res 2019;47:1072-9. [PMID: 30632438 DOI: 10.1177/0300060518821790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
450 Basso PJ, Câmara NOS, Sales-Campos H. Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease - An Overview of Human Studies. Front Pharmacol 2018;9:1571. [PMID: 30687107 DOI: 10.3389/fphar.2018.01571] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 15.0] [Reference Citation Analysis]
451 Takahashi M, Ishikawa D, Sasaki T, Lu YJ, Kuwahara-Arai K, Kamei M, Shibuya T, Osada T, Hiramatsu K, Nagahara A. Faecal freezing preservation period influences colonization ability for faecal microbiota transplantation. J Appl Microbiol 2019;126:973-84. [PMID: 30489686 DOI: 10.1111/jam.14167] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
452 Garg M, Hendy P, Ding JN, Shaw S, Hold G, Hart A. The Effect of Vitamin D on Intestinal Inflammation and Faecal Microbiota in Patients with Ulcerative Colitis. J Crohns Colitis 2018;12:963-72. [PMID: 29726893 DOI: 10.1093/ecco-jcc/jjy052] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 10.5] [Reference Citation Analysis]
453 Pan P, Oshima K, Huang YW, Yearsley M, Zhang J, Arnold M, Yu J, Wang LS. Gut bacteria are required for the benefits of black raspberries in Apc Min/+ mice. J Berry Res 2018;8:239-49. [PMID: 30636993 DOI: 10.3233/JBR-180337] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
454 Porras D, Nistal E, Martínez-Flórez S, González-Gallego J, García-Mediavilla MV, Sánchez-Campos S. Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease. Front Physiol 2018;9:1813. [PMID: 30618824 DOI: 10.3389/fphys.2018.01813] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
455 Ko CW, Singh S, Feuerstein JD, Falck-Ytter C, Falck-Ytter Y, Cross RK; American Gastroenterological Association Institute Clinical Guidelines Committee. AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis. Gastroenterology 2019;156:748-64. [PMID: 30576644 DOI: 10.1053/j.gastro.2018.12.009] [Cited by in Crossref: 64] [Cited by in F6Publishing: 91] [Article Influence: 16.0] [Reference Citation Analysis]
456 Singh S, Feuerstein JD, Binion DG, Tremaine WJ. AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis. Gastroenterology 2019;156:769-808.e29. [PMID: 30576642 DOI: 10.1053/j.gastro.2018.12.008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 56] [Article Influence: 9.8] [Reference Citation Analysis]
457 Tabbaa OM, Aboelsoud MM, Mattar MC. Long-Term Safety and Efficacy of Fecal Microbiota Transplantation in the Treatment of Clostridium difficile Infection in Patients With and Without Inflammatory Bowel Disease: A Tertiary Care Center's Experience. Gastroenterology Res 2018;11:397-403. [PMID: 30627262 DOI: 10.14740/gr1091] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
458 Shah A, Morrison M, Holtmann G. A novel treatment for patients with constipation: Dawn of a new age for translational microbiome research? Indian J Gastroenterol 2018;37:388-91. [PMID: 30402680 DOI: 10.1007/s12664-018-0912-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
459 Lamarche D, Johnstone J, Zytaruk N, Clarke F, Hand L, Loukov D, Szamosi JC, Rossi L, Schenck LP, Verschoor CP, McDonald E, Meade MO, Marshall JC, Bowdish DME, Karachi T, Heels-Ansdell D, Cook DJ, Surette MG; PROSPECT Investigators., Canadian Critical Care Trials Group., Canadian Critical Care Translational Biology Group. Microbial dysbiosis and mortality during mechanical ventilation: a prospective observational study. Respir Res 2018;19:245. [PMID: 30526610 DOI: 10.1186/s12931-018-0950-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 42] [Article Influence: 8.3] [Reference Citation Analysis]
460 Burrello C, Garavaglia F, Cribiù FM, Ercoli G, Lopez G, Troisi J, Colucci A, Guglietta S, Carloni S, Guglielmetti S, Taverniti V, Nizzoli G, Bosari S, Caprioli F, Rescigno M, Facciotti F. Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells. Nat Commun 2018;9:5184. [PMID: 30518790 DOI: 10.1038/s41467-018-07359-8] [Cited by in Crossref: 69] [Cited by in F6Publishing: 106] [Article Influence: 17.3] [Reference Citation Analysis]
461 Yang L, Tang S, Baker SS, Arijs I, Liu W, Alkhouri R, Lan P, Baker RD, Tang Z, Ji G, Rutgeerts P, Vermeire S, Zhu R, Zhu L. Difference in Pathomechanism Between Crohn’s Disease and Ulcerative Colitis Revealed by Colon Transcriptome. Inflammatory Bowel Diseases 2019;25:722-31. [DOI: 10.1093/ibd/izy359] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
462 Alexandre-Silva GM, Brito-Souza PA, Oliveira ACS, Cerni FA, Zottich U, Pucca MB. The hygiene hypothesis at a glance: Early exposures, immune mechanism and novel therapies. Acta Trop 2018;188:16-26. [PMID: 30165069 DOI: 10.1016/j.actatropica.2018.08.032] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
463 Gundling F, Roggenbrod S, Schleifer S, Sohn M, Schepp W. Patient perception and approval of faecal microbiota transplantation (FMT) as an alternative treatment option for obesity. Obes Sci Pract 2019;5:68-74. [PMID: 30820331 DOI: 10.1002/osp4.302] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
464 Sood A, Mahajan R, Juyal G, Midha V, Grewal CS, Mehta V, Singh A, Joshi MC, Narang V, Kaur K, Sidhu H. Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis. Intest Res 2019;17:78-86. [PMID: 30449078 DOI: 10.5217/ir.2018.00089] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
465 Sitkin SI, Vakhitov TY, Demyanova EV. Microbiome, gut dysbiosis and inflammatory bowel disease: That moment when the function is more important than taxonomy. Alʹm klin med 2018;46:396-425. [DOI: 10.18786/2072-0505-2018-46-5-396-425] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
466 Imdad A, Nicholson MR, Tanner-Smith EE, Zackular JP, Gomez-Duarte OG, Beaulieu DB, Acra S. Fecal transplantation for treatment of inflammatory bowel disease. Cochrane Database Syst Rev 2018;11:CD012774. [PMID: 30480772 DOI: 10.1002/14651858.CD012774.pub2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 72] [Article Influence: 9.8] [Reference Citation Analysis]
467 Yu LC. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis. J Biomed Sci 2018;25:79. [PMID: 30413188 DOI: 10.1186/s12929-018-0483-8] [Cited by in Crossref: 95] [Cited by in F6Publishing: 140] [Article Influence: 23.8] [Reference Citation Analysis]
468 Eisenstein M. Gut reaction. Nature 2018;563:S34-5. [DOI: 10.1038/d41586-018-07277-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
469 Sun X, Jia Z. Microbiome modulates intestinal homeostasis against inflammatory diseases. Vet Immunol Immunopathol 2018;205:97-105. [PMID: 30459007 DOI: 10.1016/j.vetimm.2018.10.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
470 Weisshof R, El Jurdi K, Zmeter N, Rubin DT. Emerging Therapies for Inflammatory Bowel Disease. Adv Ther 2018;35:1746-62. [PMID: 30374806 DOI: 10.1007/s12325-018-0795-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 11.8] [Reference Citation Analysis]
471 Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore DJ, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Goldenberg SD, Williams HRT. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut 2018;67:1920-41. [PMID: 30154172 DOI: 10.1136/gutjnl-2018-316818] [Cited by in Crossref: 159] [Cited by in F6Publishing: 155] [Article Influence: 39.8] [Reference Citation Analysis]
472 Wang H, Cui B, Li Q, Ding X, Li P, Zhang T, Yang X, Ji G, Zhang F. The Safety of Fecal Microbiota Transplantation for Crohn's Disease: Findings from A Long-Term Study. Adv Ther 2018;35:1935-44. [PMID: 30328062 DOI: 10.1007/s12325-018-0800-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 10.8] [Reference Citation Analysis]
473 Shah SC, Faith J, Colombel J. Microbial-Host Interactions in Inflammatory Bowel Disease, Functional Bowel Disease, Obesity and Obesity-Related Metabolic Disease. Gastroenterology 2018;155:1283-6. [DOI: 10.1053/j.gastro.2018.06.081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
474 Zaidi D, Wine E. Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases. Front Pediatr 2018;6:317. [PMID: 30425977 DOI: 10.3389/fped.2018.00317] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
475 Li P, Zhang T, Xiao Y, Tian L, Cui B, Ji G, Liu YY, Zhang F. Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn's disease. Appl Microbiol Biotechnol. 2019;103:349-360. [PMID: 30357440 DOI: 10.1007/s00253-018-9447-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
476 M’koma A. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. GastrointestDisord 2018;1:75-105. [DOI: 10.3390/gidisord1010007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
477 Jitsumura M, Cunningham AL, Hitchings MD, Islam S, Davies AP, Row PE, Riddell AD, Kinross J, Wilkinson TS, Jenkins GJ, Williams JG, Harris DA. Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study. BMJ Open 2018;8:e021987. [PMID: 30341117 DOI: 10.1136/bmjopen-2018-021987] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
478 Jackson B, De Cruz P. Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitis. Expert Rev Gastroenterol Hepatol 2018;12:1079-100. [PMID: 30284911 DOI: 10.1080/17474124.2018.1530109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
479 Al Bakir I, Curtius K, Graham TA. From Colitis to Cancer: An Evolutionary Trajectory That Merges Maths and Biology. Front Immunol 2018;9:2368. [PMID: 30386335 DOI: 10.3389/fimmu.2018.02368] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
480 Radstake TRDJ. Extraintestinal translocation of microbes and tissue specificity in rheumatic musculoskeletal disease (RMD): its more than a gut feeling. Ann Rheum Dis 2018;77:1702-4. [PMID: 30297328 DOI: 10.1136/annrheumdis-2018-213974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
481 Abautret-Daly Á, Dempsey E, Parra-Blanco A, Medina C, Harkin A. Gut-brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease. Acta Neuropsychiatr 2018;30:275-96. [PMID: 28270247 DOI: 10.1017/neu.2017.3] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 19.8] [Reference Citation Analysis]
482 Krajicek E, Fischer M, Allegretti JR, Kelly CR. Nuts and Bolts of Fecal Microbiota Transplantation. Clin Gastroenterol Hepatol 2019;17:345-52. [PMID: 30268564 DOI: 10.1016/j.cgh.2018.09.029] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
483 Li Z, Zhu H, Zhang L, Qin C. The intestinal microbiome and Alzheimer's disease: A review. Animal Model Exp Med 2018;1:180-8. [PMID: 30891563 DOI: 10.1002/ame2.12033] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
484 Mcilroy JR, Nalagatla N, Hansen R, Hart A, Hold GL. Faecal microbiota transplantation as a treatment for inflammatory bowel disease: a national survey of adult and paediatric gastroenterologists in the UK. Frontline Gastroenterol 2018;9:250-5. [PMID: 30245786 DOI: 10.1136/flgastro-2017-100936] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
485 Hayes CL, Dong J, Galipeau HJ, Jury J, McCarville J, Huang X, Wang XY, Naidoo A, Anbazhagan AN, Libertucci J, Sheridan C, Dudeja PK, Bowdish DME, Surette MG, Verdu EF. Commensal microbiota induces colonic barrier structure and functions that contribute to homeostasis. Sci Rep 2018;8:14184. [PMID: 30242285 DOI: 10.1038/s41598-018-32366-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 75] [Article Influence: 12.3] [Reference Citation Analysis]
486 Quraishi MN, Critchlow T, Bhala N, Sharma N, Iqbal T. Faecal transplantation for IBD management-pitfalls and promises. Br Med Bull 2017;124:181-90. [PMID: 29140453 DOI: 10.1093/bmb/ldx040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
487 Fang H, Fu L, Wang J. Protocol for Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Biomed Res Int. 2018;2018:8941340. [PMID: 30302341 DOI: 10.1155/2018/8941340] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
488 Somineni HK, Kugathasan S. The Microbiome in Patients With Inflammatory Diseases. Clin Gastroenterol Hepatol 2019;17:243-55. [PMID: 30196163 DOI: 10.1016/j.cgh.2018.08.078] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
489 Bouri S, Hart A. Fecal microbial transplantation: an update. Current Opinion in Clinical Nutrition & Metabolic Care 2018;21:405-10. [DOI: 10.1097/mco.0000000000000488] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
490 White LS, Van den Bogaerde J, Kamm M. The gut microbiota: cause and cure of gut diseases. Med J Aust 2018;209:312-7. [PMID: 30257633 DOI: 10.5694/mja17.01067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
491 Sunkara T, Rawla P, Ofosu A, Gaduputi V. Fecal microbiota transplant - a new frontier in inflammatory bowel disease. J Inflamm Res 2018;11:321-8. [PMID: 30214266 DOI: 10.2147/JIR.S176190] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 7.8] [Reference Citation Analysis]
492 Landman C, Grill JP, Mallet JM, Marteau P, Humbert L, Le Balc'h E, Maubert MA, Perez K, Chaara W, Brot L, Beaugerie L, Sokol H, Thenet S, Rainteau D, Seksik P, Quévrain E; Saint Antoine IBD Network. Inter-kingdom effect on epithelial cells of the N-Acyl homoserine lactone 3-oxo-C12:2, a major quorum-sensing molecule from gut microbiota. PLoS One 2018;13:e0202587. [PMID: 30157234 DOI: 10.1371/journal.pone.0202587] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
493 Ihekweazu FD, Versalovic J. Development of the Pediatric Gut Microbiome: Impact on Health and Disease. Am J Med Sci 2018;356:413-23. [PMID: 30384950 DOI: 10.1016/j.amjms.2018.08.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
494 Groen AK, Nieuwdorp M. An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases. EMBO Mol Med. 2017;9:1-3. [PMID: 27861129 DOI: 10.15252/emmm.201607035] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
495 Smillie CS, Sauk J, Gevers D, Friedman J, Sung J, Youngster I, Hohmann EL, Staley C, Khoruts A, Sadowsky MJ, Allegretti JR, Smith MB, Xavier RJ, Alm EJ. Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation. Cell Host Microbe. 2018;23:229-240.e5. [PMID: 29447696 DOI: 10.1016/j.chom.2018.01.003] [Cited by in Crossref: 153] [Cited by in F6Publishing: 120] [Article Influence: 38.3] [Reference Citation Analysis]
496 Gagliardi A, Totino V, Cacciotti F, Iebba V, Neroni B, Bonfiglio G, Trancassini M, Passariello C, Pantanella F, Schippa S. Rebuilding the Gut Microbiota Ecosystem. Int J Environ Res Public Health 2018;15:E1679. [PMID: 30087270 DOI: 10.3390/ijerph15081679] [Cited by in Crossref: 91] [Cited by in F6Publishing: 60] [Article Influence: 22.8] [Reference Citation Analysis]
497 Wehkamp J, Stange EF. Recent advances and emerging therapies in the non-surgical management of ulcerative colitis. F1000Res 2018;7:F1000 Faculty Rev-1207. [PMID: 30135722 DOI: 10.12688/f1000research.15159.1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
498 Singh S. Evolution of Clinical Trials in Inflammatory Bowel Diseases. Curr Gastroenterol Rep 2018;20:41. [PMID: 30078058 DOI: 10.1007/s11894-018-0648-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
499 Vaughn BP, Rank KM, Khoruts A. Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease. Clin Gastroenterol Hepatol. 2019;17:353-361. [PMID: 30055267 DOI: 10.1016/j.cgh.2018.07.026] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 8.5] [Reference Citation Analysis]
500 Su HJ, Chiu YT, Chiu CT, Lin YC, Wang CY, Hsieh JY, Wei SC. Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates. J Formos Med Assoc. 2019;118:1083-1092. [PMID: 30054112 DOI: 10.1016/j.jfma.2018.07.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
501 Kriss M, Hazleton KZ, Nusbacher NM, Martin CG, Lozupone CA. Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery. Curr Opin Microbiol. 2018;44:34-40. [PMID: 30036705 DOI: 10.1016/j.mib.2018.07.003] [Cited by in Crossref: 105] [Cited by in F6Publishing: 96] [Article Influence: 26.3] [Reference Citation Analysis]
502 Basson AR, Lam M, Cominelli F. Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches. Gastroenterol Clin North Am. 2017;46:689-729. [PMID: 29173517 DOI: 10.1016/j.gtc.2017.08.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
503 Yan ZX, Gao XJ, Li T, Wei B, Wang PP, Yang Y, Yan R. Fecal Microbiota Transplantation in Experimental Ulcerative Colitis Reveals Associated Gut Microbial and Host Metabolic Reprogramming. Appl Environ Microbiol 2018;84:e00434-18. [PMID: 29728388 DOI: 10.1128/AEM.00434-18] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
504 Ni J, Shen TD, Chen EZ, Bittinger K, Bailey A, Roggiani M, Sirota-Madi A, Friedman ES, Chau L, Lin A, Nissim I, Scott J, Lauder A, Hoffmann C, Rivas G, Albenberg L, Baldassano RN, Braun J, Xavier RJ, Clish CB, Yudkoff M, Li H, Goulian M, Bushman FD, Lewis JD, Wu GD. A role for bacterial urease in gut dysbiosis and Crohn's disease. Sci Transl Med 2017;9:eaah6888. [PMID: 29141885 DOI: 10.1126/scitranslmed.aah6888] [Cited by in Crossref: 77] [Cited by in F6Publishing: 89] [Article Influence: 19.3] [Reference Citation Analysis]
505 Daliri EB, Tango CN, Lee BH, Oh D. Human microbiome restoration and safety. International Journal of Medical Microbiology 2018;308:487-97. [DOI: 10.1016/j.ijmm.2018.05.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
506 Paramsothy S, Paramsothy R, Rubin DT, Kamm MA, Kaakoush NO, Mitchell HM, Castaño-Rodríguez N. Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. J Crohns Colitis 2017;11:1180-99. [PMID: 28486648 DOI: 10.1093/ecco-jcc/jjx063] [Cited by in Crossref: 191] [Cited by in F6Publishing: 165] [Article Influence: 47.8] [Reference Citation Analysis]
507 Sundin J, Öhman L, Simrén M. Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases. Psychosom Med 2017;79:857-67. [PMID: 28422780 DOI: 10.1097/PSY.0000000000000470] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
508 Orr MR, Kocurek KM, Young DL. Gut Microbiota and Human Health: Insights From Ecological Restoration. The Quarterly Review of Biology 2018;93:73-90. [DOI: 10.1086/698021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
509 Rizzetto L, Fava F, Tuohy KM, Selmi C. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex. J Autoimmun 2018;92:12-34. [PMID: 29861127 DOI: 10.1016/j.jaut.2018.05.008] [Cited by in Crossref: 88] [Cited by in F6Publishing: 82] [Article Influence: 22.0] [Reference Citation Analysis]
510 Narula N, Kassam Z, Yuan Y, Colombel JF, Ponsioen C, Reinisch W, Moayyedi P. Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis. Inflamm Bowel Dis. 2017;23:1702-1709. [PMID: 28906291 DOI: 10.1097/mib.0000000000001228] [Cited by in Crossref: 119] [Cited by in F6Publishing: 63] [Article Influence: 29.8] [Reference Citation Analysis]
511 Cui H, Cai Y, Wang L, Jia B, Li J, Zhao S, Chu X, Lin J, Zhang X, Bian Y, Zhuang P. Berberine Regulates Treg/Th17 Balance to Treat Ulcerative Colitis Through Modulating the Gut Microbiota in the Colon. Front Pharmacol. 2018;9:571. [PMID: 29904348 DOI: 10.3389/fphar.2018.00571] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 18.3] [Reference Citation Analysis]
512 Allegretti J, Eysenbach LM, El-Nachef N, Fischer M, Kelly C, Kassam Z. The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future. Inflamm Bowel Dis. 2017;23:1710-1717. [PMID: 28858073 DOI: 10.1097/mib.0000000000001247] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 7.8] [Reference Citation Analysis]
513 D'Odorico I, Di Bella S, Monticelli J, Giacobbe DR, Boldock E, Luzzati R. Role of fecal microbiota transplantation in inflammatory bowel disease. J Dig Dis 2018;19:322-34. [PMID: 29696802 DOI: 10.1111/1751-2980.12603] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
514 Jeon SR, Chai J, Kim C, Lee CH. Current Evidence for the Management of Inflammatory Bowel Diseases Using Fecal Microbiota Transplantation. Curr Infect Dis Rep 2018;20:21. [PMID: 29804272 DOI: 10.1007/s11908-018-0627-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
515 Mu J, Chen Q, Zhu L, Wu Y, Liu S, Zhao Y, Ma T. Influence of gut microbiota and intestinal barrier on enterogenic infection after liver transplantation. Curr Med Res Opin 2019;35:241-8. [PMID: 29701490 DOI: 10.1080/03007995.2018.1470085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
516 Jalanka J, Hillamaa A, Arkkila PE, Satokari R. Letter: improvements in mental health after faecal microbiota transplantation-an underexplored treatment-related benefit? Authors’ reply. Aliment Pharmacol Ther 2018;47:1563-4. [DOI: 10.1111/apt.14668] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
517 Wang HG, Liu SP, Ma TH, Yan W, Zhou JF, Shi YT, Shen P, Yang XZ, Wu SN. Fecal microbiota transplantation treatment for refractory ulcerative colitis with allergy to 5-aminosalicylic acid: A case report. Medicine (Baltimore) 2018;97:e0675. [PMID: 29742710 DOI: 10.1097/MD.0000000000010675] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
518 Hvas CL, Bendix M, Dige A, Dahlerup JF, Agnholt J. Current, experimental, and future treatments in inflammatory bowel disease: a clinical review. Immunopharmacol Immunotoxicol 2018;40:446-60. [PMID: 29745777 DOI: 10.1080/08923973.2018.1469144] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
519 Fairhurst NG, Travis SPL. Why is it so difficult to evaluate faecal microbiota transplantation as a treatment for ulcerative colitis? Intest Res 2018;16:209-15. [PMID: 29743833 DOI: 10.5217/ir.2018.16.2.209] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
520 Kragsnaes MS, Kjeldsen J, Horn HC, Munk HL, Pedersen FM, Holt HM, Pedersen JK, Holm DK, Glerup H, Andersen V, Fredberg U, Kristiansen K, Christensen R, Ellingsen T. Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial. BMJ Open 2018;8:e019231. [PMID: 29703851 DOI: 10.1136/bmjopen-2017-019231] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 7.8] [Reference Citation Analysis]
521 Zhang F, Cui B, He X, Nie Y, Wu K, Fan D; FMT-standardization Study Group. Microbiota transplantation: concept, methodology and strategy for its modernization. Protein Cell. 2018;9:462-473. [PMID: 29691757 DOI: 10.1007/s13238-018-0541-8] [Cited by in Crossref: 120] [Cited by in F6Publishing: 102] [Article Influence: 30.0] [Reference Citation Analysis]
522 Kurokawa S, Kishimoto T, Mizuno S, Masaoka T, Naganuma M, Liang KC, Kitazawa M, Nakashima M, Shindo C, Suda W, Hattori M, Kanai T, Mimura M. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study. J Affect Disord 2018;235:506-12. [PMID: 29684865 DOI: 10.1016/j.jad.2018.04.038] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 16.8] [Reference Citation Analysis]
523 Skowron KB, Shogan BD, Rubin DT, Hyman NH. The New Frontier: the Intestinal Microbiome and Surgery. J Gastrointest Surg 2018;22:1277-85. [PMID: 29633119 DOI: 10.1007/s11605-018-3744-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
524 Cao Y, Zhang B, Wu Y, Wang Q, Wang J, Shen F. The Value of Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis Patients: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract 2018;2018:5480961. [PMID: 29849592 DOI: 10.1155/2018/5480961] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
525 Bakker GJ, Nieuwdorp M. Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond Clostridium difficile. Microbiol Spectr 2017;5. [PMID: 28840809 DOI: 10.1128/microbiolspec.BAD-0008-2017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
526 Hoare A, Marsh PD, Diaz PI. Ecological Therapeutic Opportunities for Oral Diseases. Microbiol Spectr 2017;5. [PMID: 28840820 DOI: 10.1128/microbiolspec.BAD-0006-2016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 5.8] [Reference Citation Analysis]
527 Syal G, Kashani A, Shih DQ. Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Primer for Internists. Am J Med 2018;131:1017-24. [PMID: 29605414 DOI: 10.1016/j.amjmed.2018.03.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
528 Lübbert C, Salzberger B, Mössner J. [Fecal microbiota transplantation]. Internist (Berl) 2017;58:456-68. [PMID: 28235986 DOI: 10.1007/s00108-017-0203-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
529 O'Neill S, Young C, Grehan J. Harnessing the microbiome for human health. Microb Biotechnol 2018;11:435-6. [PMID: 29578645 DOI: 10.1111/1751-7915.13172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
530 Jacob V, Crawford C, Cohen-Mekelburg S, Viladomiu M, Putzel GG, Schneider Y, Chabouni F, OʼNeil S, Bosworth B, Woo V, Ajami NJ, Petrosino JF, Gerardin Y, Kassam Z, Smith M, Iliev ID, Sonnenberg GF, Artis D, Scherl E, Longman RS. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis. Inflamm Bowel Dis 2017;23:903-11. [PMID: 28445246 DOI: 10.1097/MIB.0000000000001132] [Cited by in Crossref: 64] [Cited by in F6Publishing: 44] [Article Influence: 16.0] [Reference Citation Analysis]
531 Verstockt B, Ferrante M, Vermeire S, Van Assche G. New treatment options for inflammatory bowel diseases. J Gastroenterol 2018;53:585-90. [PMID: 29556726 DOI: 10.1007/s00535-018-1449-z] [Cited by in Crossref: 99] [Cited by in F6Publishing: 81] [Article Influence: 24.8] [Reference Citation Analysis]
532 Yeh A, Morowitz MJ. Probiotics and fecal microbiota transplantation in surgical disorders. Seminars in Colon and Rectal Surgery 2018;29:37-43. [DOI: 10.1053/j.scrs.2017.09.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
533 Palmela C, Chevarin C, Xu Z, Torres J, Sevrin G, Hirten R, Barnich N, Ng SC, Colombel JF. Adherent-invasive Escherichia coli in inflammatory bowel disease. Gut 2018;67:574-87. [PMID: 29141957 DOI: 10.1136/gutjnl-2017-314903] [Cited by in Crossref: 199] [Cited by in F6Publishing: 203] [Article Influence: 49.8] [Reference Citation Analysis]
534 Shen Z, Zhu C, Quan Y, Yuan W, Wu S, Yang Z, Luo W, Tan B, Wang X. Update on intestinal microbiota in Crohn's disease 2017: Mechanisms, clinical application, adverse reactions, and outlook. J Gastroenterol Hepatol. 2017;32:1804-1812. [PMID: 28677158 DOI: 10.1111/jgh.13861] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
535 Cho JA, Chinnapen DJF. Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease. J Microbiol 2018;56:183-8. [PMID: 29492875 DOI: 10.1007/s12275-018-8037-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
536 Huang Z, Peng K, Li X, Zhao R, You J, Cheng X, Wang Z, Wang Y, Wu B, Wang H, Zeng H, Yu Z, Zheng C, Wang Y, Huang Y. Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early Onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey. Inflamm Bowel Dis. 2017;23:578-590. [PMID: 28267044 DOI: 10.1097/mib.0000000000001058] [Cited by in Crossref: 37] [Cited by in F6Publishing: 20] [Article Influence: 9.3] [Reference Citation Analysis]
537 Kistangari G, Lopez R, Shen B. Frequency and Risk Factors of Clostridium difficile Infection in Hospitalized Patients With Pouchitis: A Population-based Study. Inflamm Bowel Dis 2017;23:661-71. [PMID: 28296825 DOI: 10.1097/MIB.0000000000001057] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
538 Quezada SM, Briscoe J, Cross RK. Complementary and Alternative Medicine. Inflamm Bowel Dis 2016;22:1523-30. [PMID: 27057686 DOI: 10.1097/MIB.0000000000000761] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
539 Vaughn BP, Vatanen T, Allegretti JR, Bai A, Xavier RJ, Korzenik J, Gevers D, Ting A, Robson SC, Moss AC. Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease. Inflamm Bowel Dis. 2016;22:2182-2190. [PMID: 27542133 DOI: 10.1097/mib.0000000000000893] [Cited by in Crossref: 132] [Cited by in F6Publishing: 82] [Article Influence: 33.0] [Reference Citation Analysis]
540 Heath RD, Cockerell C, Mankoo R, Ibdah JA, Tahan V. Fecal microbiota transplantation and its potential therapeutic uses in gastrointestinal disorders. North Clin Istanb. 2018;5:79-88. [PMID: 29607440 DOI: 10.14744/nci.2017.10692] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
541 Zhang X, Tian H, Gu L, Nie Y, Ding C, Ge X, Yang B, Gong J, Li N. Long-term follow-up of the effects of fecal microbiota transplantation in combination with soluble dietary fiber as a therapeutic regimen in slow transit constipation. Sci China Life Sci 2018;61:779-86. [PMID: 29441452 DOI: 10.1007/s11427-017-9229-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
542 Rao K, Higgins PD. Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:1744-54. [PMID: 27120571 DOI: 10.1097/MIB.0000000000000793] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 8.8] [Reference Citation Analysis]
543 Lu Y, Li X, Liu S, Zhang Y, Zhang D. Toll-like Receptors and Inflammatory Bowel Disease. Front Immunol 2018;9:72. [PMID: 29441063 DOI: 10.3389/fimmu.2018.00072] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 19.0] [Reference Citation Analysis]
544 Fischer M, Kao D, Kelly C, Kuchipudi A, Jafri SM, Blumenkehl M, Rex D, Mellow M, Kaur N, Sokol H. Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22:2402-2409. [PMID: 27580384 DOI: 10.1097/mib.0000000000000908] [Cited by in Crossref: 105] [Cited by in F6Publishing: 66] [Article Influence: 26.3] [Reference Citation Analysis]
545 Takeshita K, Mizuno S, Mikami Y, Sujino T, Saigusa K, Matsuoka K, Naganuma M, Sato T, Takada T, Tsuji H, Kushiro A, Nomoto K, Kanai T. A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients. Inflamm Bowel Dis. 2016;22:2802-2810. [PMID: 27824645 DOI: 10.1097/mib.0000000000000972] [Cited by in Crossref: 72] [Cited by in F6Publishing: 44] [Article Influence: 18.0] [Reference Citation Analysis]
546 Mullineaux-Sanders C, Suez J, Elinav E, Frankel G. Sieving through gut models of colonization resistance. Nat Microbiol 2018;3:132-40. [PMID: 29358683 DOI: 10.1038/s41564-017-0095-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
547 Duvallet C. Meta-analysis generates and prioritizes hypotheses for translational microbiome research. Microb Biotechnol 2018;11:273-6. [PMID: 29349912 DOI: 10.1111/1751-7915.13047] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
548 Nanki K, Mizuno S, Matsuoka K, Ono K, Sugimoto S, Kiyohara H, Arai M, Nakashima M, Takeshita K, Saigusa K, Senoh M, Fukuda T, Naganuma M, Kato H, Suda W, Hattori M, Kanai T. Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis. Intest Res 2018;16:142-6. [PMID: 29422809 DOI: 10.5217/ir.2018.16.1.142] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
549 Goyal A, Yeh A, Bush BR, Firek BA, Siebold LM, Rogers MB, Kufen AD, Morowitz MJ. Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2018;24:410-21. [DOI: 10.1093/ibd/izx035] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 17.5] [Reference Citation Analysis]
550 Clemente JC, Manasson J, Scher JU. The role of the gut microbiome in systemic inflammatory disease. BMJ. 2018;360:j5145. [PMID: 29311119 DOI: 10.1136/bmj.j5145] [Cited by in Crossref: 147] [Cited by in F6Publishing: 192] [Article Influence: 36.8] [Reference Citation Analysis]
551 Shen ZH, Zhu CX, Quan YS, Yang ZY, Wu S, Luo WW, Tan B, Wang XY. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation. World J Gastroenterol 2018; 24(1): 5-14 [PMID: 29358877 DOI: 10.3748/wjg.v24.i1.5] [Cited by in CrossRef: 213] [Cited by in F6Publishing: 188] [Article Influence: 53.3] [Reference Citation Analysis]
552 Ford AC. Stool as a treatment for IBS: more questions than answers? The Lancet Gastroenterology & Hepatology 2018;3:2-3. [DOI: 10.1016/s2468-1253(17)30337-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
553 Moayyedi P. Fecal transplantation: any real hope for inflammatory bowel disease? Curr Opin Gastroenterol 2016;32:282-6. [PMID: 27152872 DOI: 10.1097/MOG.0000000000000285] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
554 Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018;11:1-10. [PMID: 29285689 DOI: 10.1007/s12328-017-0813-5] [Cited by in Crossref: 308] [Cited by in F6Publishing: 284] [Article Influence: 61.6] [Reference Citation Analysis]
555 Malikowski T, Khanna S, Pardi DS. Fecal microbiota transplantation for gastrointestinal disorders. Curr Opin Gastroenterol 2017;33:8-13. [PMID: 28134687 DOI: 10.1097/MOG.0000000000000326] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
556 Kashyap PC, Chia N, Nelson H, Segal E, Elinav E. Microbiome at the Frontier of Personalized Medicine. Mayo Clin Proc 2017;92:1855-64. [PMID: 29202942 DOI: 10.1016/j.mayocp.2017.10.004] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 13.8] [Reference Citation Analysis]
557 Pagnini C, Martorelli M, Lanini C, Delle Fave G. Development of an Ex Vivo Organ Culture Technique to Evaluate Probiotic Utilization in IBD. J Clin Gastroenterol. 2016;50:S179-S182. [PMID: 27741170 DOI: 10.1097/mcg.0000000000000698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
558 Osaka T, Moriyama E, Arai S, Date Y, Yagi J, Kikuchi J, Tsuneda S. Meta-Analysis of Fecal Microbiota and Metabolites in Experimental Colitic Mice during the Inflammatory and Healing Phases. Nutrients 2017;9:E1329. [PMID: 29211010 DOI: 10.3390/nu9121329] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 10.4] [Reference Citation Analysis]
559 Tandon P, Madsen K, Kao D. Fecal microbiota transplantation for hepatic encephalopathy: Ready for prime time? Hepatology 2017;66:1713-5. [PMID: 28734127 DOI: 10.1002/hep.29396] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
560 Bajaj JS, Kassam Z, Fagan A, Gavis EA, Liu E, Cox IJ, Kheradman R, Heuman D, Wang J, Gurry T, Williams R, Sikaroodi M, Fuchs M, Alm E, John B, Thacker LR, Riva A, Smith M, Taylor-Robinson SD, Gillevet PM. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial. Hepatology 2017;66:1727-38. [PMID: 28586116 DOI: 10.1002/hep.29306] [Cited by in Crossref: 312] [Cited by in F6Publishing: 276] [Article Influence: 62.4] [Reference Citation Analysis]
561 Staley C, Khoruts A, Sadowsky MJ. Contemporary Applications of Fecal Microbiota Transplantation to Treat Intestinal Diseases in Humans. Arch Med Res 2017;48:766-73. [PMID: 29183720 DOI: 10.1016/j.arcmed.2017.11.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
562 Llewellyn SR, Britton GJ, Contijoch EJ, Vennaro OH, Mortha A, Colombel JF, Grinspan A, Clemente JC, Merad M, Faith JJ. Interactions Between Diet and the Intestinal Microbiota Alter Intestinal Permeability and Colitis Severity in Mice. Gastroenterology 2018;154:1037-1046.e2. [PMID: 29174952 DOI: 10.1053/j.gastro.2017.11.030] [Cited by in Crossref: 127] [Cited by in F6Publishing: 164] [Article Influence: 25.4] [Reference Citation Analysis]
563 Houlihan B, Cha P, Zasloff M, Fishbein TM, Kroemer A. An integrated understanding of the immunology of allograft inflammation. Curr Opin Organ Transplant 2017;22:155-9. [PMID: 28212158 DOI: 10.1097/MOT.0000000000000395] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
564 Khanna S. Microbiota Replacement Therapies: Innovation in Gastrointestinal Care. Clin Pharmacol Ther. 2018;103:102-111. [PMID: 29071710 DOI: 10.1002/cpt.923] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
565 Craven LJ, Nair Parvathy S, Tat-Ko J, Burton JP, Silverman MS. Extended Screening Costs Associated With Selecting Donors for Fecal Microbiota Transplantation for Treatment of Metabolic Syndrome-Associated Diseases. Open Forum Infect Dis 2017;4:ofx243. [PMID: 29255739 DOI: 10.1093/ofid/ofx243] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
566 López-sanromán A, Rodríguez de Santiago E, Cobo Reinoso J, del Campo Moreno R, Foruny Olcina JR, García Fernández S, García García de Paredes A, Aguilera Castro L, Ferre Aracil C, Albillos Martínez A. Resultados de la implementación de un programa multidisciplinar de trasplante de microbiota fecal por colonoscopia para el tratamiento de la infección recurrente por Clostridium difficile. Gastroenterología y Hepatología 2017;40:605-14. [DOI: 10.1016/j.gastrohep.2017.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
567 Lahtinen P, Mattila E, Anttila VJ, Tillonen J, Teittinen M, Nevalainen P, Salminen S, Satokari R, Arkkila P. Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications: A case series. World J Gastroenterol 2017; 23(39): 7174-7184 [PMID: 29093626 DOI: 10.3748/wjg.v23.i39.7174] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
568 Kump P, Wurm P, Gröchenig HP, Wenzl H, Petritsch W, Halwachs B, Wagner M, Stadlbauer V, Eherer A, Hoffmann KM, Deutschmann A, Reicht G, Reiter L, Slawitsch P, Gorkiewicz G, Högenauer C. The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis. Aliment Pharmacol Ther 2018;47:67-77. [PMID: 29052237 DOI: 10.1111/apt.14387] [Cited by in Crossref: 96] [Cited by in F6Publishing: 73] [Article Influence: 19.2] [Reference Citation Analysis]
569 McIlroy J, Ianiro G, Mukhopadhya I, Hansen R, Hold GL. Review article: The gut microbiome in inflammatory bowel disease-avenues for microbial management. Aliment Pharmacol Ther. 2018;47:26-42. [PMID: 29034981 DOI: 10.1111/apt.14384] [Cited by in Crossref: 114] [Cited by in F6Publishing: 107] [Article Influence: 22.8] [Reference Citation Analysis]
570 Ananthakrishnan AN, Bernstein CN, Iliopoulos D, Macpherson A, Neurath MF, Ali RAR, Vavricka SR, Fiocchi C. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol. 2018;15:39-49. [PMID: 29018271 DOI: 10.1038/nrgastro.2017.136] [Cited by in Crossref: 326] [Cited by in F6Publishing: 298] [Article Influence: 65.2] [Reference Citation Analysis]
571 Zhang T, Xiang J, Cui B, He Z, Li P, Chen H, Xu L, Ji G, Nie Y, Wu K, Fan D, Huang G, Bai J, Zhang F. Cost-effectiveness analysis of fecal microbiota transplantation for inflammatory bowel disease. Oncotarget 2017;8:88894-903. [PMID: 29179485 DOI: 10.18632/oncotarget.21491] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
572 Browne AS, Kelly CR. Fecal Transplant in Inflammatory Bowel Disease. Gastroenterol Clin North Am 2017;46:825-37. [PMID: 29173524 DOI: 10.1016/j.gtc.2017.08.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
573 Abraham BP, Quigley EMM. Probiotics in Inflammatory Bowel Disease. Gastroenterol Clin North Am. 2017;46:769-782. [PMID: 29173520 DOI: 10.1016/j.gtc.2017.08.003] [Cited by in Crossref: 75] [Cited by in F6Publishing: 57] [Article Influence: 15.0] [Reference Citation Analysis]
574 Aroniadis OC, Drossman DA, Simrén M. A Perspective on Brain–Gut Communication: The American Gastroenterology Association and American Psychosomatic Society Joint Symposium on Brain–Gut Interactions and the Intestinal Microenvironment. Psychosom Med 2017;79:847-56. [DOI: 10.1097/psy.0000000000000431] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 4.2] [Reference Citation Analysis]
575 El Hage R, Hernandez-Sanabria E, Van de Wiele T. Emerging Trends in "Smart Probiotics": Functional Consideration for the Development of Novel Health and Industrial Applications. Front Microbiol 2017;8:1889. [PMID: 29033923 DOI: 10.3389/fmicb.2017.01889] [Cited by in Crossref: 69] [Cited by in F6Publishing: 49] [Article Influence: 13.8] [Reference Citation Analysis]
576 Cui M, Xiao H, Li Y, Zhou L, Zhao S, Luo D, Zheng Q, Dong J, Zhao Y, Zhang X, Zhang J, Lu L, Wang H, Fan S. Faecal microbiota transplantation protects against radiation-induced toxicity. EMBO Mol Med 2017;9:448-61. [PMID: 28242755 DOI: 10.15252/emmm.201606932] [Cited by in Crossref: 88] [Cited by in F6Publishing: 81] [Article Influence: 17.6] [Reference Citation Analysis]
577 Holleran G, Lopetuso L, Petito V, Graziani C, Ianiro G, McNamara D, Gasbarrini A, Scaldaferri F. The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease. Int J Mol Sci. 2017;18. [PMID: 28934123 DOI: 10.3390/ijms18102020] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
578 Hudson LE, Anderson SE, Corbett AH, Lamb TJ. Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin Microbiol Rev. 2017;30:191-231. [PMID: 27856521 DOI: 10.1128/cmr.00049-16] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 7.6] [Reference Citation Analysis]
579 Kelly BJ, Tebas P. Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection. Chest. 2018;153:266-277. [PMID: 28923757 DOI: 10.1016/j.chest.2017.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
580 Geirnaert A, Calatayud M, Grootaert C, Laukens D, Devriese S, Smagghe G, De Vos M, Boon N, Van de Wiele T. Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity. Sci Rep 2017;7:11450. [PMID: 28904372 DOI: 10.1038/s41598-017-11734-8] [Cited by in Crossref: 144] [Cited by in F6Publishing: 191] [Article Influence: 28.8] [Reference Citation Analysis]
581 Qazi T, Amaratunga T, Barnes EL, Fischer M, Kassam Z, Allegretti JR. The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis. Gut Microbes. 2017;8:574-588. [PMID: 28723262 DOI: 10.1080/19490976.2017.1353848] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 15.0] [Reference Citation Analysis]
582 Vetter M, Neurath MF. Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges. Therap Adv Gastroenterol 2017;10:773-90. [PMID: 29051788 DOI: 10.1177/1756283X17727388] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 3.6] [Reference Citation Analysis]
583 Blum HE. The human microbiome. Adv Med Sci 2017;62:414-20. [PMID: 28711782 DOI: 10.1016/j.advms.2017.04.005] [Cited by in Crossref: 100] [Cited by in F6Publishing: 73] [Article Influence: 20.0] [Reference Citation Analysis]
584 Qiao YQ, Cai CW, Ran ZH. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered. J Dig Dis. 2016;17:800-810. [PMID: 27743467 DOI: 10.1111/1751-2980.12422] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
585 Pai N, Popov J. Protocol for a randomised, placebo-controlled pilot study for assessing feasibility and efficacy of faecal microbiota transplantation in a paediatric ulcerative colitis population: PediFETCh trial. BMJ Open. 2017;7:e016698. [PMID: 28827258 DOI: 10.1136/bmjopen-2017-016698] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
586 Costello SP, Soo W, Bryant RV, Jairath V, Hart AL, Andrews JM. Editorial: faecal microbiota transplantation for ulcerative colitis-not quite there yet? Authors' reply. Aliment Pharmacol Ther 2017;46:631-2. [PMID: 28805321 DOI: 10.1111/apt.14246] [Reference Citation Analysis]
587 Guariso G, Gasparetto M. Treating children with inflammatory bowel disease: Current and new perspectives. World J Gastroenterol 2017; 23(30): 5469-5485 [PMID: 28852307 DOI: 10.3748/wjg.v23.i30.5469] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
588 Lim MH, Radford-smith GL. Editorial: faecal microbiota transplantation for ulcerative colitis-not quite there yet? Aliment Pharmacol Ther 2017;46:630-1. [DOI: 10.1111/apt.14228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
589 Whelan FJ, Surette MG. A comprehensive evaluation of the sl1p pipeline for 16S rRNA gene sequencing analysis. Microbiome 2017;5:100. [PMID: 28807046 DOI: 10.1186/s40168-017-0314-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 49] [Article Influence: 8.2] [Reference Citation Analysis]
590 Grigg JB, Sonnenberg GF. Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases. J Immunol 2017;198:564-71. [PMID: 28069751 DOI: 10.4049/jimmunol.1601621] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 10.8] [Reference Citation Analysis]
591 Millan B, Laffin M, Madsen K. Fecal Microbiota Transplantation: Beyond Clostridium difficile. Curr Infect Dis Rep. 2017;19:31. [PMID: 28770495 DOI: 10.1007/s11908-017-0586-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
592 Zhou M, He J, Shen Y, Zhang C, Wang J, Chen Y. New Frontiers in Genetics, Gut Microbiota, and Immunity: A Rosetta Stone for the Pathogenesis of Inflammatory Bowel Disease. Biomed Res Int 2017;2017:8201672. [PMID: 28831399 DOI: 10.1155/2017/8201672] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 8.2] [Reference Citation Analysis]
593 Ni X, Fan S, Zhang Y, Wang Z, Ding L, Li Y, Li J. Coordinated Hospital-Home Fecal Microbiota Transplantation via Percutaneous Endoscopic Cecostomy for Recurrent Steroid-Dependent Ulcerative Colitis. Gut Liver 2016;10:975-80. [PMID: 27282271 DOI: 10.5009/gnl15456] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
594 Cheng YW, Fischer M. The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly. Curr Treat Options Gastroenterol 2017;15:349-62. [PMID: 28748314 DOI: 10.1007/s11938-017-0143-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
595 D’Aoust J, Battat R, Bessissow T. Management of inflammatory bowel disease with Clostridium difficile infection. World J Gastroenterol 2017; 23(27): 4986-5003 [PMID: 28785153 DOI: 10.3748/wjg.v23.i27.4986] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 27] [Article Influence: 7.2] [Reference Citation Analysis]
596 Raffals LE, Chang EB. Navigating the Microbial Basis of Inflammatory Bowel Diseases: Seeing the Light at the End of the Tunnel. Gut Liver 2016;10:502-8. [PMID: 27377740 DOI: 10.5009/gnl15491] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
597 Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol. 2017;14:573-584. [PMID: 28743984 DOI: 10.1038/nrgastro.2017.88] [Cited by in Crossref: 633] [Cited by in F6Publishing: 600] [Article Influence: 126.6] [Reference Citation Analysis]
598 Shaffer M, Armstrong AJS, Phelan VV, Reisdorph N, Lozupone CA. Microbiome and metabolome data integration provides insight into health and disease. Transl Res 2017;189:51-64. [PMID: 28764956 DOI: 10.1016/j.trsl.2017.07.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
599 Quraishi MN, Widlak M, Bhala N, Moore D, Price M, Sharma N, Iqbal TH. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Aliment Pharmacol Ther. 2017;46:479-493. [PMID: 28707337 DOI: 10.1111/apt.14201] [Cited by in Crossref: 300] [Cited by in F6Publishing: 245] [Article Influence: 60.0] [Reference Citation Analysis]
600 Laffin M, Madsen K. Fecal Microbial Transplantation in Inflammatory Bowel Disease: A Movement Too Big to Be Ignored. Clin Pharmacol Ther 2017;102:588-90. [DOI: 10.1002/cpt.747] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
601 Khajah MA. The potential role of fecal microbiota transplantation in the treatment of inflammatory Bowel disease. Scand J Gastroenterol 2017;52:1172-84. [PMID: 28685630 DOI: 10.1080/00365521.2017.1347812] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
602 He Z, Li P, Zhu J, Cui B, Xu L, Xiang J, Zhang T, Long C, Huang G, Ji G, Nie Y, Wu K, Fan D, Zhang F. Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn's disease complicated with inflammatory mass. Sci Rep. 2017;7:4753. [PMID: 28684845 DOI: 10.1038/s41598-017-04984-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 50] [Article Influence: 8.4] [Reference Citation Analysis]
603 Thaiss CA, Elinav E. The remedy within: will the microbiome fulfill its therapeutic promise? J Mol Med (Berl) 2017;95:1021-7. [PMID: 28656322 DOI: 10.1007/s00109-017-1563-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
604 Panés J, Alfaro I. New treatment strategies for ulcerative colitis. Expert Rev Clin Immunol 2017;13:963-73. [PMID: 28617055 DOI: 10.1080/1744666X.2017.1343668] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
605 Mizuno S, Masaoka T, Naganuma M, Kishimoto T, Kitazawa M, Kurokawa S, Nakashima M, Takeshita K, Suda W, Mimura M, Hattori M, Kanai T. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome. Digestion 2017;96:29-38. [PMID: 28628918 DOI: 10.1159/000471919] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 11.2] [Reference Citation Analysis]
606 Sommer F, Anderson JM, Bharti R, Raes J, Rosenstiel P. The resilience of the intestinal microbiota influences health and disease. Nat Rev Microbiol 2017;15:630-8. [DOI: 10.1038/nrmicro.2017.58] [Cited by in Crossref: 305] [Cited by in F6Publishing: 371] [Article Influence: 61.0] [Reference Citation Analysis]
607 Andrews JM. Editorial: yoga for QoL in ulcerative colitis-any better than other supportive activities? Aliment Pharmacol Ther 2017;46:201-2. [DOI: 10.1111/apt.14115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
608 Costello SP, Soo W, Bryant RV, Jairath V, Hart AL, Andrews JM. Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Aliment Pharmacol Ther. 2017;46:213-224. [PMID: 28612983 DOI: 10.1111/apt.14173] [Cited by in Crossref: 148] [Cited by in F6Publishing: 131] [Article Influence: 29.6] [Reference Citation Analysis]
609 Biedermann L. Vancomycin in Very-Early Onset Inflammatory Bowel Disease-Dysbiosis: Fight Fire with Fire? Digestion 2017;95:327-8. [PMID: 28609775 DOI: 10.1159/000477088] [Reference Citation Analysis]
610 Lane ER, Zisman TL, Suskind DL. The microbiota in inflammatory bowel disease: current and therapeutic insights. J Inflamm Res. 2017;10:63-73. [PMID: 28652796 DOI: 10.2147/jir.s116088] [Cited by in Crossref: 105] [Cited by in F6Publishing: 65] [Article Influence: 21.0] [Reference Citation Analysis]
611 Allegretti JR, Kassam Z, Osman M, Budree S, Fischer M, Kelly CR. The 5D framework: a clinical primer for fecal microbiota transplantation to treat Clostridium difficile infection. Gastrointest Endosc 2018;87:18-29. [PMID: 28583769 DOI: 10.1016/j.gie.2017.05.036] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
612 Yamamoto-Furusho JK. Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies. Pharmgenomics Pers Med 2017;10:197-204. [PMID: 28603427 DOI: 10.2147/PGPM.S109648] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
613 Suez J, Elinav E. The path towards microbiome-based metabolite treatment. Nat Microbiol. 2017;2:17075. [PMID: 28540921 DOI: 10.1038/nmicrobiol.2017.75] [Cited by in Crossref: 58] [Cited by in F6Publishing: 67] [Article Influence: 11.6] [Reference Citation Analysis]
614 Vujkovic-Cvijin I, Rutishauser RL, Pao M, Hunt PW, Lynch SV, McCune JM, Somsouk M. Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals. Gut Microbes 2017;8:440-50. [PMID: 28541799 DOI: 10.1080/19490976.2017.1334034] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 8.4] [Reference Citation Analysis]
615 Zitvogel L, Daillère R, Roberti MP, Routy B, Kroemer G. Anticancer effects of the microbiome and its products. Nat Rev Microbiol 2017;15:465-78. [PMID: 28529325 DOI: 10.1038/nrmicro.2017.44] [Cited by in Crossref: 205] [Cited by in F6Publishing: 222] [Article Influence: 41.0] [Reference Citation Analysis]
616 Khanna S, Vazquez-Baeza Y, González A, Weiss S, Schmidt B, Muñiz-Pedrogo DA, Rainey JF 3rd, Kammer P, Nelson H, Sadowsky M, Khoruts A, Farrugia SL, Knight R, Pardi DS, Kashyap PC. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease. Microbiome 2017;5:55. [PMID: 28506317 DOI: 10.1186/s40168-017-0269-3] [Cited by in Crossref: 64] [Cited by in F6Publishing: 72] [Article Influence: 12.8] [Reference Citation Analysis]
617 Adachi S, Hoshi N, Inoue J, Yasutomi E, Otsuka T, Dhakhwa R, Wang Z, Koo Y, Takamatsu T, Matsumura Y, Yamairi H, Watanabe D, Ooi M, Tanahashi T, Nishiumi S, Yoshida M, Azuma T. Indigo Naturalis Ameliorates Oxazolone-Induced Dermatitis but Aggravates Colitis by Changing the Composition of Gut Microflora. Int Arch Allergy Immunol 2017;173:23-33. [PMID: 28482341 DOI: 10.1159/000471923] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
618 Lee STM, Kahn SA, Delmont TO, Shaiber A, Esen ÖC, Hubert NA, Morrison HG, Antonopoulos DA, Rubin DT, Eren AM. Tracking microbial colonization in fecal microbiota transplantation experiments via genome-resolved metagenomics. Microbiome 2017;5:50. [PMID: 28473000 DOI: 10.1186/s40168-017-0270-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 8.4] [Reference Citation Analysis]
619 Wang Y, Shou J, Li X, Zhao Z, Fu J, He C, Feng R, Ma C, Wen B, Guo F, Yang X, Han Y, Wang L, Tong Q, You X, Lin Y, Kong W, Si S, Jiang J. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism. Metabolism 2017;70:72-84. [DOI: 10.1016/j.metabol.2017.02.003] [Cited by in Crossref: 94] [Cited by in F6Publishing: 90] [Article Influence: 18.8] [Reference Citation Analysis]
620 Uygun A, Ozturk K, Demirci H, Oger C, Avci IY, Turker T, Gulsen M. Fecal microbiota transplantation is a rescue treatment modality for refractory ulcerative colitis. Medicine (Baltimore) 2017;96:e6479. [PMID: 28422836 DOI: 10.1097/MD.0000000000006479] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
621 Bak SH, Choi HH, Lee J, Kim MH, Lee YH, Kim JS, Cho YS. Fecal microbiota transplantation for refractory Crohn's disease. Intest Res. 2017;15:244-248. [PMID: 28522956 DOI: 10.5217/ir.2017.15.2.244] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
622 Slingerland AE, Schwabkey Z, Wiesnoski DH, Jenq RR. Clinical Evidence for the Microbiome in Inflammatory Diseases. Front Immunol 2017;8:400. [PMID: 28446909 DOI: 10.3389/fimmu.2017.00400] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
623 Fuentes S, Rossen NG, van der Spek MJ, Hartman JH, Huuskonen L, Korpela K, Salojärvi J, Aalvink S, de Vos WM, D'Haens GR, Zoetendal EG, Ponsioen CY. Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation. ISME J 2017;11:1877-89. [PMID: 28398347 DOI: 10.1038/ismej.2017.44] [Cited by in Crossref: 86] [Cited by in F6Publishing: 106] [Article Influence: 17.2] [Reference Citation Analysis]
624 Chiriac MT, Mahapatro M, Neurath MF, Becker C. The Microbiome in Visceral Medicine: Inflammatory Bowel Disease, Obesity and Beyond. Visc Med 2017;33:153-62. [PMID: 28560232 DOI: 10.1159/000470892] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
625 Navarro F, Muniesa M. Phages in the Human Body. Front Microbiol 2017;8:566. [PMID: 28421059 DOI: 10.3389/fmicb.2017.00566] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
626 Cammarota G, Ianiro G, Tilg H, Rajilić-Stojanović M, Kump P, Satokari R, Sokol H, Arkkila P, Pintus C, Hart A, Segal J, Aloi M, Masucci L, Molinaro A, Scaldaferri F, Gasbarrini G, Lopez-Sanroman A, Link A, de Groot P, de Vos WM, Högenauer C, Malfertheiner P, Mattila E, Milosavljević T, Nieuwdorp M, Sanguinetti M, Simren M, Gasbarrini A; European FMT Working Group. European consensus conference on faecal microbiota transplantation in clinical practice. Gut 2017;66:569-80. [PMID: 28087657 DOI: 10.1136/gutjnl-2016-313017] [Cited by in Crossref: 518] [Cited by in F6Publishing: 459] [Article Influence: 103.6] [Reference Citation Analysis]
627 Buttó LF, Haller D. Functional relevance of microbiome signatures: The correlation era requires tools for consolidation. Journal of Allergy and Clinical Immunology 2017;139:1092-8. [DOI: 10.1016/j.jaci.2017.02.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
628 Rapozo DCM, Bernardazzi C, de Souza HSP. Diet and microbiota in inflammatory bowel disease: The gut in disharmony. World J Gastroenterol 2017; 23(12): 2124-2140 [PMID: 28405140 DOI: 10.3748/wjg.v23.i12.2124] [Cited by in CrossRef: 83] [Cited by in F6Publishing: 70] [Article Influence: 16.6] [Reference Citation Analysis]
629 Cohen NA, Maharshak N. Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature. Dig Dis Sci. 2017;62:1131-1145. [PMID: 28315032 DOI: 10.1007/s10620-017-4535-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 8.6] [Reference Citation Analysis]
630 Thomas S, Izard J, Walsh E, Batich K, Chongsathidkiet P, Clarke G, Sela DA, Muller AJ, Mullin JM, Albert K, Gilligan JP, DiGuilio K, Dilbarova R, Alexander W, Prendergast GC. The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists. Cancer Res 2017;77:1783-812. [PMID: 28292977 DOI: 10.1158/0008-5472.CAN-16-2929] [Cited by in Crossref: 133] [Cited by in F6Publishing: 84] [Article Influence: 26.6] [Reference Citation Analysis]
631 Zachariassen LF, Krych L, Engkilde K, Nielsen DS, Kot W, Hansen CH, Hansen AK. Sensitivity to oxazolone induced dermatitis is transferable with gut microbiota in mice. Sci Rep 2017;7:44385. [PMID: 28290517 DOI: 10.1038/srep44385] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
632 Barnes D, Park KT. Donor Considerations in Fecal Microbiota Transplantation. Curr Gastroenterol Rep 2017;19. [DOI: 10.1007/s11894-017-0548-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
633 Cummins EP, Crean D. Hypoxia and inflammatory bowel disease. Microbes and Infection 2017;19:210-21. [DOI: 10.1016/j.micinf.2016.09.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
634 Hov JR, Kummen M. Intestinal microbiota in primary sclerosing cholangitis. Current Opinion in Gastroenterology 2017;33:85-92. [DOI: 10.1097/mog.0000000000000334] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
635 Kim DH, Cheon JH. Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies. Immune Netw 2017;17:25-40. [PMID: 28261018 DOI: 10.4110/in.2017.17.1.25] [Cited by in Crossref: 129] [Cited by in F6Publishing: 123] [Article Influence: 25.8] [Reference Citation Analysis]
636 Drew L. Microbiota: Reseeding the gut. Nature. 2016;540:S109-S112. [PMID: 28002392 DOI: 10.1038/540s109a] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
637 Günaltay S, Rademacher L, Hultgren Hörnquist E, Bohr J. Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis. World J Gastroenterol 2017; 23(7): 1319-1324 [PMID: 28275312 DOI: 10.3748/wjg.v23.i7.1319] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
638 Paramsothy S, Kamm MA, Kaakoush NO, Walsh AJ, van den Bogaerde J, Samuel D, Leong RWL, Connor S, Ng W, Paramsothy R, Xuan W, Lin E, Mitchell HM, Borody TJ. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017;389:1218-1228. [PMID: 28214091 DOI: 10.1016/s0140-6736(17)30182-4] [Cited by in Crossref: 509] [Cited by in F6Publishing: 265] [Article Influence: 101.8] [Reference Citation Analysis]
639 Siegmund B. Is intensity the solution for FMT in ulcerative colitis? Lancet 2017;389:1170-2. [PMID: 28214090 DOI: 10.1016/S0140-6736(17)30313-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
640 Weingarden AR, Vaughn BP. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes. 2017;8:238-252. [PMID: 28609251 DOI: 10.1080/19490976.2017.1290757] [Cited by in Crossref: 135] [Cited by in F6Publishing: 130] [Article Influence: 27.0] [Reference Citation Analysis]
641 Bouter KE, van Raalte DH, Groen AK, Nieuwdorp M. Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction.Gastroenterology. 2017;152:1671-1678. [PMID: 28192102 DOI: 10.1053/j.gastro.2016.12.048] [Cited by in Crossref: 175] [Cited by in F6Publishing: 210] [Article Influence: 35.0] [Reference Citation Analysis]
642 Olesen SW, Gurry T, Alm EJ. Designing fecal microbiota transplant trials that account for differences in donor stool efficacy. Stat Methods Med Res 2018;27:2906-17. [DOI: 10.1177/0962280216688502] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
643 Sun D, Li W, Li S, Cen Y, Xu Q, Li Y, Sun Y, Qi Y, Lin Y, Yang T. Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis: A Systematic Review and Meta-Analysis. Medicine (Baltimore). 2016;95:e3765. [PMID: 27281075 DOI: 10.1097/md.0000000000003765] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 4.2] [Reference Citation Analysis]
644 Hu Y, Wong FS, Wen L. Antibiotics, gut microbiota, environment in early life and type 1 diabetes. Pharmacol Res 2017;119:219-26. [PMID: 28188825 DOI: 10.1016/j.phrs.2017.01.034] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
645 Neurath MF. Current and emerging therapeutic targets for IBD. Nat Rev Gastroenterol Hepatol. 2017;14:269-278. [PMID: 28144028 DOI: 10.1038/nrgastro.2016.208] [Cited by in Crossref: 287] [Cited by in F6Publishing: 267] [Article Influence: 57.4] [Reference Citation Analysis]
646 Mizuno S, Nanki K, Matsuoka K, Saigusa K, Ono K, Arai M, Sugimoto S, Kiyohara H, Nakashima M, Takeshita K, Naganuma M, Suda W, Hattori M, Kanai T. Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients. Intest Res 2017;15:68-74. [PMID: 28239315 DOI: 10.5217/ir.2017.15.1.68] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
647 Lee HJ, Choi JK, Ryu HS, Choi CH, Kang EH, Park KS, Min YW, Hong KS. Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders. J Neurogastroenterol Motil 2017;23:9-19. [PMID: 28049862 DOI: 10.5056/jnm16124] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
648 Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, Kucharzik T, Molnár T, Raine T, Sebastian S, de Sousa HT, Dignass A, Carbonnel F; for the European Crohn’s and Colitis Organisation [ECCO]. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. Journal of Crohn's and Colitis 2017;11:769-84. [DOI: 10.1093/ecco-jcc/jjx009] [Cited by in Crossref: 492] [Cited by in F6Publishing: 414] [Article Influence: 98.4] [Reference Citation Analysis]
649 Woodworth MH, Carpentieri C, Sitchenko KL, Kraft CS. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review. Gut Microbes. 2017;8:225-237. [PMID: 28129018 DOI: 10.1080/19490976.2017.1286006] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 11.6] [Reference Citation Analysis]
650 Chu ND, Smith MB, Perrotta AR, Kassam Z, Alm EJ. Profiling Living Bacteria Informs Preparation of Fecal Microbiota Transplantations. PLoS One 2017;12:e0170922. [PMID: 28125667 DOI: 10.1371/journal.pone.0170922] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 9.8] [Reference Citation Analysis]
651 Kang DW, Adams JB, Gregory AC, Borody T, Chittick L, Fasano A, Khoruts A, Geis E, Maldonado J, McDonough-Means S, Pollard EL, Roux S, Sadowsky MJ, Lipson KS, Sullivan MB, Caporaso JG, Krajmalnik-Brown R. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome. 2017;5:10. [PMID: 28122648 DOI: 10.1186/s40168-016-0225-7] [Cited by in Crossref: 466] [Cited by in F6Publishing: 529] [Article Influence: 93.2] [Reference Citation Analysis]
652 Fischer M, Bittar M, Papa E, Kassam Z, Smith M. Can you cause inflammatory bowel disease with fecal transplantation? A 31-patient case-series of fecal transplantation using stool from a donor who later developed Crohn's disease. Gut Microbes 2017;8:205-7. [PMID: 28103145 DOI: 10.1080/19490976.2017.1283469] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
653 Baro E, Galperine T, Denies F, Lannoy D, Lenne X, Odou P, Guery B, Dervaux B. Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France. PLoS One 2017;12:e0170258. [PMID: 28103289 DOI: 10.1371/journal.pone.0170258] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
654 Chen ML, Sundrud MS. Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2016;22:1157-1167. [PMID: 26863267 DOI: 10.1097/mib.0000000000000714] [Cited by in Crossref: 74] [Cited by in F6Publishing: 48] [Article Influence: 14.8] [Reference Citation Analysis]
655 Chen ML, Sundrud MS. Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2016;22:1157-1167. [PMID: 26863267 DOI: 10.1097/mib.000000 0000000714] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
656 Rosenstiel P. Molekulare Darmmikrobiomdiagnostik: Einblick in unser anderes Genom. Gastroenterologe 2017;12:49-59. [DOI: 10.1007/s11377-016-0129-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
657 Kazerouni A, Wein LM. Exploring the Efficacy of Pooled Stools in Fecal Microbiota Transplantation for Microbiota-Associated Chronic Diseases. PLoS One. 2017;12:e0163956. [PMID: 28068341 DOI: 10.1371/journal.pone.0163956] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
658 Jin B. Fecal microbiota transplantation in ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2017; 25(1): 23-30 [DOI: 10.11569/wcjd.v25.i1.23] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
659 Scaldaferri F, Pecere S, Petito V, Zambrano D, Fiore L, Lopetuso LR, Schiavoni E, Bruno G, Gerardi V, Laterza L, Pizzoferrato M, Ianiro G, Stojanovic J, Poscia A, Papa A, Paroni Sterbini F, Sanguinetti M, Masucci L, Cammarota G, Gasbarrini A. Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis. Transplant Proc. 2016;48:402-407. [PMID: 27109966 DOI: 10.1016/j.transproceed.2015.12.040] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
660 Sheehan D, Shanahan F. The Gut Microbiota in Inflammatory Bowel Disease. Gastroenterol Clin North Am 2017;46:143-54. [PMID: 28164847 DOI: 10.1016/j.gtc.2016.09.011] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 8.8] [Reference Citation Analysis]
661 Chang BW, Rezaie A. Irritable Bowel Syndrome-Like Symptoms Following Fecal Microbiota Transplantation: A Possible Donor-Dependent Complication. American Journal of Gastroenterology 2017;112:186-7. [DOI: 10.1038/ajg.2016.472] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
662 Ishikawa D, Sasaki T, Osada T, Kuwahara-arai K, Haga K, Shibuya T, Hiramatsu K, Watanabe S. Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis: . Inflammatory Bowel Diseases 2017;23:116-25. [DOI: 10.1097/mib.0000000000000975] [Cited by in Crossref: 74] [Cited by in F6Publishing: 42] [Article Influence: 14.8] [Reference Citation Analysis]
663 Oancea I, Movva R, Das I, Aguirre de Cárcer D, Schreiber V, Yang Y, Purdon A, Harrington B, Proctor M, Wang R, Sheng Y, Lobb M, Lourie R, Ó Cuív P, Duley JA, Begun J, Florin TH. Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism. Gut 2017;66:59-69. [PMID: 27411368 DOI: 10.1136/gutjnl-2015-310874] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 8.8] [Reference Citation Analysis]
664 Knoll RL, Forslund K, Kultima JR, Meyer CU, Kullmer U, Sunagawa S, Bork P, Gehring S. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis. Am J Physiol Gastrointest Liver Physiol 2017;312:G327-39. [PMID: 28039159 DOI: 10.1152/ajpgi.00293.2016] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 8.3] [Reference Citation Analysis]
665 Keshteli AH, Millan B, Madsen KL. Pretreatment with antibiotics may enhance the efficacy of fecal microbiota transplantation in ulcerative colitis: a meta-analysis. Mucosal Immunol 2017;10:565-6. [PMID: 28000680 DOI: 10.1038/mi.2016.123] [Cited by in Crossref: 23] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
666 Wang AY, Popov J, Pai N. Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease. World J Gastroenterol 2016; 22(47): 10304-10315 [PMID: 28058011 DOI: 10.3748/wjg.v22.i47.10304] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
667 Gong D, Gong X, Wang L, Yu X, Dong Q. Involvement of Reduced Microbial Diversity in Inflammatory Bowel Disease. Gastroenterol Res Pract. 2016;2016:6951091. [PMID: 28074093 DOI: 10.1155/2016/6951091] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 7.7] [Reference Citation Analysis]
668 Bravo-Blas A, Wessel H, Milling S. Microbiota and arthritis: correlations or cause? Curr Opin Rheumatol 2016;28:161-7. [PMID: 26814405 DOI: 10.1097/BOR.0000000000000261] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
669 Armstrong CW, Mcgregor NR, Lewis DP, Butt HL, Gooley PR. The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome. Metabolomics 2017;13. [DOI: 10.1007/s11306-016-1145-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 5] [Article Influence: 4.2] [Reference Citation Analysis]
670 Chin SM, Sauk J, Mahabamunuge J, Kaplan JL, Hohmann EL, Khalili H. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Single-Center Experience. Clin Gastroenterol Hepatol. 2017;15:597-599. [PMID: 27923723 DOI: 10.1016/j.cgh.2016.11.028] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
671 Narula N, Rubin DT, Sands BE. Novel Therapies in Inflammatory Bowel Disease: An Evaluation of the Evidence. Am J Gastroenterol Suppl 2016;3:38-44. [DOI: 10.1038/ajgsup.2016.19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
672 Deterding K, Spinner C, Schott E, Welzel T, Gerken G, Klinker H, Spengler U, Wiegand J, Schulze zur Wiesch J, Pathil A, Cornberg M, Umgelter A, Zöllner C, Zeuzem S, Papkalla A, Weber K, Hardtke S, Leyen H, Koch A, Witzendorff D, Manns M, Wedemeyer H, Preda C, Popescu C, Baicus C, Manuc M, Voiosu R, Ceausu E, Fulger L, Nisanian A, Pop C, Oproiu A, Arezzo A, Passera R, Bullano A, Mintz Y, Kedar A, Boni L, Cassinotti E, Rosati R, Fumagalli U, Sorrentino M, Brizzolari M, Di Lorenzo N, Gaspari A, Andreone D, De Stefani E, Navarra G, Lazzara S, Degiuli M, Shishin K, Khatkov I, Kazakov I, Schrittwieser R, Carus T, Corradi A, Sitzman G, Lacy A, Uranues S, Szold A, Bonino M, Morino M, Strömberg J, Sandblom G, Coelen R, Gaspersz M, Labeur T, Vugt J, Dieren S, Willemssen F, Nio C, Ijzermans J, Klümpen H, Groot Koerkamp B, Gulik T, Sturgess R, Palmer D, Trojan J, Hoffmeister A, Neu B, Kasper S, Dechêne A, Jürgensen C, Schirra J, Jakobs R, Høgset A, Finnesand L, Abd Elrazek A, Saab S, Salem T, Abdel‐aty M, Hawary B, Ismail A, Zayied M, Alboraie M, Orenstein R, Dubberke E, Lee C, Khanna S, Hecht G, Wong S, Kwong T, Wang X, Tang R, Ng S, Sung J, Yu J, Ott S, Waetzig G, Rehmann A, Moltzau‐anderson J, Bharti R, Grasis J, Cassidy L, Tholey A, Fickenscher H, Seegert D, Rosenstiel P, Schreiber S, Mazzawi T, Lied G, El‐salhy M, Gilja O, Hatlebakk J, Hausken T, Witt S, Bednarska O, Icenhour A, Elsenbruch S, Ström M, Söderholm J, Engström M, Mayer E, Keita Å, Walter S, Kump P, Wurm P, Gröchenig H, Wenzl H, Petritsch W, Halwachs B, Wagner M, Stadlbauer‐köllner V, Eherer A, Hoffmann K, Deutschmann A, Reicht G, Reiter L, Slawitsch P, Gorkiewicz G, Hoegenauer C, Zhou Y, Kakuturu R, Jung D, Jørgensen K, Olsen I, Goll G, Lorentzen M, Bolstad N, Haavardsholm E, Lundin K, Mørk C, Jahnsen J, Kvien T, Feagan B, Sands B, Rossiter G, Li X, Usiskin K, Zhan X, Colombel J, Feagan B, Sandborn W, Panés J, Ferrante M, Louis E, D'haens G, Franchimont D, Kaser A, Dewit O, Seidler U, Kim K, Neurath M, Scholl P, Visvanathan S, Padula S, Herichova I, Sha N, Hall D, Böcher W, Bloemendaal F, Levin A, Wildenberg M, Koelink P, Verbeek S, Claassens J, D'haens G, Mcrae B, Vidarsson G, Brink G, Badke M, Rose‐john S, Spehlmann M, Peyrin‐biroulet L, Gatlin J, Soloman M, Unett D, Al‐shamma H, Behan D, Langhorst J, Boone J, Koch A, Rueffer A, Dobos G, Beiderwellen K, Lauenstein T, Ngu W, Bevan R, Tsiamoulos Z, Bassett P, Hoare Z, Rutter M, Totton N, Lee T, Ramadas A, Silcock J, Painter J, Neilson L, Saunders B, Rees C, Schmidt A, Goelder S, Messmann H, Goetz M, Kratt T, Meining A, Birk M, Delius J, Albert M, Escher J, Lau A, Hoffman R, Wiest K, Caca, Siddiqui A, Wilson D, Cangelosi M, Tsiamoulos Z, Rameshshanker R, Wall P, Cocks K, Doulton T, Yusuf A, Hancock C, Saunders B, Valori R, Rutter M, Aravani A, Rashbass J, Vernon S, Morris E, ‐Choi J, Seo D, Song T, Park D, Lee S, Lee S, Kim ‐, Somani P, Sharma M. LB01 SIX WEEKS OF SOFOSBUVIR/LEDIPASVIR TREATMENT OF ACUTE HEPATITIS C VIRUS GENOTYPE 1 MONOINFECTION: FINAL RESULTS OF THE THE GERMAN HEPNET ACUTE HCV IV STUDY. United European Gastroenterol j 2016;4:800-11. [DOI: 10.1177/2050640616678364] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
673 Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389:1756-1770. [PMID: 27914657 DOI: 10.1016/s0140-6736(16)32126-2] [Cited by in Crossref: 830] [Cited by in F6Publishing: 381] [Article Influence: 138.3] [Reference Citation Analysis]
674 König J, Siebenhaar A, Högenauer C, Arkkila P, Nieuwdorp M, Norén T, Ponsioen CY, Rosien U, Rossen NG, Satokari R, Stallmach A, de Vos W, Keller J, Brummer RJ. Consensus report: faecal microbiota transfer - clinical applications and procedures. Aliment Pharmacol Ther 2017;45:222-39. [PMID: 27891639 DOI: 10.1111/apt.13868] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 12.8] [Reference Citation Analysis]
675 Zhang T, Ding C, Zhao M, Dai X, Yang J, Li Y, Gu L, Wei Y, Gong J, Zhu W, Li N, Li J. Sodium Butyrate Reduces Colitogenic Immunoglobulin A-Coated Bacteria and Modifies the Composition of Microbiota in IL-10 Deficient Mice. Nutrients 2016;8:E728. [PMID: 27886121 DOI: 10.3390/nu8120728] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
676 Ding NS, Mullish BH, McLaughlin J, Hart A, Marchesi JR. Meeting update: faecal microbiota transplantation--bench, bedside, courtroom? Frontline Gastroenterol 2018;9:45-8. [PMID: 29484160 DOI: 10.1136/flgastro-2016-100752] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
677 Wei Y, Gong J, Zhu W, Tian H, Ding C, Gu L, Li N, Li J. Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora. BMC Microbiol 2016;16:255. [PMID: 27809778 DOI: 10.1186/s12866-016-0869-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
678 Gianotti RJ, Moss AC. The Use and Efficacy of Fecal Microbiota Transplantation for Refractory Clostridium difficile in Patients with Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2016;22:2704-10. [DOI: 10.1097/mib.0000000000000950] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
679 Selvanantham T, Lin Q, Guo CX, Surendra A, Fieve S, Escalante NK, Guttman DS, Streutker CJ, Robertson SJ, Philpott DJ, Mallevaey T. NKT Cell–Deficient Mice Harbor an Altered Microbiota That Fuels Intestinal Inflammation during Chemically Induced Colitis. J I 2016;197:4464-72. [DOI: 10.4049/jimmunol.1601410] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 8.5] [Reference Citation Analysis]
680 Buret AG. Good Bugs, Bad Bugs in the Gut: The Role of Microbiota Dysbiosis in Chronic Gastrointestinal Consequences of Infection. Am J Gastroenterol Suppl 2016;3:25-32. [DOI: 10.1038/ajgsup.2016.11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
681 Park L, Mone A, Price JC, Tzimas D, Hirsh J, Poles MA, Malter L, Chen LA. Perceptions of fecal microbiota transplantation for Clostridium difficile infection: factors that predict acceptance. Ann Gastroenterol 2017;30:83-8. [PMID: 28042242 DOI: 10.20524/aog.2016.0098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
682 Ince MN, Blazar BR, Edmond MB, Tricot G, Wannemuehler MJ. Understanding Luminal Microorganisms and Their Potential Effectiveness in Treating Intestinal Inflammation. Inflamm Bowel Dis 2016;22:194-201. [PMID: 26457381 DOI: 10.1097/MIB.0000000000000599] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
683 Sartor RB, Wu GD. Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches. Gastroenterology 2017; 152: 327-339. e4. [PMID: 27769810 DOI: 10.1053/j.gastro.2016.10.012] [Cited by in Crossref: 332] [Cited by in F6Publishing: 393] [Article Influence: 55.3] [Reference Citation Analysis]
684 Nishida A, Imaeda H, Ohno M, Inatomi O, Bamba S, Sugimoto M, Andoh A. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis. J Gastroenterol 2017;52:476-82. [DOI: 10.1007/s00535-016-1271-4] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 8.7] [Reference Citation Analysis]
685 Raghu Subramanian C, Triadafilopoulos G. Care of inflammatory bowel disease patients in remission. Gastroenterol Rep (Oxf) 2016;4:261-71. [PMID: 27899522 DOI: 10.1093/gastro/gow032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
686 Seth AK, Rawal P, Bagga R, Jain P. Successful colonoscopic fecal microbiota transplantation for active ulcerative colitis: First report from India. Indian J Gastroenterol 2016;35:393-5. [DOI: 10.1007/s12664-016-0696-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
687 Palmer BS, Metcalfe C, Fraser A, Creed T, Schumacher U. Does education influence the acceptability of faecal microbiota transplantation in colitis: A cross-sectional study. Cogent Medicine 2016;3:1233685. [DOI: 10.1080/2331205x.2016.1233685] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
688 Daillère R, Vétizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, Duong CPM, Flament C, Lepage P, Roberti MP, Routy B, Jacquelot N, Apetoh L, Becharef S, Rusakiewicz S, Langella P, Sokol H, Kroemer G, Enot D, Roux A, Eggermont A, Tartour E, Johannes L, Woerther PL, Chachaty E, Soria JC, Golden E, Formenti S, Plebanski M, Madondo M, Rosenstiel P, Raoult D, Cattoir V, Boneca IG, Chamaillard M, Zitvogel L. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. Immunity 2016;45:931-43. [PMID: 27717798 DOI: 10.1016/j.immuni.2016.09.009] [Cited by in Crossref: 298] [Cited by in F6Publishing: 282] [Article Influence: 49.7] [Reference Citation Analysis]
689 Mimee M, Citorik RJ, Lu TK. Microbiome therapeutics - Advances and challenges. Adv Drug Deliv Rev 2016;105:44-54. [PMID: 27158095 DOI: 10.1016/j.addr.2016.04.032] [Cited by in Crossref: 141] [Cited by in F6Publishing: 107] [Article Influence: 23.5] [Reference Citation Analysis]
690 Hirata Y, Ihara S, Koike K. Targeting the complex interactions between microbiota, host epithelial and immune cells in inflammatory bowel disease. Pharmacol Res 2016;113:574-84. [PMID: 27702681 DOI: 10.1016/j.phrs.2016.09.044] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
691 Carlucci C, Petrof EO, Allen-Vercoe E. Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity. EBioMedicine 2016;13:37-45. [PMID: 27720396 DOI: 10.1016/j.ebiom.2016.09.029] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 6.5] [Reference Citation Analysis]
692 Kerman DH. Endoscopic Delivery of Fecal Biotherapy in Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America 2016;26:707-17. [DOI: 10.1016/j.giec.2016.06.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
693 Wonderlick JS, D'Agostino R. Fecal microbiota transplantation via fluoroscopy-guided nasojejunal catheter placement: indications, technique, and the role of radiology. Abdom Radiol (NY) 2016;41:2020-5. [PMID: 27315076 DOI: 10.1007/s00261-016-0801-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
694 Kumagai H, Yokoyama K, Imagawa T, Inoue S, Tulyeu J, Tanaka M, Yamagata T. Failure of Fecal Microbiota Transplantation in a Three-Year-Old Child with Severe Refractory Ulcerative Colitis. Pediatr Gastroenterol Hepatol Nutr 2016;19:214-20. [PMID: 27738605 DOI: 10.5223/pghn.2016.19.3.214] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
695 Rosenbaum JT, Asquith MJ. The Microbiome: a Revolution in Treatment for Rheumatic Diseases? Curr Rheumatol Rep 2016;18. [DOI: 10.1007/s11926-016-0614-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
696 Hand TW, Vujkovic-Cvijin I, Ridaura VK, Belkaid Y. Linking the Microbiota, Chronic Disease, and the Immune System. Trends Endocrinol Metab 2016;27:831-43. [PMID: 27623245 DOI: 10.1016/j.tem.2016.08.003] [Cited by in Crossref: 105] [Cited by in F6Publishing: 95] [Article Influence: 17.5] [Reference Citation Analysis]
697 Hindryckx P, Jairath V, D'Haens G. Acute severe ulcerative colitis: from pathophysiology to clinical management. Nat Rev Gastroenterol Hepatol. 2016;13:654-664. [PMID: 27580687 DOI: 10.1038/nrgastro.2016.116] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 11.2] [Reference Citation Analysis]
698 Gallo A, Passaro G, Gasbarrini A, Landolfi R, Montalto M. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World J Gastroenterol 2016; 22(32): 7186-7202 [PMID: 27621567 DOI: 10.3748/wjg.v22.i32.7186] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 50] [Article Influence: 9.3] [Reference Citation Analysis]
699 Wang S, Xu M, Wang W, Cao X, Piao M, Khan S, Yan F, Cao H, Wang B. Systematic Review: Adverse Events of Fecal Microbiota Transplantation. PLoS One. 2016;11:e0161174. [PMID: 27529553 DOI: 10.1371/journal.pone.0161174] [Cited by in Crossref: 163] [Cited by in F6Publishing: 145] [Article Influence: 27.2] [Reference Citation Analysis]
700 Dolan KT, Chang EB. Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases. Mol Nutr Food Res 2017;61. [PMID: 27346644 DOI: 10.1002/mnfr.201600129] [Cited by in Crossref: 50] [Cited by in F6Publishing: 57] [Article Influence: 8.3] [Reference Citation Analysis]
701 Prosberg M, Bendtsen F, Vind I, Petersen AM, Gluud LL. The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis. Scand J Gastroenterol. 2016;51:1407-1415. [PMID: 27687331 DOI: 10.1080/00365521.2016.1216587] [Cited by in Crossref: 88] [Cited by in F6Publishing: 77] [Article Influence: 14.7] [Reference Citation Analysis]
702 Stallmach A, Lange K, Buening J, Sina C, Vital M, Pieper DH. Fecal Microbiota Transfer in Patients With Chronic Antibiotic-Refractory Pouchitis. Am J Gastroenterol 2016;111:441-3. [PMID: 27018122 DOI: 10.1038/ajg.2015.436] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 8.3] [Reference Citation Analysis]
703 Lankelma JM, Belzer C, Hoogendijk AJ, de Vos AF, de Vos WM, van der Poll T, Wiersinga WJ. Antibiotic-Induced Gut Microbiota Disruption Decreases TNF-α Release by Mononuclear Cells in Healthy Adults. Clin Transl Gastroenterol 2016;7:e186. [PMID: 27489950 DOI: 10.1038/ctg.2016.43] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15